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Abstract 
Diabetes mellitus (DM) is associated with the compromised digestion of carbohydrates. 
This complication is described as exocrine pancreatic insufficiency. Whilst this causes 
malnutrition in patients and contributes to diabetic morbidity, the physiology and molecular 
biology leading to this state is not well defined. This disease-induced inability to digest 
foodstuffs could have many levels of regulation. Obvious candidates are ligand proteins 
involved in stimulating secretion, receptor defects, intracellular ion levels and post-receptor 
signal transduction encompassing transcription and translation. To address these points, the 
current studies aimed to characterise the effects of experimental type I DM upon both 
physiological and molecular events. 
The first study investigated the effects of cholecystokinin-octapeptide (CCK-8) and 
exogenous insulin on exocrine pancreatic amylase secretion in streptozotocin (STZ)-
induced diabetic rats compared to healthy age-matched controls in vivo and in vitro. Seven 
- eight weeks after the induction of diabetes, animals were either anaesthetised for the 
study of in vivo exocrine secretion or humanely killed and pancreatic acinar cells isolated 
for the measurement of intracellular free calcium and magnesium concentrations ([Ca 2 ]1 
and [Mg2 ]1), total protein, and amylase output employing the Phadebas method. For rats in 
both in vivo and in vitro studies, fasting blood glucose in control and diabetic rats was 73.3 
± 3.4 mg dl' (n = 44) and 380.0 ± 25.9 mg di' (n = 27), respectively. Basal pancreatic 
juice flow rate in STZ-diabetic rats was significantly increased (P<0.001) whereas protein 
and amylase outputs were significantly decreased (Pc0.001) compared to control rats. 
CCK-8 infusion (150 pmol kg' h' for 100 mm) resulted in marked elevations in flow rate 
as well as in protein and amylase secretion in control animals (P<0.05 compared with the 
corresponding basals). In contrast, in diabetic rats, CCK-8 evoked a small increase in flow 
rate, which was not significant when compared to basal. In these animals, CCK-8 
stimulated the secretion of amylase and protein output, but the secretory rates were 
dramatically lower compared with those in control rats. Administration of insulin (1 U, 
I.P.) in healthy rats significantly increased pancreatic flow rate, amylase secretion, protein 
output and blood glucose levels in vivo compared to basal (P<0.05). Infusion of CCK-8 
together with insulin (1 U) in control rats markedly potentiated pancreatic juice flow and 
amylase secretion. Pretreatment with atropine (0.2 mg kg', I.P.) abolished the effects of 
insulin on secretory parameters despite a similar reduction in glycaemia. In diabetic rats, 
insulin (4 U, I.P.) did not modi& exocrine pancreatic secretion either alone or in 
combination with CCK-8. In vitro experiments revealed that either (ACh (10.8 - 10 M) or 
CCK-8 (10" - lO M)) can evoke total amylase release which was elevated in healthy 
control pancreatic acinar cells compared to diabetic acinar cells. In contrast, 10.6  M insulin 
produced a significant increase (Pc0.05) in the amount of total amylase output in control 
acinar cells compared to diabetic acinar cells. Combining insulin (10. 8  - 10.6 M) with 
either ACh or CCK-8 had little or no effect on total amylase release in both control and 
diabetic acinar cells. There were no significant differences among the groups in 
unstimulated [Ca2]j 
 and [Mg2 . However, the peak [Ca 2+  ]i induced by 10.8  M CCK-8 was 
depressed (Pc0.05) in diabetic cells (275.3 ± 11.5 nM n = 8) compared to (359.7 ± 27.5 
nM, n = 6) control cells. Similarly, CCK-8 significantly decreased (P<0.05) [Mg2 ']1 in 
diabetic acinar cells compared to control. 
On a molecular level, the gene encoding amylase was under transcriptional dysregulation. 
Healthy control animals had a significantly lower (P>0.05) crossing point value (8.54 ± 
11 
0.131. n = 8) compared to STZ-induced diabetic animals (17.96 ± 0.272, n = 7), 
respectively. On a protein level, those mediators controlling translation such as p70 S6K 
and 4E-BPI were present at significantly lower (P>0.05) relative concentrations, 
suggesting an impaired capacity for protein synthesis. Interestingly, the actual activity of 
these proteins as measured by phosphorylation was slightly increased. It is suggested that 
this is a cellular mechanism to counteract loss in transcription and/or translation of mRNA 
encoding these proteins. Protein ubiquitination was also elevated suggesting increased 
protein breakdown which could be responsible for pancreatic atrophy and net protein loss. 
The NFicB protein widely implicated in tissue atrophy was actually lower in STZ-induced 
DM, and therefore probably does not contribute to pancreatic wasting. 
To conclude, the results indicate that DM-induced exocrine pancreatic insufficiency is 
associated with decreased levels of total protein output and amylase secretion and these 
changes may be in part be associated with derangements in cellular Ca 2 and Mg2 
homeostasis. Furthermore, transcription of the a-amylase gene is reduced suggesting a 
reduced protein level and thus capacity for stimulus-secretion coupling. Finally, there 
appears impaired protein translation and elevated ATP-dependent protreasome mediated 
protein breakdown in STZ-induced DM. 
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CHAPTER 1 
INTRODUCTION 
1.1 The pancreas 
The pancreas is the second largest extraparietal gland associated with the alimentary tract. 
It lies retroperitoneally, close to the second and the third lumbar vertebrae, with a head 
adherent to the duodenum, a body extended transversally through the posterior wall of the 
abdomen, and a tail reaching the hilus of the spleen (Figure 1.1). The pancreas is formed 
by two distinct compartments, different in morphology and function: the exocrine and 
endocrine portion, both developing from the fusion of two pancreatic buds that originate 
from the endodermal epithelium just caudal to the presumptive stomach (Bock et al., 1997; 
Motta et at, 1997). 
Bile duct 
Duodeni 
Tail of pancreas 
Pancreatic duct 
ad of pancreas 
all intestine 
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Figure I.I. Diagram showing the location of the pancreas. The head of the pancreas is 
tucked into a curve of the duodenum that begins at the pylorus of the stomach. 
2 
1.2 Historical perspective of the exocrine pancreas 
The pancreas was known to the ancient Greek Anatomists of the third century B.C. and its 
name derives from the Greek word pan meaning 'all' and .creas meaning 'flesh', which 
pertains to its solid parenchymatous nature. In 1869 Paul Langerhans, a student in Berlin 
described the islets of the pancreas which were subsequently to be known as the "islets of 
Langerhans", an endocrine system within the pancreas. 
1.3 The structure and function of the pancreas 
The human pancreas lies deep in the stomach and extends across the duodenum for about 
20 cm, occupying the space formed by the concavity of the duodenum (Figure 1.1). It 
weighs approximately 100 g in adult males, 85 g in adult females, and is structurally and 
functionally segregated into two parts; the exocrine and endocrine pancreas. Thus, the 
pancreas is usually regarded as two separate organ systems. The interrelationship between 
the endocrine and exocrine pancreas has not properly been investigated since 
Gastroenterologists study the physiology of the exocrine pancreas and the Endocrinologists 
undertake research investigations into the function of the endocrine pancreas. The structure 
of the pancreas is similar to the salivary glands, being made up of lobules consisting of 
acinar cells, which secrete enzymes and fluid into microscopic ducts lined with epithelial 
cells. These drain into larger intralobular ducts which, in turn, empty into interlobular 
ducts and finally the main pancreatic duct, which extends from left to right through the 
pancreas itself. 
3 
1.4 The exocrine pancreas 
The exocrine pancreas, which comprises about 95 % of the gland due to its peculiar 
arrangement, has been traditionally compared to a bunch of grapes. In fact, the acinar cells 
are grouped together in structures called acini (from Latin acinus, i.e., berry of grape). 
These structures, round or elongate in shape, are tagged to the duct system. 
Figure 1.2. Schematic representation of the cellular morphology of one pancreatic acinus. 
[Taken from httD://www.trinity.edu/rbl  ystonfMicroA/LecturesfL28-html/sldOO8.htm] 
The presence of the acini, together with the rich excretory apparatus of the exocrine 
pancreas allows its classification as a compound acinus (or alveolar) gland (Motta ci al., 
1997). For these reasons, the acinus and acinar components are viewed in general as the 
morphofunctional secretory units of the exocrine pancreas (Figure 1.2). 
El 
1.4.1 The acinar unit 
The enzyme secreting units of the exocrine pancreas appear by light microscopy as 
pyramid-shaped cells. The basal portion of the acinar cells, when examined contains a 
round nucleus with a prominent nucleolus and filamentous mitochondria whereas the apical 
portion of the cells is filled predominantly with secretory zymogen granules (McCuskey & 
Chapman, 1969). 
1.4.2 BackRround and theories 
The predominant acinar arrangement of the exocrine pancreas was first described by 
Langerhans (1869) who demonstrated that the architecture of the excretory passages of the 
pancreas corresponded to a compound acinar gland. Different opinions have formed during 
the last decades as to whether the secretory passage of the exocrine pancreas is acinar or 
rectangular in nature. Bockman (1980) demonstrated by applying wax reconstruction of 
zymogen granule containing cells, that the exocrine pancreas of some mammals does not 
seem to have a true acinar organisation but a 'rectangular' arrangement. However, 
scanning electron microscopic (SEM) studies on the rat exocrine pancreas confirmed the 
traditional view that the exocrine pancreas is a compound acinar gland in which the acini 
may be both round and long, sometimes 'tubularlike' in shape, but do not anatomise with 
each other (Takahashi, 1984). 
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1.4.3 The apical cytoplasm and the zymogen granules 
The apical pole of the cell is concentrated with numerous, large, dense zymogen granules, 
0.3 - 1.5 pm in diameter (Zelander et al., 1962). Usually, zymogen granules remain 
individual structures although in actively secreting cells, series of interconnected granules 
may be found (Zelander et aL, 1962; Motta et at, 1977; Naguro & Lino, 1990). In actively 
secreting cells, zymogen granules may be found emptying their contents into the lumen by 
exocytosis. However, the mechanism(s) by which granules develop this fusion competency 
with the luminal membrane surface are largely unknown (Hand, 1990). According to the 
general view that the cells extensively recycle their membrane, it may be believable that 
secretory granule membranes after exocytosis, are rescued by the cell, recirculate to the 
Golgi saccules (Adler & Kern, 1990) and to the rough endoplasmic reticulum (RER) 
(Uchiyama & Watanabe, 1990), and are then reutilised for the formation and growth of new 
granules (Hand, 1990). 
1.4.4 The nucleus 
The nucleus tends to be slightly eccentric towards the basal part of the cell and is usually 
spherical (Zelander et al., 1962) although its shape seems to vary with the cells 
physiological activity, having a more irregular shape and a smaller volume in animals with 
restricted access to food than those with free access (Naguro & Lino, 1990). Binucleated 
cells (10 %) were also sometimes found (Uchiyama & Saito, 1982). 
r4 
1.4.5 The rough endoplasmic reticulum (RER) 
The basal half of the acinar cells is abundantly occupied (up to 20 % of the cell volume) by 
stacks of cisternae of RER and is densely studded by ribosomes. Free ribosomes are also 
present (Adler & Kern, 1990). Some researchers have also shown that the RER usually 
forms flattened cisternae lying parallel to each other in a lamellated fashion whereas, others 
have described the RER to be arranged in tubules and/or isolated vesicles (Naguro & Lino, 
1990). However, all these morphological patterns may vary depending upon the functional 
activity of the cell (Motta et at, 1997). Small vesicles bud from a regionally specialised, 
ribosome-free, transitional elements of RER. It is these vesicles that transfer digestive 
enzymes into the Golgi compartments (Caro & Palade, 1964; Jamieson & Palade, 1967; 
Sesso etal., 1983), where the former are concentrated into typical zymogen granules. 
1.4.6 The Golgi complex 
The Golgi complex is formed by several curved stacks of parallel cisternae, or saccules, 
associated with numerous small vesicles in the convex forming (or cis) face, and with 
vacuoles at the concave condensing (or trans) face (Adler & Kern, 1990). At the inner 
concave side of the complex (trans or maturing face), different stages in the formation of 
zymogen granules and lysosomes are observed. Small, irregular shaped, immature granules 
called condensing vacuoles are formed in continuity with the Golgi cisternae, at the level of 
the condensing face of the Golgi. These condensing vacuoles have moderately low density 
and mature to form new secretory granules. During maturation, they become filled with 
dense material, lose their connection with the Golgi complex, and, moving away from the 
7 
Golgi complex, acquire the appearance of mature secretory granules (Hand, 1990; 
(Rambourg et al., 1988). The pathways of Golgi traffic are not completely understood 
(Hand, 1990) since there are studies supporting the concept that all saccules of the Golgi 
complex actively participate to the transfer and condensation of molecules in the process of 
granule formation (Rambourg etal., 1988). On the contrary, other authors have suggested 
that secretory proteins were vectorially transferred from the forming to the condensing face 
of the Golgi by means of small carrier vesicles that bud and fuse at the edge of the saccules, 
without involving the saccules themselves (Farquhar, 1985). 
1.4.7 The mitochondria 
Morphological studies have illustrated the presence of two types of mitochondria (differing 
in shape) scattered in the acinar cell cytoplasm. Rod-shaped mitochondria are generally 
situated in the basal cytoplasm near the RER and, spherical-shaped mitochondria are often 
found in the apical cytoplasm at the Golgi periphery (Naguro & Lino, 1990). The fl-cell 
mitochondria serve as fuel sensors, generating factors that couple nutrient metabolism to 
the exocytosis of insulin-containing vesicles (Maechler& Wollheim, 2001). Ultrastructural 
examination of the 0-cell showed that the mitochondria are often in close proximity to the 
secretory insulin granules and a direct link may exist between mitochondrial activation and 
insulin exocytosis (Maechler & Wollheim, 1999). Findings such as these reflect the 
importance of mitochondria in the control of insulin secretion and DM. 
[:3 
1.5 The duct system 
While secretory cells and acini of the exocrine pancreas have received attention in the past, 
the morphology of the pancreatic duct system has not been well studied. The entire system 
of excretory ducts is of particular importance since pancreatitis and certain kinds of 
pancreatic carcinoma originate from the duct epithelium (Egerbacher & Bock, 1997). 
Secretions from acini flow out of the pancreas through a tree-like series of ducts (Ashizawa 
et aL, 1991). Duct cells secrete a watery, bicarbonate-rich fluid, which flush the enzymes 
through the ducts and play a pivotal role in neutralising acid within the small intestine. 
Pancreatic ducts are subdivided into four major parts, which are summarised here 
beginning with the terminal branches which extend into acini: 
. Intercalated ducts - these receive secretions from acini and have flattened cuboidal 
epithelium that extends up into the lumen of the acinus to form what are called 
centroacinar cells. 
. Intralobular ducts - have a classical cuboidal epithelium and are seen within 
lobules. They drain pancreatic juice received from intercalated ducts. 
• Interlobular ducts - found between lobules within the connective tissue together 
with the major branches of vessels and nerves. Interlobular ducts transmit 
secretions from intralobular ducts to the main pancreatic duct. 
The major pancreatic duct - receives secretions from interlobular ducts and 
penetrates through the wall of the duodenum. In some species including human, the 
pancreatic duct joins the bile duct prior to entering the intestine thus is sometimes 
referred to as the main pancreatic bile duct. 
El 
1.5.1 The centroacinar cells and the intercalated ducts 
The lumen of the acinus directly continues with the narrow lumen of a ductile (intercalated 
duct) bounded by centroacinar cells, so called because, in sections passing through the 
centre of the acini unit they often appear to penetrate the acinar unit occupying the acinar 
lumen. Centroacinar cells show morphological features different from those previously 
described for acinar cells (Motta el at, 1997). Yet they show striking ultrastructural 
similarities to the epithelia of intercalated ducts and intralobular ducts (Ashizawa el al., 
1991; Egerbacher & Bock, 1997) indicating one similar function of these cells; i.e. the 
production of low-enzyme, high bicarbonate pancreatic juice after stimulation with secretin 
(Case, 1978). Occurrence of carbonic anhydrase activity in all these cells further supports 
this interpretation (Boquist & Hagstrom, 1979; Churg & Richter, 1972). 
1.5.2 The intralobular ducts 
The terminal portion of the duct system conveys the acinar secretions into larger ducts 
called intralobular ducts. Intralobular ducts branch almost at a right angle from the 
interlobular ducts (Ashizawa et at, 1999). The cells lining these ducts are monolayed, flat 
or low columnar and are very similar in morphology to the centroacinar cells. Kinocilia are 
also present on the ductal cells. It has been hypothesized that these kinocilia could play a 
role in the mixing and propulsion of the pancreatic juice (Adler & Kern, 1990). 
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1.5.3 The interlobular ducts 
The wall of the interlobular duct is formed by cuboidal and pyramidal cells which project 
short microvilli from the luminal surface and contain abundant secretory granules in their 
cytoplasm (Kloppel et aL, 1986). The epithelial lining of smaller and larger interlobular 
ducts and that of the main pancreatic duct consists of principal cells (the majority of 
epithelial cells) and specialised cells (Madden & Sarras, Jr., 1989). Principal cells are 
simple colunmar cells with apical microvilli (Lederer et al., 1976) while specialised cells 
comprise of light cells, basal cells, goblet cells, endocrine cells, and brush cells (Madden & 
Sarras, Jr., 1989). The interlobular ducts reach the main pancreatic ducts of Wirsung (the 
largest) and Santorini (the smallest). The former begins in the tail and runs towards the 
duodenum gradually increasing in size. The latter, also called accessory pancreatic duct, is 
not always present and runs cranial to the duct of Wirsung (Motta ci at, 1997). 
1.5.4 Main pancreatic duct 
The main pancreatic duct is also known as the 'duct of Wirsung' after the German scientist 
who first discovered it in 1642. The epithelial cells in the main pancreatic duct of the 
human pancreas share many of the fine structural characteristics with cells of interlobular 
ducts. One unique feature of the main pancreatic duct cells is the high frequency of cell 
exfoliation and replacement (Kioppel et al., 1986). A high level of cell turnover in the 
main pancreatic duct was verified in the rat by tritiated thymidine incorporation, as judged 
by quantitative autoradiography (Elsasser et al., 1991). It is this portion of the duct system 
where reflux of duodenal contents containing bile and hydrolytic enzymes may occur at 
low levels and damage the epithelial barrier. The high turnover of cells may therefore be 
considered a response to injury. On the other hand, the high rate of cell division can be 
expected to render this portion of the duct system especially susceptible to factors that lead 
to cell transformation (Kloppel etal., 1986). 
1.6 The endocrine pancreas 
Approximately 2 - 5 % of the total pancreatic mass is comprised of endocrine cells. These 
endocrine cells are clustered in groups within the pancreas which look like little islands of 
cells when examined under a microscope. This appearance led to these groups of 
pancreatic endocrine cells being called "pancreatic islets" and is named after Langerhans' 
who first discovered them in 1869 (Bishop & Polak, 1997). The human pancreas contains 
about one million islets of Langerhans comprised of 4 types which make specific pancreatic 
hormones (see Figure 1.3). The islets consist of several cell types: 
• 13 cells, which secrete insulin 
• a cells, which secrete glucagon 
• S cells, which secrete somatostatin, and 
• y cells, which secrete pancreatic polypeptide (PP). 
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Figure 1.3. Close up view of the islets of Langerhans and their relationship with the 
exocrine pancreas. 
In adult man, each islet in this portion contains about 60 - 70 % 13-cells, 20 % a-cells, 10 % 
S-cells and 2 % PP cells (Rahier et aL, 1981; Berne etal., 1998). Like all endocrine glands, 
pancreatic islet cells secrete their hormones into the bloodstream and not into tubes or ducts 
like the exocrine pancreas. Because of this need to secrete their hormones into the 
bloodstream, pancreatic islets are surrounded by numerous small blood vessels. The islets 
of Langerhans have very rich vascularisation and receive about 10 % of the total pancreatic 
blood flow. These highly vascularised islets receive both sympathetic, adrenergic 
innervation (via the splanchnic nerve from the celiac plexus) and cholinergic input (via the 
vagus nerve). 
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1.7 History of insulin 
Banting and Best in 1921 were the first to isolate insulin from pancreatic -ceIls following 
their discovery by Langerhans in 1869. In 1955 the primary sequence of insulin and in 
1965 the crystal structure of the biologically active part of insulin which binds to the 
receptor were elucidated by Sanger and Hodgkin, respectively. In 1965, insulin was 
synthesized by chemical means. Today, human insulin is produced using bioengineered 
E.co/i (Escherichia coli) as a source. Steiner discovered pro-insulin in 1967, and elucidated 
the processing of pro-insulin with the formation and the release of the insulin C-peptide, in 
1972 (Steiner, 1967). Moreover, the receptor for insulin was the first membrane-bound 
receptor to be identified (Cuatrecasas et al., 1968). 
Insulin has an essential life-supporting function by maintaining glucose homeostasis. 
Glucose itself or a metabolite of glucose triggers the release of insulin from 13-cells 
(Maechler & Wollheim, 1999). If the response to insulin fails or is not released sufficiently 
or both processes do not function properly, blood glucose regulation fails and the 
hyperglycaemia that follows is the cause of a rather common, life-threatening disease, 
diabetes mellitus (DM). The synthesis and secretion of insulin is controlled by a number of 
metabolic, hormonal and neural factors. Such stimuli to insulin secretion include: 
• An elevated concentration of free amino-acids and plasma blood glucose 
• Increased glucagon concentration 
• A number of gastro-intestinal hormones (e.g. gastrin, secretin, cholecystokinin 
(CCK)) 
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• Low concentrations of noradrenaline (NA) (released from sympathetic neurones; 
acting via a-adrenergic receptors) 
Acetylcholine (ACh) (released from parasympathetic neurones) 
Conversely, insulin synthesis and secretion are suppressed by: 
• A decrease in the plasma glucose concentration 
• Pancreatic (and gastric) somatostatin 
High concentrations of NA (released from sympathetic neurones; acting via 13-
adrenergic receptors) 
• Adrenaline (also acting via 13-adrenergic receptors) 
Since adrenaline is also capable of activating 13-adrenergic receptors, increased release of 
adrenaline (e.g. as triggered by exercise, hypothermia and surgery) can suppress pancreatic 
insulin release. 
The secretion of insulin is mainly controlled by the concentration of glucose in the 
bloodstream. Insulin concentrations increase as the level of blood glucose increases, which 
usually follows eating a meal. Insulin plays a major part in the uptake of glucose by the 
cells of the body (Kumar & Clark, 2002). 
The majority (approximately 85 %) of insulin-mediated glucose is disposed into skeletal 
muscle and adipose tissue following the insertion of GLUT4 glucose transporters into the 
plasma membrane of insulin target cells (Wilson & Cushman, 1994). Following 
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phosphorylation by either hexokinase or glucokinase, the glucose-6-phosphate is either 
incorporated into glycogen (as in muscle and liver) or into triglycerides (as in adipose 
tissue). Insulin also controls the uptake of amino acids such as valine, leucine and 
isoleucine by the muscles, which in turn helps to increase the synthesis of muscle proteins 
(Stryer, 1995). It is particularly noteworthy that abnormalities in fat metabolism which is 
associated with acidosis and atherosclerosis are responsible for death in diabetic patients. 
1.7.1 Structure of insulin 
Insulin is a small protein, with a molecular weight of 6,000 Daltons. It is composed of two 
chains; a a-chain containing 21 amino acids and a 13-chain containing 30 amino acids, both 
held together by two disulfide (S-S) bridges formed between specific cysteine residues in 
each chain (Figure 1.4). 
Before insulin was synthesised, bovine and porcine insulin was used. Since the binding 
receptors for insulin bind bovine and porcine insulin with the same affinity it has for human 
insulin, the addition of these types of insulin is successful. This is mainly because there are 
only 3 amino acid differences between the three different types of insulin (Hopkins & 
Williams, 1997). The differences between bovine insulin and human insulin occur at 
positions 8 and 10 on the u-chain, and 30 on the 13-chain. However, the majority of insulin 
now in clinical use is recombinant insulin. The two cDNA (complementary 
deoxyribonucleic acid) sequences encoding the a- and 13-chains of insulin are translated in 
E.coli, isolated, purified and chemically combined with the disulphide bonds at the 
appropriate molecular positions. 
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pro-insulin undergo complete conversion. Mature secretory granules contain a small 
amount of unconverted pro-insulin as well as a much larger amount of insulin and C-
peptide. About 1 % of pro-insulin also escapes storage in granules; this "free" pro-insulin 
maintains a low rate of constitutive insulin secretion (Berne etal., 1998). When the j3-cell 
is appropriately stimulated, insulin is secreted from the cell by exocytosis into the 
pancreatic venules draining the islet. The pro-insulin C-peptide has been held to be merely 
a by-product in insulin biosynthesis. Recent reports by Johansson et al., (2002) showed 
that C-peptide is biologically active eliciting both molecular and physiological cellular 
responses including Ca 2 influx, activation of mitogen-activated protein (MAP)-kinases 
ERKI and 2, and stimulation of Nat, K-ATPase. 
1.7.3 Intracellular mechanism of glucose-induced insulin secretion 
Insulin induces its effect by binding to specific insulin receptors (IR) embedded in the 
plasma membrane of its target cells. The JR is a glycoprotein composed of two a-subunits 
and two n-subunits linked by disulfide bonds. The a-subunits are entirely extracellular, 
while the linked 13-subunits penetrate through the plasma membrane. The IR is a tyrosine 
kinase (TK) and hence, binding of insulin causes autophosphorylation, thus facilitating the 
entrance of glucose into the cell. The enzyme glucokinase functions as a glucose sensor 
phosphorylating glucose to glucose-6-phosphate. At the same time that glucose is being 
oxidised, intracellular adenosine triphosphate (ATP) concentration increases. As this 
happens, and ATP-sensitive K (KATP) channel closes, K efflux from the 13-cell is 
suppressed causing the cell to depolarise (Berne et al., 1998). Depolarisation opens a 
voltage-regulated Ca 2 channel, rapidly increasing intracellular Ca 2t The elevated Ca 2 
IC 
concentration activates exocytosis of secretory granules and insulin release. In addition, a 
secondary rise in cAMP levels in n-cells also follows exposure to glucose; a cAMP 
dependent protein kinase stimulates insulin release, possibly by phosphorylating the 
proteins involved in exocytosis (Berne etal., 1998). Gene defects in KAIp channels could 
be associated with impaired insulin release leading to DM (Dunne etal., 1997). 
1.8 Microcirculation of the pancreas 
It has been well established that there is both neurological and hormonal control of 
pancreatic function and a major pathway for hormonal control is through the circulatory 
system, the level of action of which is in the microcirculation. The microcirculation is at 
the locus of most of the important interactions between the blood stream and the 
surrounding tissue. To get some perspective on the relationship of the islets to the 
remainder of the pancreas one must realise that, according to Bonner-Weir (1993), 
endocrine tissue represents only 1 - 2 % of the volume of the adult pancreas but it receives 
some 10 % of the blood volume to that organ. The largest islets, ~: 140 im in diameter, 
account for 72 % of the islet volume and 64 % of the islet blood flow. The small islets 
seem to be largely devoted to supplying hormones to the acinar part of the pancreas, and 
are distributed throughout this tissue, while the larger islets are more deeply involved with 
supplying insulin and other hormones to the body as a whole (Wayland, 1997). Within the 
pancreas, the arterial branches form an interlobutary plexus in the connective tissue of the 
interlobular septa. From these plexus single intralobular arteries pass into each lobule 
where they form glumerular-like tafis supplying individual islets of Langerhans and then 
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continue to adjacent acini. Thus, a portal system is formed where the exocrine pancreas 
receives blood rich in islet cell hormones (HoIst, 1993). 
Since this study is concerned mainly with exocrine pancreatic insufficiency, more emphasis 
will be placed on the exocrine pancreas. 
1.9 Nervous innervation of the exocrine pancreas and its control in 
secretion 
Neural innervation of the pancreas is known to control secretion and is composed of an 
intrinsic component consisting of neuronal cell bodies and nerve processes of the enteric 
neurons (i.e., the enteric nervous system) and an extrinsic component (i.e., nerve fibres and 
cellular bodies localised outside the digestive tract (Salvioli et al., 2002). The extrinsic 
nerve fibres can be anatomically and functionally classified in afferents, conveying sensory 
information from the digestive system to the central nervous system, and efferent nerves, 
through which the central nervous system-mediated response (excitatory or inhibitory) 
occurs. The extrinsic fibres belong to the sympathetic and parasympathetic systems 
(Furness et al., 1995; Salvioli etal., 2002; Lenninger, 1974; Richens, 1945). The two main 
extrinsic components are anatomically identified in the vagus nerves (anterior and posterior 
branches) and the splanchnic nerve trunks. Preganglionic parasympathetic fibres reach the 
pancreas directly or pass the celiac ganglion uninterrupted to terminate in intrapancreatic 
ganglia. Postsynaptic sympathetic fibres are interrupted in the celiac plexus, and 
postganglionic fibres terminate in nonadrenergic intrapancreatic ganglia, ducts, and vessels 
(Yago et al., 1999). Nerve endings on or between acinar cells and around ducts are 
Roil 
believed to represent mainly terminations of cholinergic neurons (Lenninger, 1974). The 
concept of an important peptidergic component is well established (Hoist et al., 1993; 
Adeghate etal., 1997; Juma et al., 1997). 
1.9.1 Sympathetic innervation 
In addition to the cholinergic nervous system, sympathetic adrenergic innervation of the 
acinar cells has also been implicated in regulating and cdntrolling exocrine pancreatic 
function. It was initially thought that any effect of adrenérgic stimulation on pancreatic 
secretion was a consequence of alterations in pancreatic blood flow (Yago et al., 1999). 
Sympathetic innervation of pancreatic acinar cells has been shown extensively to elicit 
amylase release from acinar cells (Pearson et at, 1984b; Singh & Pearson, 1984). 
Furthermore, adrenergic fibres and noradrenergic cell bodies have been observed within the 
pancreas in rats (Hoist et at, 1993; Yago et al., 1999). Electrical field stimulation (EFS) of 
rat pancreatic segments stimulated amylase release, an effect that was inhibited 80 % by 
atropine (Varga et al., 1990), the j3-adrenergic blocker propranolol inhibited the remaining 
20 % (Pearson et at, 1984b). NA had both inhibitory (in low concentrations) and 
stimulator>' actions (in high concentrations), and it was concluded that adrenergic actions 
could be duel (Varga et al., 1990). Sympathetic adrenergic innervation was also found to 
influence fluid secretion, since isoprenaline illustrated to stimulate a bicarbonate rich fluid 
from the rat pancreas (Lingard & Young, 1983). Hoist et at, (1993) recently reviewed 
sympathetic nervous control of the exocrine pancreas and drew attention to the possibility 
that the role of the sympathetic innervation may be to modifS' the pattern of secretion (in 
response to other stimuli) rather than to be responsible for a particular pattern of secretion. 
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1.9.2 Storage and release of noradrenaline (NA) 
NA isa neurotransmitter released by nerves of the sympathetic division. Most of the NA in 
nerve terminals is contained in vesicles. The concentration in the vesicles is very high, and 
is maintained by a transport mechanism similar to the amine transporter responsible for NA 
uptake into the transvesicular proton gradient as its driving force (Liu & Edwards, 1997). 
The processes linking the arrival of a nerve impulse at a noradrenergic nerve terminal to the 
release of NA are basically the same as those at other chemically transmitting synapses 
(Rang et al., 1999). Depolarisation of the nerve terminal opens calcium channels in the 
nerve terminal membrane, and the resulting entry of calcium promotes the fusion and 
discharge of synaptic vesicles via exocytosis. 
1.9.3 Role of adrenergic receptors in secretion 
Adrenergic receptors can be pharmacologically classified into a or 3 subtypes, which can 
be further subdivided. Activation of a1 adrenergic receptors by NA leads to the production 
of 1P3 (inositol trisphosphate) and DAG as second messengers. Activation of a2 receptors 
classically leads to the inhibition of adenylate cyclase, and thus decreases cAMP formation. 
Interaction of the 0, P2, and 13  receptors leads to the activation of adenylate cyclase and 
cAMP accumulation (Pearson etal., 1984b; Singh & Pearson, 1984). Therefore, both these 
responses by NA evoke pancreatic secretion. 
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1.9.4 Parasympathetic innervation 
The preganglionic fibres of the parasympathetic limb originate from perikarya located in 
the dorsal motor nucleus of the vagus and possibly also in the nucleus ambiguus, which are 
both under the control of the hypothalamus. They are organised in well separated branches 
travelling within the vagus nerves (cranial nerve X), and through the hepatic, gastric, and 
possibly celiac branches of the vagus; they reach intrapancreatic ganglia that are dispersed 
in the exocrine tissue (Gilon & Henquin, 2001). Postganglionic vagal fibres release several 
neurotransmitters: ACh, vasoactive intestinal polypeptide (VIP), gastrin-releasing peptide 
(GRP), nitric oxide (NO), and pituitary adenylate cyclase-activating polypeptide (PACAP) 
(Gilon & Henquin, 2001). Activation of efferent vagal nerve impulses by electrical 
stimulation causes strong stimulation of pancreatic enzyme secretion (Hoist ci al., 1979). 
Similarly, stimulation of enzyme secretion occurs after vagal activation induced by insulin 
hypoglycaemia or administration of the glucose antagonist 2-deoxy-D-glucose (Yago etal., 
1999). Consistent with these findings are the observations that administration of ACh or 
muscarinic cholinergic agonists to intact animals or humans also stimulates pancreatic 
enzyme secretion (Hoist ci aL, 1979; Lenninger, 1974; Richins, 1945). It can be concluded 
that vagal stimulation effectively augments pancreatic exocrine secretion, and 
intrapancreatic ganglia and cholinergic postganglionic neurons have been demonstrated 
near acini and ducts (Coupland, 1958). The exocrine pancreas contains several enzymes 
which are involved in the synthesis and inactivation of ACh (Godfrey & Matschinsky, 
1975). 
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1.9.5 Storage and release of acetylcholine (ACh) 
ACh was the first neurotransmitter to be identified at the neuromuscular junction by Dale 
and his colleagues in 1936 (Bennett, 2000). It is released by nerves of the parasympathetic 
division via a highly regulated process. ACh is stored in membrane bound storage vesicles 
in the parasympathetic nerve terminals. Upon depolarisation of the axon membrane, the 
permeability of the membrane transiently increases to sodium and chloride ions (Vander et 
al., 1998). This change then governs the movement of these ions into the axon terminal 
increasing the likelihood of an action potential. For ACh to be released from the vesicles in 
which it is stored, it must first migrate to the surface membrane of the axon terminal, where 
they will empty their contents into the synaptic cleft (Foster, 1996). Synaptic vesicle 
exocytosis is tightly regulated by calcium entry during excitation of the presynaptic cell 
(Llinas et al., 1995). During an action potential, voltage gated calcium channels are 
activated causing the mobilisation of extracellular calcium into intracellular space. Once 
calcium cations enter the axon terminal, they influence the migration of the vesicles to the 
surface membrane, where they release ACh by the process of exocytosis. The empty 
vesicular membranes are recycled and refilled with newly synthesised neurotransmitter. 
Antonov et al., (1999) detected a gradient of secretory ACh activity along growing axons, 
with the highest level at the growth cone region. 
1.9.6 Role of muscarinic receptors in secretion 
The activation of muscarinic receptors can lead to P1 turnover, inhibition of adenylate 
cyclase, activation of guanylate cyclase, and activation of ion channels (Nathanson, 1987). 
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Muscarinic receptor subtypes M1, M3, and M5 are linked to P1 turnover, whereas M2 and M4 
are linked to adenylate cyclase inhibition. Most tissues have been shown to have more than 
one receptor subtype. Studies using specific M1 and M3 receptor antagonists (e.g. atropine, 
pirenzepine, and 4-DAMP) have supported evidence of both M1 and M3 receptors on 
pancreatic acinar cells in vivo and in vitro (Louie & Owyang, 1986; van Zwam etal., 1990; 
Kato etal., 1992; Singer et aL, 1991). This was confirmed by the demonstration of specific 
mRNA for both receptor subtypes in rat pancreatic acinar cells (Schmid et al., 1998). In 
addition, some experimental data have also shown that nonacinar M1 receptors also 
contribute to the control of pancreatic enzyme secretion (Niebergall-Roth & Singer, 2003). 
The effects of ACh can successfully be antagonised in a competitive manner by the non-
specific receptor antagonist atropine (He etal., 1996; Foster, 1996). 
1.9.7 Non-cholinergic non-adrenergic innervation 
In addition to cholinergic and adrenergic innervation systems, evidence suggests that 
peptidergic nerves also exhibit control on pancreatic exocrine secretion. From previous 
evidence, administration of atropine reduced but not abolished pancreatic enzyme secretion 
when EFS was applied indicating that a non-cholinergic neural component was involved 
(Pearson et aL, 1981). Together with similar studies of the effects of EFS, such as fluid and 
bicarbonate responses in cats and pigs, atropine resistance was illustrated (Yago et al., 
1999). From studies with adrenergic blockade, it was found also to be non-adrenergic 
(Hoist etal., 1979). The pancreas is innervated with nerve fibres that contain VIP and GRP 
(HoIst, 1993). However, VIP has found to be the most predominant as it is not only found 
in intrinsic nerves that are closely related to the pancreatic ducts and the pancreatic vessels, 
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but VIP is a full agonist for pancreatic secretion of fluid and bicarbonate in cats, guinea 
pigs, humans and pigs (Pearson et at, 1981; HoIst, 1993). VIP is released from pancreatic 
nerves upon stimulation of the vagus nerves (I-JoIst et at, 1984) and also by cholinergic 
agonists acting on nicotinic receptors, suggesting that intrinsic VlPergic neurons may be 
activated by cholinergic preganglionic parasympathetic fibres. 
1.10 Hormonal control of exocrine pancreatic secretion 
The secretion of pancreatic juice is controlled mainly by the autonomic nervous system 
(Pearson et al., 1984a; HoIst et at, 1979; Lenninger, 1974; Richens, 1945) and by the two 
naturally occurring gut hormones, secretin and cholecystokinin-octapeptide (CCK-8) 
(Singh et at, 1992; Chey, 1993). Other hormones, esters and peptides that can regulate 
pancreatic exocrine secretion include the islet hormones, VIP, GRP, phorbol esters, NO, 
histamine and the growth hormones (Singh et at, 1999). The gut hormones secretin and 
CCK-8 are released from specialised cells in the intestinal mucosa into the blood 
circulation following the arrival of acidic chyme and partially digested food from the 
stomach. The hormones are then transported to the pancreas where they regulate the 
secretion of pancreatic juice (Singh et at, 1992; Patel et at, 2004c; Yago et al., 1999). 
1.10.1 Secretin 
It has been well established that secretin can stimulate the major portion (as much as 80 % 
of fluid and bicarbonate release from the exocrine pancreas. Endogenous acid (chyme from 
the stomach) has been shown to be the major stimulant of secretin release from the mucosal 
cells of the duodenum after a meal (Chey, 1993; Yago et al., 1999). Secretin enters the 
blood and is taken to the pancreas where it stimulates mainly the ductal cells and to a lesser 
extent acinar cells resulting in the metabolism of adenosine 3',5'-cyclic monophosphate 
(cAMP) which in turn mediates the secretion of bicarbonate and enzymes (Jensen & 
Gardner, 1981; Singh el at, 1992). 
1.10.2 CCK-8 
Previously, CCK was also known as "pancreozymin", referring to its stimulation of the 
pancreas to release digestive enzymes (Vander et al., 2002). 
Besides cholinergic nerves, the gut hormone CCK is considered as the most important 
mediator of pancreatic exocrine secretion. CCK-8 is released by electrical vagal 
stimulation, an excessive amount of HCI in the duodenum, and bombesin or GRP (Chey, 
1993). Many studies have shown that CCK-8 mainly stimulates pancreatic acinar cells by 
stimulating cellular calcium metabolism and protein kinase C to release a juice which is 
rich in digestive enzymes (Yago et al., 1999; Singh et al., 1999; 2004). The stimulatory 
effect of physiological doses of exogenous CCK was almost completely inhibited by 
atropine (Soudah et al., 1992), suggesting that exogenous CCK at physiological 
concentrations stimulates pancreatic secretion by interaction with the cholinergic system. 
The development and use of specific CCK-8 receptor antagonist MK329 (Cantor et al., 
1991) have enabled researchers to investigate the physiological role of CCK-8 better. 
MK329 inhibited 74 - 89 % trypsin and amylase secretion respectively stimulated by 
physiological doses of CCK-8 (Yago et at, 1999). A similar observation illustrated 
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reduced trypsin and chymotrypsin output (by 70 %) and amylase output (by 55 %) as a 
result of CCK-8 receptor blockade (Schwarzendrube el al., 1991). Studies like these have 
therefore demonstrated that CCK-8 is a major stimulant of the intestinal phase of pancreatic 
enzyme secretion. 
1.11 Stimulus-secretion coupling 
Pancreatic acinar cells synthesise and secrete a variety of digestive enzymes that constitute 
the pancreatic juice necessary for the digestion of food. Secretion is activated 
physiologically by the gut hormones CCK-8 and secretin, by the autonomic 
neurotransmitters ACh and NA, and the neuropeptide VIP (Williams & Yule, 1993; Patel et 
al., 2004c; Singh et al., 2004). All these agents interact with specific receptors on the 
basolateral plasma membrane of the acinar cell to bring about their effects. 
Stimulus-secretion coupling refers to the stages following receptor occupation that leads to 
the secretion of enzymes, fluid and bicarbonate by the gland. Receptor activation leads to 
the stimulation of one of two pathways. In the exocrine pancreas, there are several 
mechanisms by which secretagogues can elicit pancreatic secretion (Schulz & Stolze, 1980; 
Jensen & Gardner, 1981; Singh et at, 1992; Patel et al., 2004c). When secretagogues such 
as ACh and CCK specifically interact with their receptors on the surface of the acinar cells, 
the a-subunit of G-protein (Ga) is activated. The G-protein then activates a membrane-
bound enzyme called phospholipase C (or PDE = phosphodiestarase) which in turn breaks 
down membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol 
(DAG), 1P3 and 1,3,4,5—tetrakis-phosphate (1P 4) (Nishizuka, 1988; Berridge, 1993). These 
are compounds which act as second messengers. The elevation of 1P3 is postulated to 
mobilise calcium from the intracellular stores in the ER (Thom ci al., 1993; Kasai ci al., 
1993). Intracellular calcium stores such as the ER play a dominant role in calcium 
signalling in pancreatic acinar cells. The calcium-mobilising action of the intracellular 
messenger 1P3 was first demonstrated using a permeabilised pancreatic acinar cell 
preparation (Streb ci al., 1983). This initial work also identified the ER as the intracellular 
calcium store responsible for agonist-induced increases in [Ca 2 ] (Streb el al., 1983). The 
ER has been shown to act as the main functional calcium store in all subcellular regions of 
the pancreatic acinar cell including the apical pole where the zymogen granules are 
clustered (van de Put & Elliott, 1997; Yule et at, 1997). It is also believed that the 
secretagogue-induced release of calcium in one part of the ER leads to a second calcium-
induced calcium release (CICR) at other sites in the ER (Yago ci al., 1999). This, in turn 
releases calcium, which subsequently acts on a separate caffeine-sensitive calcium channel 
in another entirely distinct compartment of the ER (Berridge & Irvine, 1989). Zymogen 
granules have also been proposed to act as a calcium store in pancreatic acinar cells 
(Gerasimenko ci al., 1996). However, IP3 was found not to trigger calcium release from 
highly purified zymogen granules (Yule et al., 1997). Intracellular calcium together with 
raised 1P4 levels are also thought to trigger the uptake of calcium from the extracellular 
space through their respective calcium channels (Berridge & Irvine, 1989). Therefore, the 
overall increase in calcium originates from two major sources: a) the release of calcium 
from intracellular stores sensitive to 1P3 and, b) the influx from the extracellular medium. 
Elevation of cytosolic calcium concentration from a resting level of 0.1 xM to the levels 
required to trigger exocytosis can occur via a variety of entry mechanisms such as; second 
messenger-operated (SMOC), voltage-operated (VOC) receptor-operated (ROC), and 
calcium release activated (CRAC) calcium channels (Burgoyne & Morgan, 2003). The 
elevated cytosolic calcium together with DAG from the hydrolysis of PIP2 are then 
associated with the activation of their respective protein kinases: calmodulin, and the 
calcium-phospholipid-dependent protein kinase C. On the other hand, either VIP, secretin 
or NA can activate their specific receptors leading to an elevation of intracellular cAMP. 
This mechanism mediates the secretion of bicarbonate from ductal cells, and enzyme from 
acinar cells (Jensen & Gardner, 1981). Stimulation of VIP and secretin receptors leads to 
the activation of a G-(stimulator) protein in the basal membrane of the acinar cell. The Gs 
protein in turn activates a membrane bound enzyme called adenylate cyclase, which is 
responsible for converting adenosine triphosphate (ATP) into cAMP - an intracellular 
messenger. All known effects for cAMP are mediated by cAMP-activated protein kinases 
(e.g. protein kinase A), and are initiated by the binding of cAMP to the regulatory subunit 
of the kinase (Jensen & Gardner, 1981). Protein kinase A, as well as calmodulin and 
protein kinase C from the other pathway goes on to phosphorylate zymogen granules, 
which in turn swell and migrate to the luminal membrane of the cell. Here the zymogen 
granules secrete their contents by exocytosis (Figure 1.5) (Streb ci at, 1983). Despite 
similarities in the process of exocytosis in most cell types, differences are evident that 
reflect the physiological function of a particular cell (Burgoyne & Morgan, 2003). 
Pancreatic 13-cells can initiate exocytosis on a millisecond time scale (Ammala ci aL, 1993; 
Proks ci al., 1996; Smith ci aL, 1999) but also continue to secrete for minutes, hours and 
even days (Burgoyne & Morgan, 2003). 
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Figure 1.5. Schematic model of stimulus-secretion coupling process in the exocrine 
pancreatic acinar cells. [Taken from Yago et i1., 1999] 
1.11.1 Exocytosis 
Digestive enzymes are stored in large secretory vesicles known as zymogen granu!es. 
Upon stimulation of the cell by secretagogues such as ACh and CCK acting on specific 
receptors, second messengers are activated which trigger the elevation of intracellular 
calcium (Figure 1.5). This signal, in turn, triggers the fusion of the zymogen granule with 
the apical plasma membrane, leading to the secretion of enzymes via exocytosis (Yago et 
al., 1999). 
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Significant progress has been made over the last few years in understanding the 
mechanisms involved by which stimulation of the acinar cell leads to exocytotic membrane 
fusion. Soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors 
(SNAREs) proteins are now widely assumed to mediate exocytotic membrane fusion by 
forming tight complexes between the two interacting membranes (Jahn & Sudhof, 1999). 
The actin cytoskeleton which lies directly underneath the plasma membrane, particularly at 
the apical pole (Muallem et al., 1995) is important for the maintenance of cell shape and 
cell movement. Recent experiments demonstrated that the actin cytoskeleton was involved 
not only in calcium signalling (Fogarty et al., 2000; Grindstaff et at, 1998) but in both 
exocytosis and endocytosis at the apical membrane of the acinar cell (Valentijn et al., 
1999). In addition to these findings, actin cytoskeleton was also found to be responsible for 
active (i.e. ATP-dependent) granule transport (Lang et al., 2000). 
1.11.2 Role of G-proteins 
OTP-binding regulatory proteins or 0-proteins are a specific class of membrane bound 
regulatory proteins that are activated when a receptor binds its specific ligand (Rang et al., 
1999). The receptor-linked 0-proteins have three subunits (ci, 0 and y), each with a 
different amino acid composition. Intracellular levels of cAMP are predominantly under 
the control of 0-protein-coupled receptors that mediate the activity of the different 
adenylate cyclase. There are many different kinds of 0-protein, but they either act to open 
an ion channel or to alter the rate of production of a second messenger e.g. cAMP or 1P3. 
The 0 protein is involved in the activation of adenylate cyclase; 0, which is involved in 
inhibition of AC; and transducin (0j, which is involved in the regulation of a cyclic GMP- 
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specific phosphodiesterase found in the eye. There is also evidence that G proteins may be 
involved in the regulation of calcium channels (Birnbaumer etal., 1990). 
1.11.3 The role of guanosine 3', 5'-cyclic monophosphate (cGMP) 
The formation of cGMP from GTP is catalysed by two different enzymes, a membrane-
bound glycoprotein and a soluble haem-containing guanylate cyclase (Waldman & Murad, 
1987). The degradation of cGMP is controlled by different types of phosphodiesterases, 
several of them modulated by phosphorylation, dephosphorylation or by 
calcium/calmodulin (Tremblay etal., 1988). Studies by Sternfeld etal., (2003) have shown 
that intracellular levels of cGMP are increased by ACh and CCK-8 in the pancreas. 
Moreover, cGMP has also been shown to interact and modulate agonist-induced secretion 
of amylase from rat pancreatic acini (Rogers et at, 1988). In the absence of calcium, 
cGMP levels decreased in parallel to the discharge of secretory proteins (Rochette-Egly et 
al., 1980). Thus, these studies demonstrate that cGMP formation requires extracellular 
calcium (Spearman & Pritchard, 1979) and that one way by which calcium might evoke 
secretory responses is by generating cGMP. Reviewing the literature into the role of 
cOMP, it is possible to state that the protein kinase C pathway may be regulated by cGMP. 
In agreement with these authors, it has been demonstrated in isolated permealised 
pancreatic acini in combination with elevated intracellular calcium that cGMP can indeed 
elicit secretion, but not inhibit that secretion elicited by increasing intracellular calcium 
levels (Francis & Singh, 1990). Nevertheless, protein kinase C is a major mediator of 
CCK-8-evoked secretion. Even though in the stimulus-secretion coupling process, cGMP 
is thought of as an intracellular messenger without a function, it may be possible that 
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cGMP may have an important role in light of protein kinase C. This suggested role of 
cOMP in secretion remains one of great contention and has as yet to be confirmed by other 
investigators (Francis & Singh, 1990). 
1.11.4 The role of cyclic adenosine monophosphate (cAMP) 
cAMP is generated when adenylyl cyclase (often called adenylate cyclase (AC)) is 
activated by binding the a-subunit of a G-protein called G. The cAMP formed as a result 
of receptor activation then binds to other proteins (enzymes and ion channels) within the 
cell and thereby alters their activity (Rang et al., 1999). cAMP appears to play a central 
role in regulating pancreatic secretory activity. An increase in cAMP concentration and 
thereby activation of protein kinase A (PKA) have been found to regulate calcium-triggered 
exocytosis in both pancreatic n-cells (Ammala et al., 1993) and pancreatic acinar cells 
(O'Sullivan & Jamieson, 1992). Such views are based on several lines of evidence: 
. Several hormones, drugs or neurotransmitters that stimulate protein andlor fluid 
secretion augments intracellular cAMP levels 
Synthetic analogues of cAMP stimulate protein and electrolyte secretion from 
acinar cells 
Agents that stimulate adenylate cyclase or inhibit cyclic nucleotide 
phosphodiesterase activity either evoke acinar secretory activity themselves, or 
potentiate the stimulation of secretion elicited by other agonists that elevate 
endogenous cAMP (Schulz & Stolze, 1980; Pearson et aL, 1981; Petersen, 1982; 
Williams, 1984) 
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Jensen & Gardner, (1981) demonstrated that CCK-8 at high concentrations can activate 
pancreatic adenylate cyclase, but contrary to these findings, substances such as ACh have 
been shown to decrease cAMP levels (Pearson et al., 1981; Singh, 1983). Intracellular 
levels of cAMP. are predominantly under the control of G-protein-coupled receptors that 
modulate the activity of the different adenylate cyclases. Agents that modi& these proteins 
will modulate adenylate cyclase activity and therefore cAMP levels (Neer, 1995). There is 
also some evidence that phosphorylation of regulatory proteins in granular membranes by 
cAMP-dependent protein kinase may be associated with exocytosis (Bumham etal., 1986), 
however, an elevation in cAMP alone in the absence of a calcium rise is not sufficient to 
trigger exocytosis (OS ullivan 
 & Jamieson, 1992). The molecular mechanism by which 
cAMP triggers exocytosis still remains to be established (Burgoyne & Morgan, 2003). 
1.11.5 Calcium (Ca 21) 
Calcium is a ubiquitous intracellular signalling molecule, which controls a wide range of 
cellular processes such as secretion, contraction, cell proliferation and gene transcription 
(Bootman & Berridge, 1995). In unstimulated pancreatic acinar cells, as in other cells, the 
free intracellular calcium concentration ([Ca 2 ]1) is between 50 - 100 nM. In order to 
maintain this low resting level, a variety of pumps and uptake systems are present in the 
plasma membrane and in intracellular organdIes to buffer [Ca2*]j 
 (Williams & Yule, 1993). 
Calcium mobilisation is dependent upon intracellular calcium stores as well as extracellular 
calcium ([Ca 2 ]0). An increase in cellular calcium originates from two major sources: 
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• The release of Ca 2 from intracellular stores (ER) which is rapid. Calcium release 
from the ER after IF3 generation is crucial for exocytosis 
• The influx of Ca2 from extracellular sources with the aid of 1P3 by the depletion of 
an intracellular pool (Putney, Jr. etal., 1989; Irvine, 1989; Berridge & Irvine, 1989; 
Putney, Jr., 1986) 
Both these mechanisms give rise to high-localised Ca 2 signals. Many agonists can 
promote an influx of Ca 2 from the extracellular medium by the following processes: 
Opening of voltage-operated Ca 2 channels 
. Phosphorylation of Ca2 channel proteins by cAMP and cGMP and, 
Receptor-operated Ca 2 channels in which modulation of channel activity does not 
involve cytosolic signal molecules but a direct control by receptor channel coupling 
G-proteins (Berridge & Irvine, 1989) 
Another possibility is that when the ER once depleted of Ca 2 can be directly replenished 
from extracellular Ca 2 by autoregulatory Ca 2 pathway, which bypasses the cytoplasm via 
a pore analogous to the observation that emptying of an internal pool is a prerequisite for 
Ca2 entry (Hallam & Rink, 1989). Removal of Ca 2 from the cytosol is mainly mediated 
by two mechanisms: 
I. Sequestration of Ca 2 into intracellular compartments (ER and mitochondria) 
2. Ca2 extrusion across the plasma membrane 
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1.11.5.1 Calcium sinaIling 
The intracellular level of Ca 2 in resting cells is maintained within a normal range of 50 - 
100 nM. Ca2 homeostasis is tightly controlled to prevent and overcome problems of 
cytotoxicity due to its very tow diffusibility in the cytoplasm. Distributed throughout the 
cytoplasm is an extensive array of Ca 2 pumps (Carafoli, 1994b). There are two main 
intracellular mechanisms allowing [Ca 2 ] increase; 
1. Ca2 release from internal stores via intracellular calcium channels, activated via the 
ryanodine receptors (RYRs), and the inositol 1 ,4,5—trisphosphate receptor (IP3R) 
2. Ca2 entry from the outside [Ca 2 ]0 through a variety of channels such as the VOCs, 
ROCs or store-operated channels (SOCs) 
Cytosolic Ca 2 homeostasis in resting cells is achieved by balancing the leak of Ca 2 
(entering from the outside of from the stores) by the constant removal of Ca 2 using pumps 
either on the plasma membrane or on the internal stores. These pumps ensure that 
cytoplasmic [Ca 2+ 
 ]i remain low and that the stores are loaded with signal Ca 2t In most 
cells, it is the internal stores which provide most of the signal calcium. Studies in non-
excitable cells show that IP3Rs are associated with the ER (Streb et al., 1983) and initiates 
the release of sequested Ca 2 to enter the cytoplasm when activated (Petersen et al., 1994; 
Bootman & Lipp, 2001). Activation of the IP3Rs is also regulated by cytosolic Ca 2 
concentrations. Intact and internally perfused cells have evidently shown that an increase 
in [Ca2t] can inhibit 1P3-evoked Ca 2 release (Wakui & Petersen, 1990; Parker & Ivorra, 
1990) whereas opening of the IP3R is enhanced by low concentrations of Ca 2t This is 
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crucial in the generation of complex patterns of Ca 2 signals seen in many cells (Bootman 
etal., 2001; Bootman & Lipp, 2001; Toescu, 1995). Unlike the RYR where Ca 2 can act as 
the sole trigger for its activation, IP3Rs usually requires the simultaneous presence of Ca 2 
and 1P3 (Berridge, 1987). Recent studies have also demonstrated that IP3R function is also 
influenced by cAMP and cGMP via phosphorylation by protein kinase A and G (Rosado & 
Sage, 2002b). 
Another ER calcium release channel, particularly predominant in skeletal and heart muscle 
cells (Lai et al., 1988; Anderson et al., 1989) is the RYR. RYRs are activated by cyclic 
adenosine diphosphate (ADP) ribose (Galione, 1994) as well as millimolar caffeine 
concentrations which increases the sensitivity of RYR to calcium (Bootman & Lipp, 2001; 
Lee, 1993). 
The caffeine-sensitive Ca 2 -release channel is structurally and functionally analogous to 
IP3Rs. Both proteins have the same subunit structure and sensitivity to bind ATP and 
calmodulin (Ferris & Snyder, 1992). Another property that the RYR and the IP3R share is 
the modulatory effect of Ca 2 ; they are generally activated at 1 - 10 mM U' and inhibited 
at> 10mM U' (Rosado & Sage, 2002a). 
1.11.5.2 Calcium oscillations 
Oscillations in intracellular Ca 2 can be induced be a variety of cellular signalling processes 
(Woods et al., 1986; Berridge, 1988; Jacob et al., 1988) and appear to play a role in 
secretion (Stojilkovic etal., 1994). 
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The most important messenger for activating both IP3Rs and RYRS is Ca 2 itself. The 
process of Ca2tinduced 
 Ca2 release (CICR) is fundamentally important in regulating the 
way in which cells mobilise Ca 2 from their internal stores and the generation of complex 
signals. These receptors display a unique catalytic process. As the [Ca 2+ 
 Ji is increased, it 
initially exerts a positive feedback effect by enhancing the opening of CICR channels, but 
as soon as the [Ca 2+ 
 ]i reaches a certain level the feedback switches from positive to negative 
and Ca2 then inhibits the channel (Bezprozvanny & Ehrlich, 1995). Upon continued 
stimulation, the process could repeat giving rise to oscillations. This positive feedback 
effect ensures that just enough Ca 2 is released to give a meaningful signal, thus avoiding 
cytotoxicity induced by high [Ca 2 ]1. 
A specific region within the cell (termed the 'trigger zone') usually functions as an 
initiation site where it is the first to release Ca 2t This initiation zone is a region where the 
IP3R and RYR seem to be particularly sensitive (Berridge & Dupont, 1994). Released Ca 2 
diffuses outwards to excite neighbouring receptors thereby setting up a Ca 2 wave that 
sweeps through the cytoplasm. In pancreatic acinar cells, the trigger zone is located at the 
apical cell pole where the zymogen granules are located (Nathanson et at, 1992). Very low 
agonist concentrations can generate local Ca 2 signals which are localised to the granular 
area in acinar cells (Thom et aL, 1993). On the other hand, high agonist concentrations 
lead to a global Ca2 signal that involves the whole cytoplasm of the cell. The Ca 2 wave 
has been shown to propagate towards the basolateral side of the acinar cell (Thom et at, 
1993; Gonzalez et at, 1998) and at different time rates (Pariente et at, 2003). 
The speed of Ca 2 waves throughout the cytosol is sensitive not only to agonist 
concentration but also the type of agonist (Pfeiffer et al., 1998; Gonzalez et al., 1999). 
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High concentrations of agonist lead to a great and sustained Ca 2 signal consisting of an 
initial rapid increase followed by a slow decrease towards the basal level. The initial rise in 
Ca2 
 signal is due to its release from intracellular stores; the second phase of the signal 
illustrates Ca 2 entry form the extracellular space. When a physiological concentration of 
agonist is employed, a different pattern of Ca 2 signalling is observed. In response to low 
doses, the sustained increase in [Ca 2+ 
 ]i is changed into oscillations of [Ca 2 ], consisting of 
spikes of Ca2 release from intracellular stores that rapidly decreases and returns towards 
the prestimulation level (Pariente ci aL, 2003). Tinel ci aL, (1999) proposed the 
involvement of mitochondria in modulating the propagation of calcium signals. Yu ci al., 
(2002) noted that at low concentrations of CCK (1042 
 Mol/L - low Mol/L) transient 
increases of [Ca 2+ 
 ]i oscillations were illustrated, whereas high concentrations of CCK 
evoked a single peak of[Ca 2 ]1. 
In response to cell stimulation, Ca 2 release from the intracellular store is often insufficient 
for full activation, hence Ca 2 from the extracellular medium is additionally required. The 
depletion of intracellular stores is believed to trigger Ca 2 entry through a Ca-permeable 
channel in the plasma membrane called the SOC (Nilius, 2004). However, the precise 
mechanism underlying the activation of this store-mediated Ca 2 entry is poorly 
understood. A number of hypotheses have been suggested to explain how the depleted 
2+ intracellular Ca 2+ 
 stores might signal plasma membrane Ca channels. Some studies 
propose a role of second messengers such as cAMP and cGMP (Parekh & Penner, 1997) 
and others propose a direct interaction between the IP3R in the ER and a Ca 2 permeable 
channel in the plasma membrane (Berridge, 1995; Patterson ci al., 1999; Rosado & Sage, 
2000b; Redondo ci al., 2003). In some types of cells Ca 2 influx is activated in an all-or-
nothing fashion after almost complete emptying of the intracellular Ca 2 stores (Fierro & 
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Parekh, 2000; Fierro ci al., 2000), whereas in other cell types, there is a gradual activation 
with increasing depletion of the stores (Hofer ci al., 1998; Sedova c/at, 2000). 
1.11.5.3 Intracellular mechanism of Ca 2 removal 
Calcium reuptake into the intracellular ER stores proceeds against its concentration 
gradient via the calcium ATPase pump. This type of pump is also often referred to as the 
sarco/endoplasmic reticulum Ca 2 -ATPase (SERCA) and is expressed in both the 
sarcoplasmic reticulum and the ER (Pozzan ci al., 1994). The SERCA is known to be 
regulated by intracellular Ca 2 concentration. An increase in [Ca 2+  ] i activates the pump 
whereas free Ca 2 concentrations in the ER lumen inhibit the pump (Petersen ci al., 1994). 
It has been reported that the SERCA plays an important role in the Ca 2 oscillatory 
response in several cell types (Pariente ci al., 2003). 
The other route for the removal of excess cytosolic Ca 2 is via the plasma membrane Ca 2 -
ATPase pump (PMCA). Together with the PMCA, the NatICa 2 
 exchanger is also capable 
of removing Ca2 from the cell. Controversial to this, Rosado & Sage (2000a) revealed that 
the Na/Ca2 exchanger does not significantly contribute to Ca 2 efflux in non-excitable 
human platelet cells at resting Ca 2 levels and that the active transport via the PMCA might 
be the only mechanism responsible for the maintenance of low resting [Ca 2 ]. The PMCA 
is modulated by calmodulin, PIP2, and a number of protein kinases such as A and C 
(Carafoli, 1994a). 
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Mitochondria are intracellular organelles normally described as the "cells energy 
producers". They are the site of cellular respiration and they convert energy into forms that 
are usable by the cell in order for its survival, function and proliferation. The location of 
mitochondria in the exocrine pancreas led to researchers proposing that the mitochondria 
might play a role in Ca 2 signalling. By measuring mitochondria Ca 2 content, an increase 
in mitochondrial Ca2 concentration ([Ca 2 ]mi) in response to stimuli was found (Tinel et 
at, 1999; Gonzalez et at, 2000). Mitochondria have the ability to take up Ca 2 from the 
cytoplasm (Gunter & Gunter, 2001; Thayer etal., 2002), thus establishing itself as acting as 
buffers to shape [Ca2 ]1. Research has also provided evidence that the mitochondria can 
modulate Ca2 release from intracellular stores and/or accumulate Ca 2 following an 
elevation in [Ca2 }. Due to findings, mitochondrial Ca 2 was suggested to contribute to 
CICR in the exocrine pancreas (Nathanson et at, 1992). However, Gonzalez et at, (2000) 
found that mitochondria in pancreatic acinar cells did not show agonist-dependent Ca 2 
release. As the Ca2 enters the mitochondria, it is found to activate and regulate 
dehydrogenases (McCormack etal., 1990). 
1.11.6 The role of protein kinase C and diacyllycerol (DAG) 
Another pathway activated by calcium is the protein kinase pathway. DAG is an 
endogenous activator of protein kinase C (Nishizuka, 1984; 1988). This kinase is a 
cytoplasmic enzyme, which interacts on the plasma membrane with phosphatidylserine, 
calcium, and DAG, resulting in its activation. Kinetic analysis indicates that a small 
amount of DAG dramatically increases the apparent affinity of protein kinase C for 
calcium, fully activating the enzyme without any change in calcium levels (Kishimoto et 
at, 1980). Protein kinase C activated by DAG-like substances has been shown to elicit 
secretion (Case, 1978; Williams & Goldflne, 1993; Francis et al., 1990a) and to have a 
stimulatory role on other stimulus-secretion pathways (Singh, 1985), including signal 
transduction pathways which potentiate glucose-induced insulin secretion from 13-cells 
(Howell et at, 1994; Wang et al., 1993). 
1.11.7 JEa and phospholipid si2nalling 
There are three types of phosphoinositides: phosphatidylinositol (IP); inositol 1,4,5-
trisphosphate (1P3); and PIP2, which all differs according to the phosphates on the inositol 
ring structure. 1P3 is a water-soluble molecule that can mobilise calcium from the store 
within the ER. There is overwhelming evidence that stimulation of phospholipase C 
activity leads to the hydrolysis of PIP2 and to the formation of 1P3 and DAG (Stryer, 1995). 
Both molecules act as primary intracellular messengers in the pancreas (Williams & Yule, 
1993). In this way, activation of the IP3 signalling pathway regulates the pattern of 
enzymatic activity within the cell, thereby leading to secretion. At low and high Ca 2 
levels, the 1P3 receptor is relatively insensitive to 1P3. The sensitivity of the 1P3 receptor to 
which is also biphasic, is greatest in the physiological range between 0.5 jiM and 1.0 jiM 
1P3 (Berridge, 1993; Clapham, 1995). The involvement of phospholipids in cell signalling 
is very complicated, as more potential signalling systems emerge, it becomes even less 
clear (Berridge & Irvine, 1989; Berridge, 1993; Divecha & Irvine, 1995). 
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1.11.8 The role of tyrosine kinase (TK) 
Tyrosine-phosphorylated substances of growth factor receptor kinases are essential 
mediators of signal transduction processes that eventually lead to cellular responses. 
Tyrosine kinases consist of three subclasses: 
. Membrane receptor TK's, including the IR and the receptors for epidermal growth 
factor (EGF) and platelet-derived growth factor (PDGF) 
• Cytosolic non-receptor protein TK's such as the proto-oncogene products AbI and 
Fes 
• Membrane associated non-receptor TK's related closely to p60 t  the transforming 
gene of the tumorigenic Rous sarcoma virus 
Tyrosine kinase is stimulated when insulin and growth factors bind to specific receptors 
(IR) on the cell surface. The activated tyrosine kinase brings about exocytosis and hence 
secretion. Tyrosine kinase can stimulate calcium influx. When an animal is rendered 
diabetic, the calcium influx induced by tyrosine kinase (as well as calcium release from the 
ER) seems to be impaired (Yago etal., 1999). 
1.11.9 Ma2nesium (Mg 24) 
The role of magnesium (Mg 2 ) in cellular processes is gradually becoming recognised. The 
amount of magnesium found within the intracellular organelles of a cell is approximately 
98 % of all cellular ions - second most abundant intracellular cation, exceeded only by K. 
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Within cells, Mg2t  plays a vital role in several physiological and biochemical processes. 
Mg2 has shown to be the co-factor for over 300 enzymes (Wacker, 1968; 1993). Mg2t  is 
involved in the synthesis and replication of RNA and DNA (Flenrotte, 1993), and with 
muscle contraction (Altura & Altura, 1995; Birch, 1993). Intracellular Mg 2t has shown to 
be necessary for optimal performance of the Nat/K+_ATPase  and calcium pumps (Heaton, 
1993). In addition, several studies have demonstrated that both Mg 2 and Ca2t can be 
released in conjunction with digestive enzymes following stimulation of the pancreas with 
secretagogues (Sullivan et al., 1974; Schreurs etal., 1976; Francis et aL, 1990b). Mooren 
et al., (1997) demonstrated that Mg 2 was closely linked with the mobilisation of cellular 
calcium from stores, because it was seen to effect the mobilisation of 1P3 and Ca2tATPase 
in the ER, and the plasma membrane, resulting in the release of Ca 2 from the ER and its 
influx into cells. As 5 - 10 % of intracellular Mg 2 is in its free form, Mg 2 exists 
predominantly in the bound form (Gunther, 1990). It is this distribution of Mg 2t between 
the free form and bound form that regulates the activity of many magnesium-activated 
enzymes involved in protein synthesis, ion transport and other cellular processes. Previous 
studies and research have provided evidence that the divalent cation Mg2t  commands an 
important role in the events involved in secretion of proteins and calcium mobilisation from 
the exocrine pancreas stimulated with ACh (Yago et al., 1999). A number of mechanisms 
for the interaction between Mg2t  and Ca2 signalling have also been proposed (Singh & 
Wisdom, 1995; Wisdom et al., 1996; Lennard & Singh, 1992; Yago et aL, 2000). Mg2t 
deficiency has also been frequently observed in diabetic patients (Laires et al., 2004). Mg2t 
deficiency has shown to decrease insulin sensitivity and insulin secretion raising 
expectations in the near future for clinical trails to prove Mg2t  supplementation therapy 
(Yokota, 2005). 
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1.12 History of diabetes mellitus (OM) 
DM had long been recognised thousands of years ago, since the writings form the earliest 
civilisations (Egypt, China, and India) refer to boils and infections, excessive thirst, loss of 
weight, and the passing of large quantities of a honeysweet urine which drew ants and flies. 
The term diabetes is derived from the Greek word meaning siphon, or the passing through 
of water, while mellitus is Latin for honeysweet. The Papyrus Ebers of the Ancient 
Egyptians dated about 1500 B.C. recommended a number of remedies for combating 
polyuria resembling diabetes such as to go on a diet. Indian writings from the same era 
attributed the disease to overindulgence in food and drink. For thousands of years, no one 
knew how to live with, let alone correct diabetes. Children with the disease died quickly, 
often within days of onset, and older people struggled with devastating complications 
(Williams & Pickup, 1998). 
It was not until 1869 that a German medical student Paul Langerhans discovered what was 
soon to be recognised as a link between the pancreas and diabetes. He was the first to 
describe the islets and suggest its endocrine function. Twenty years later in 1889, Oscar 
Minkowski and Josef von Mering learned that DM developed when they removed the 
pancreas of dogs. The link between the pancreas and diabetes had now been recognised. 
This led to research which focussed on finding an effective, stable extract of pancreas 
which would predictably and consistently produce a fall in blood glucose in diabetic 
animals. The discovery of insulin by Banting and Best in 1921 transformed the work of 
physicians looking after diabetic patients. Insulin was found to have an essential life- 
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supporting function in maintaining glucose homeostasis. Over the last 50 years, 
management of diabetes has moved form refined science to educating patients. 
DM is a global health problem affecting more than 150 million people worldwide today. 
This number may well double by the year 2025. Much of this increase will occur in 
developing countries mainly due to population growth, unhealthy diets, obesity and 
sedentary lifestyles (httø://www.who.inUtoøics/diabees mel litus/en/, 2005). The 
prevention of diabetes and control of its micro- and macrovascular complications will 
require an integrated, international approach if we are to see significant reduction in the 
hugh premature morbidity and mortality it causes (Zimmet et al., 2001). 
1.12.1 Diabetic model and use of streptozotocin (STZ) 
STZ is widely used to selectively induce experimental diabetes in animals. STZ (2-deoxy-
2-(3-(methyl-3-nitrosoureido)-D-glucopyranose) is derived from the soil microorganism 
Streptoinyces achromogenes and is used to induce both type I and type II DM (Szkudelski, 
2001). A frequently used dose of Sfl to induce diabetes in adult rats is between 40 - 60 
mg kg'. Following the intraperitoneal (I.P.) administration of this carcinogen based 
chemical, STZ is taken up by the pancreatic 13-cells via the glucose transporter GLUT2 and 
causes the alkylation of DNA (EIsner et al., 2000). DNA damage induces activation of 
poly ADP-ribosylation (SandIer & Swenne, 1983) and consequently the cellular depletion 
of NAD (nicotinamide adenine dinucleotide) and ATP (Heller et al., 1994). Increased 
ATP dephosphorylation thus increases the supply of substrates for xanthine oxidase and as 
a result enhances the production of superoxide radicals - hydrogen peroxide and hydroxyl 
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radicals (Nukatsuka et al., 1988). Furthermore, STZ also liberates NO which together with 
reactive oxygen species contribute to DNA damage (Kroncke et al., 1995). As a result, 
STZ administration causes the destruction of 13-cells by necrosis inducing characteristic 
alterations in blood insulin and glucose concentrations relative to DM. 
1.12.2 The diabetic pancreas and pancreatic insufficiency 
DM is a major global health problem characterised by chronic hyperglycaemia, and 
increases in glycogen breakdown (glycolysis), gluconeogenesis, fatty-acid oxidation, 
ketone production and urea formation; a result of defective insulin secretion andlor function 
(Zimmet et al., 2001; Kumar & Clark, 2002). Untreated DM is associated with several 
major long-tenn complications including cardiomyopathy, neuropathy, nephropathy, 
retinopathy, foot ulcers, and pancreatic and salivary insufficiencies (Zimmet et al., 2001; 
Kumar & Clark, 2002). Many studies have employed the STZ-induced rat model to study 
the long-term complications of diabetes mellitus (Sharma et al., 1985). 
Immunohistochemical studies in STZ-treated rats have detected morphological 
abnormalities in the diabetic pancreas. These include i) a reduction in the size of the islets 
(Singh et al., 1999); ii) a decrease in the number of insulin positive cells (Adeghate et al., 
2001a; Singh et al., 1999; Singh & Adeghate, 1998; Ahmed et at, 1998); iii) a relative 
increase in the number of both glucagon positive cells (Singh et al., 1999; Singh & 
Adeghate, 1998; Adeghate etal., 2000) and somatostatin positive cells (Singh & Adeghate, 
1998; Ahmed et aL, 1998); iv) a disruption in the pattern of distribution of all types of 
endocrine cells within the islet (Adeghate, 1999). Moreover, total pancreatic content of NA 
was also found to be enhanced in diabetic rats (Adeghate etal., 2001b). 
There have not only been reports on impaired structure and function in diabetics regarding 
the endocrine pancreas but also on exocrine changes. It was observed by Gepts (1965) and 
Hardt ci al., (2000) that in diabetic patients, the pancreas is smaller than in healthy controls 
likely due to involution of exocrine parenchyma (Gilbeau ci al., 1992). More recently, 
STZ-induced diabetic rats were found to have reduced pancreatic weights compared to age-
matched controls thus supporting previous data (Patel ci al., 2004a). Acinar fibrosis and 
pancreatic atrophy have been reported in type II diabetics (Lazarus & Volk, 1961) and 
atrophy, diminution of pancreatic size, fibrosis and loss of acinar cells were described in 
type I diabetics (Gepts, 1965). Acinar cell volume and zymogen granule number and 
volume were found to be, respectively, 19, 36, and 46 % higher in the pancreas of normal 
rats compared with STZ-diabetic animals (Von Dorsche, 1979; Aughsteen ci at, 1996). 
Other authors have also postulated the decrease or varying size of zymogen granules more 
frequently found in diabetic pancreas compared with age-matched control (Yasuda ci aL, 
1982; Oomez Dumm ci al., 1989; Gruber ci al., 1980). No difference in the nuclear size 
between normal and diabetic rats was also recorded (Aughsteen ci aL, 1996; Von Dorsche, 
1979). In STZ-induced diabetic animals, labelling for amylase in acinar cells was markedly 
reduced (Gregoire & Bendayan, 1987). Observations such as these morphometric 
differences between the control and diabetic pancreas may demonstrate an association to 
the impairment of amylase secretion by pancreatic acinar cells. These findings are relevant, 
as many clinical studies in humans and experimental research in animals show an 
association of diabetes with pancreatic exocrine insufficiency (Kim ci at, 2000; Icks ci at, 
2001; Okabayashi ci at, 1988b). 
Scientific evidence has also shown that DM also affects the RER (Yasuda et al., 1982) and 
the Golgi apparatus within the pancreatic acinar cells (Laurent et al., 1988; Von Dorsche, 
1979). 
In previous studies employing fura-2-loaded healthy pancreatic acinar cells, either ACh or 
CCK-8 was observed to evoke large transient increases in [Ca 2 ]. Past findings have also 
demonstrated that genistein can attenuate the effects of insulin and CCK-8 on pancreatic 
[Ca2 ]1 thus suggesting the likely involvement of tyrosine kinase in pancreatic insufficiency 
(Singh et al., 1999; Juma et at, 1997). Diabetic pancreatic acinar cells evoked a much 
smaller [Ca2 ]1 transient rise in response to either ACh or CCK-8. These experiments 
suggest a derangement in Ca 2 mobilisation in DM-induced pancreatic insufficiency. 
2+ Mg deficiency in patients with DM has been well established (de Valk, 1999; Altura & 
Altura, 1995). I-Iyperglycaemia and the resulting glycosuria can contribute in causing 
lower plasma Mg 2 concentrations and hypomagnesaemia. Both type I and type II diabetic 
patients have been reported to have lower mean plasma Mg 2 concentrations compared to 
controls (Mather et all, 1979; de Valk et all, 1993; Gunn & Bums, 1987). In in vitro 
studies, animal experiments and clinical data all provide evidence that plasma Mg 2 levels 
are inversely related to insulin sensitivity. Suárez etal., (1992) have shown that binding to 
the IR in hypomagnesaemic conditions in vitro is normal, but that the IR activity is 
decreased with associated reduced peripheral glucose uptake and glucose oxidation in rats 
(Suárez et al., 1993). Induced low intracellular magnesium [Mg 2+  ]i levels are associated in 
vitro with reduced intracellular consequences of insulin action (Kandeel et al., 1996). 
Recent results have illustrated that both basal and CCK-8-evoked [Mg 2+  ]i was significantly 
decreased during diabetes in pancreatic acinar cells (Patel ci al., 2004a). Mg 2 plays a vital 
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role in numerous physiological and biochemical processes including the synthesis of RNA, 
DNA and the maintenance of their conformation. Moreover, Mg 2 is recognised as a major 
co-factor for a wide range of enzymes (Yago etal., 2000). It is tempting to suggest that the 
reduction in [Mg 2+ 
 ]i seen during DM may be directly linked to the de-activation of the 
different enzyme systems which are responsible for mRNA amylase level and amylase 
synthesis, subsequently leading to reduced amylase secretion (Patel et al., 2004a; Singh et 
al., 2004). Although no beneficial effects of oral magnesium supplementation has been 
demonstrated on glycaemic control either in type I and type II diabetic patients, oral 
magnesium supplementation reduced the development of type II diabetes in predisposed 
rats (de Valk, 1999). 
1.12.3 Glucose uptake and UM 
In eukaryotic cells, glucose uptake is mediated by transmembrane glucose transporter 
(GLUT) proteins. Normally, GLUT4 is exclusively expressed in insulin-responsive tissues, 
e.g. heart, skeletal muscle, and white and brown adipose tissues (James et al., 1993). In 
these tissues, insulin stimulates the cellular glucose uptake by inducing the translocation of 
GLUT4 from an intracellular pool to the plasma membrane (Karnieli et at, 1981). STZ-
induced diabetic rats have been associated with reduced cellular number and activity of 
GLUT4 (Karnieli etal., 1981; 1986; Kahn & Cushman, 1987) and approximately 50% of 
GLUT4 levels decreased in cardiac muscle, soleus, and gastrocnemius (Hardin et al., 
1993). A defect in insulin-stimulated glucose transport could involve an abnormality in 
either the number (Karnieli et at, 1981), function, or recruitment (Garvey et at, 1987) of 
glucose transporters. Garvey etal., (1989) reported a decline in GLUT4 mRNA in muscles 
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of STZ-induced rats; these values were found to increase with insulin therapy. Many 
studies have found that muscle GLUT4 expression varies with perturbations in glucose 
homeostasis, and, in contrast to previous findings in adipocyte, in a manner not directly 
related to plasma insulin concentrations (Bourey et at, 1990; Kahn & Cushman, 1987). 
However, Kolterman et al., (1981) state that in type II diabetic patients with the greatest 
degree of insulin resistance, decreased IRs and a post-receptor defect in insulin action 
coexists, but the post-receptor defect appears to be the major abnormality. The 
abnormalities relating to GLUT4 transporters in STZ-diabetic animals may influence 
weight loss and even malnutrition in diabetic patients. 
These concepts mentioned above throw light on the possible transformation between 
structurally and functionally different pancreatic cells when subjected to a pathological 
condition such as DM. 
1.12.4 Interactions between the endocrine and exocrine pancreas 
The interaction between the endocrine and exocrine pancreas (insulin-acinar relationship) 
employing islet peptide hormones such as insulin, glucagon, somatostatin, the 
neurotransmitters ACh and NA, and the digestive hormones CCK-8 and secretin have been 
investigated extensively (Williams & Goldfine, 1993; Yago et al., 1999; Owyang, 1993; 
Singh et at, 2001). These secretagogues (e.g. ACh, NA, CCK-8, and secretin) and islet 
hormones activate a number of intracellular signals either individually or combined to 
mediate the secretion of pancreatic juice in a sustained and voluminous manner for efficient 
digestion of food. Morphological evidence and physiological data have indicated that the 
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islet peptides can modulate the secretory effects of both ACh and CCK-8 in the exocrine 
pancreas. Moreover, a number of clinical and experimental studies show that pancreatic 
exocrine function is altered in DM. However, neither this dysfunction has been fully 
characterised nor its mechanism precisely established. 
1.12.5 Mechanism of interaction of insulin and CCK-8 in normal and 
diabetic conditions 
The islet hormones of the pancreas are necessary for the proper maintenance of acinar cells 
and they play a significant role in the metabolism of the exocrine pancreas via the insulo-
acinar system (Kim et at, 2000; Williams & Goldfine, 1993; Owyang, 1993). Despite the 
variety of in vivo studies on the effects of insulin on exocrine pancreatic secretion, there are 
many contradictory reports in the literature. In fact, it is still unknown whether insulin has 
either a stimulatory or inhibitory effect on basal exocrine secretion and it is also unclear if 
the hormone is able to potentiate the secretion evoked by CCK-8. Furthermore, although 
there is a general consensus that in untreated diabetic animals pancreatic amylase content 
and secretion are vastly reduced, there is still controversy about how this condition affects 
flow rate and the secretion of other components. These discrepancies are likely to be 
associated with the use of different animal species (rat, pig and dog) and preparations 
(isolated perfused pancreas verses whole anaesthetised animal) and with differences in the 
duration of the disease (Patel etal., 2004c). Thus, in the anaesthetised healthy rat with the 
bile-pancreatic duct cannulated, endogenously released insulin failed to influence basal 
pancreatic secretion (Iwabe et al., 2001), whereas Ferrer et ci., (2000) found a clear 
increase in flow rate after the administration of exogenous insulin by using the same 
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preparation. In the isolated perfused rat pancreas, both endogenous (Lee et at, 1996) and 
exogenous (Park et al., 1993) insulin produced increases in pancreatic flow rate. 
Accordingly, the same confusion exists regarding basal secretion of fluid during STZ-
induced diabetes, i.e. a situation where insulin availability is greatly diminished, and both 
increases (Okabayashi et al., 1988a) and reductions (Shimizu ci al., 2000) have been 
reported. Turning now to the interaction between insulin and CCK-8, a potentiation 
between both hormones has been found in the healthy rat, regardless of whether the isolated 
pancreas or the whole animal was employed (Iwabe ci al., 2001; Lee ci at, 1996; Saito ci 
al., 1980). In the dog, however, no influence of insulin on CCK-stimulated secretion was 
found (Berry & Fink, 1996). However, recently in the anaesthetised healthy rat, exogenous 
insulin significantly elevated pancreatic volume, amylase and protein secretion compared to 
basal. In this whole animal preparation, the stimulatory effects of the islet peptide did not 
seem to be direct, but mediated by hypoglycaemia-evoked vagal cholinergic activation 
(Patel ci at, 2004b). 
The precise cellular mechanism(s) for the slight effect of insulin alone and/or its interaction 
with the classical secretagogue CCK-8 and in its association with reduced digestive enzyme 
secretion during diabetes is still unclear. Kanno & Saito, (1976) suggested that two 
possibilities for the mechanism of action of insulin are that it either increases intracellular 
Ca2 mobilisation or the activity of a membrane Na-}C transport pump, which are 
important in secretion of both fluid and protein by the pancreatic acinar cells. Insulin alone 
has little or no effect on either Ca 2 efflux or on intracellular free calcium concentrations 
[Ca 2+  ]i in healthy pancreatic acinar cells (Singh, 1985). However, when insulin is 
combined with CCK-8, it results in the potentiation of the CCK-8-induced rise in [Ca 2 ]1 
level (Singh & Adeghate, 1998; Singh ci at, 1999; 2001). In diabetic animals, insulin has 
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no effect on basal [Ca 2+]i either, but in contrast to healthy rats the islet hormone fails to 
potentiate the [Ca 2+]i response when challenged with CCK-8 (Singh & Adeghate, 1998; 
Singh et aL, 1999). The increase in [Ca 2+ 
 ]i induced by the combined presence of insulin 
and CCK-8 was attenuated by the tyrosine kinase inhibitor, genistein (Juma et al., 1997; 
Singh el al., 1999). These findings suggest that activation of the intracellular mediator 
tyrosine kinase (Hunter & Cooper, 1985; Juma et al., 1997) is involved in the observed 
potentiating effect and modulation of calcium entry into pancreatic acinar cells (Yule et al., 
1994). Contradictory to these findings, it can be argued that insulin has additional modes 
of action because genistein failed to completely abolish the potentiating effect of insulin on 
the secretagogue-evoked amylase secretion and [Ca 2 ]. It is also well established that two 
secretagogues acting via the same intracellular mediator (e.g. Ca 2 or cAMP) should not 
potentiate one another (Jensen & Gardner, 1981; Singh et aL, 1992) whereas two 
secretagogues acting via different cellular mediators (e.g. Ca 2 and cAMP) can enhance the 
effects of one another. Therefore, the potentiating effects of the islet hormone may involve 
a second intracellular messenger. Other messengers which are involved in enzyme 
secretion are cAMP (Jensen & Gardner, 1981; Pearson et aL, 1984b; Schulz & Stolze, 
1980; Williams, 1984) and protein kinase C (Berridge, 1993; Nishizuka, 1984; Putney, Jr., 
1988). Previous studies have demonstrated that derivatives of cAMP can potentiate 
cholinergic-evoked pancreatic enzyme secretion in a number of studies including the rat 
(Singh, 1979). It thus appears that several intracellular mediators including calcium, cAMP 
and tyrosine kinase are all associated with the interaction of insulin with the classical 
digestive secretagogues (Lam et al., 1999; Singh et al., 1999). Further experiments are 
required to unravel the precise cellular mechanisms which are associated with pancreatic 
insufficiency suffered by diabetic patients. 
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1.13 Molecular biology of amylase deficiency 
Recent developments in molecular biology techniques have extended the opportunity to 
explore genetic alterations in diseases including DM (Morchala et al., 1990). A potential 
application relating gene expression measurements and the state of the diabetic cell would 
hopefully establish a more accurate understanding between DM and pancreatic 
insufficiency. Pancreatic acinar cells possess large amounts of CCKA receptors, which 
mediate the secretion of digestive enzymes such as amylase through CCK-8 (Williams et 
a/l, 2002). Amylase is a major product of the pancreas accounting for approximately 20% 
of total protein (MacDonald et aL, 1980). Kim et aL, (1991) reported a decrease in amylase 
protein and mRNA levels in STZ-induced diabetic rats 6 days following STZ injection. 
Insulin has been shown to reverse this effect (Korc el al., 1981; 1990; 1991; Tsai et aL, 
1994). These observations suggest that insulin itself, or a secondary effector molecule, may 
interact with specific genetic sites in order to modulate gene expression (Dranginis et al., 
1984). 
CCK is an important mediator in the growth of the normal pancreas (Povoski 
€1 aL, 1994; 
Mainz et al., 1973). Two CCK receptor subtypes have been characterised and identified, 
CCKA and CCKB. The CCKA receptor has an affinity for CCK which is 1,000-fold greater 
than that for gastrin, while the CCKB receptor has equivalent affinities for both peptides. 
Pancreatic acinar cells possess relatively large amounts of CCKA receptors and a readily 
measured biological endpoint, the secretion of amylase (Williams et al., 2002; Zhou cx al., 
1995; Wank et al., 1992). Morisset ci al., (2003) debated which CCK receptor was 
involved in the control of pancreatic hormone release. It was suggested that a potential 
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difference in CCKA receptor structure may be responsible between humans and other 
species (Liddle et al., 1990). STZ-induced diabetes demonstrated CCKA receptor 
alterations in rats utilising the reverse trancriptase-polymerase chain reaction (RT-PCR) 
technique. CCKA receptor mRNA expression remained unchanged whereas CCKA receptor 
proteins were found to be reduced in diabetic islets (Julien et al., 2002). Results have 
previously suggested that pancreatic endocrine dysftrnction in OLETF rats may be due to a 
defect in the expression of the CCKA receptor gene (Funakoshi et al., 1996). This may 
explain the loss of sensitivity of CCK receptors to CCK in pancreatic acinar cells when 
animals are rendered diabetic (Otsuki etal., 1995). 
CCK receptors have shown to activate intracellular signal transduction pathways in acinar 
cells that regulate not only secretion but also protein synthesis, growth and metabolism. 
1.13.1 Global protein signalling pathways and insulin signalling 
Protein synthesis is the mechanism by which cells are able to translate mRNA into 
functional proteins. Once an mRNA has been transcribed from DNA and spliced in the 
nucleus, it is then directed to the ribosome which is a functional unit responsible for 
housing translation. Several factors are then responsible for initiating translation and also 
for promoting peptide elongation. However, this is a highly regulated process and the 
transcription of a number of gene products does not necessarily produce an equivalent 
amount of protein. The important aspects controlling these initiation and elongation factors 
and their upstream kinases will be discussed below. 
57 
1.13.2 The P13K pathway 
The P13K (phosphatidylinositol 3-kinase) pathway is a major controller of protein 
synthesis. Traditionally, this pathway is activated by insulin or IGF- I (insulin-like growth 
factor-l) which leads to the autophosphorylation of IR substrates. Subsequent 
phosphorylation of PDKI (phosphoinositol dependent protein kinase 1) leads to the 
phosphorylation of PKB (protein kinase B) at thr308, which causes PKB to translocate to 
the cell membrane leading ultimately to GLUT4 translocation (Kido el al., 2001). PKB 
activation is not restricted to glycaemic control, since PKB when activated also 
phosphorylates mTOR (mammalian Target of Rapamycin) at 5er2448 (Nave et al., 1999). 
Phosphorylation of mTOR leads to the activation of two major downstream proteins, 
namely 4E-BPI (eukaryotic initiation factor 4E-binding protein-I) and p70 S6K (ribosomal 
protein p70 S6 kinase). Activation of 4E-BPI leads to the removal of inhibition of eIF4E 
(eukaryotic translation initiation factor 4E), making eIF4E capable of forming the eIF4F 
(eukaryotic translation initiation factor 4F) complex and ensuring recognition of the mRNA 
cap structure. Activation of p70 56K leads to phosphorylation of the 56 subunit of the 40S 
complex of the ribosome, especially regulating mRNA species with a 5' Terminal 
oligopyrimidine (5' TOP), such as ribosomal proteins (Atherton et al., 2005). Therefore 
both of these proteins are of critical importance in promoting protein translation. 
Activation of PKB not only leads to subsequent phosphorylation of mTOR, but also of the 
protein GSK313 (glycogen synthase kinase-3 beta). Activation of GSK313 leads to the 
dephosphorylation of eIF2B (eukaryotic translation initiation factor 2 beta), because in an 
unstimulated state, GSK3B phosphorylates eIF2B at Ser535 and inhibits its activation. 
However, when dephosphorylated, eIF2B remains GTP bound and this directs translocation 
of methyl tRNA to the ribosome to place the first amino acid on to the start codon (Wang et 
al., 2001 a). Thus, the regulation of eIF2B is also of critical importance in the initiation of 
translation. This pathway is not only activated by insulin or IGF- 1, but is also stimulated 
with CCK (Williams et al., 2002). The fact that CCK activates this pathway highlights a 
potential role for dysregulation of protein synthesis through this pathway in STZ-induced 
DM. In fact, it has been shown that in diabetic rats CCK is less able to stimulate the 
conversion of PIP 2 
 to PIP3 that is essential for subsequent PDKI phosphorylation and 
downstream translation (Chandrasekar & Korc, 1991). Interestingly, pancreatic size is 
reduced in STZ-induced diabetes (Yago et al., 1999). Therefore, not only could a reduction 
in protein synthesis reduce pancreatic enzyme concentrations, but it could also be 
responsible for atrophy through inducing net protein catabolism. The signalling 
responsible for atrophy of the pancreas or reduced enzyme secretion has yet to be 
investigated. 
1.13.3 ERKI/2 
MAPK (mitogen-activated protein kinase) proteins such as ERKI/2 (extracellular signal-
regulated kinase I and 2) are activated by PKC (protein kinase C) in the pancreas in 
response to increased [Ca 2 '] from PIP3 production, and also through CCK via small 0-
proteins such as Ras (Williams etal., 2002). The MAPK family of proteins are believed to 
be involved in genetic responses to a variety of cellular stresses and mitogens (Williams et 
aL, 2002), and also have an effect upon translation. Indeed, it has been shown that ERKI/2 
activation leads to the phosphorylation of eIF4E through MNK1/2 (MAP kinase activating 
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kinase 1 and 2) (Tschopp et al., 2000). How type I DM affects MAPK responses in the 
pancreas has yet to be elucidated. 
1.13.4 NFicB and the ubiuitin-proteasome pathway 
NFKB is a protein activated by TNF-alpha (tumour necrosis factor alpha), which is a 
cytokine known to be elevated in type I DM (Abdel Aziz etal., 2001). Activation of NFicB 
has been shown to be a mediator of atrophy in a variety of tissues, especially skeletal 
muscle (Ladner et al., 2003), and therefore could be a mediator of pancreatic atrophy. It is 
therefore a possibility that this is a mechanism for pancreatic atrophy. Interestingly, it has 
been recently shown that NFKB is required for glucose-stimulated insulin secretion 
(Hammar etal., 2005). Given the fact that type I diabetes is a situation of impaired insulin 
synthesis coupled with pancreatic atrophy it would be interesting to examine NFiCB in this 
situation. 
The ATP-dependent ubiquitin proteasome pathway is a mechanism by which a cell may 
degrade and recycle proteins. The protein ubiquitin is a sort of 'tag' which conjugates to 
proteins and marks them for subsequent degradation by the proteasome (Hendil & 
Hartmann-Petersen, 2004). Since there is notable atrophy of the pancreas, and protein 
secretion is reduced, then perhaps there is heightened protein breakdown in STZ diabetes. 
One way to examine this would be to look at protein ubiquitination which could indicate 
altered protein turnover patterns, and perhaps increased breakdown of cellular proteins. 
1.14 Working hvnothesis and Soecific aims 
It is now well established that DM is associated with exocrine pancreatic insufficiency 
leading to the indigestion of foodstuffs especially carbohydrates. However, the cellular 
mechanism(s) involved in this insufficiency is still unknown. The interaction between the 
endocrine and exocrine pancreas employing islet peptide hormones and the digestive 
hormones activate a number of intracellular signals which in turn, elicit efficient secretion 
of pancreatic juice. Therefore, this study was designed to investigate cellular mechanism(s) 
implicated in pancreatic insufficiency in STZ-induced type I DM compared to the healthy 
control pancreas. This study investigated the effect of different secretagogues (e.g. ACh, 
CCK-8, insulin) on pancreatic juice flow and its quality (i.e. amylase and protein output) in 
vivo and in vitro. In addition, this study also measured a number of physiological and 
biochemical parameters including total ion output, [Ca 2 ]1, [Mg2 ], mRNA gene 
expressions for CCKA receptor and ct-amylase, and specific mRNA translation mediating 
marker proteins. 
The specific aims were: 
1. To investigate and characterise the effects of CCK-8 and its interaction with the 
islet peptide insulin on pancreatic juice secretion in the anaesthetised age-matched 
healthy control and diabetic rats. 
2. To measure amylase release from pancreatic acinar cells stimulated with either 
ACh, CCK-8, or insulin alone, or either ACh or CCK-8 combined with insulin. 
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This part of the study involved employing the Phadebas technique. Total protein 
and ion content in healthy control and diabetic homogenised pancreases were also 
measured using the Lowry method and the flame atomic absorbance spectrometer 
(FASS), respectively. 
3. To measure time course changes in intracellular free [Ca 2 ] and [Mg 2 ] in pancreatic 
acinar cell suspensions taken from age-matched control and diabetic rats before and 
after the application of CCK-8. 
4. To measure [Ca 2 ] in single pancreatic acinar cells in the absence and presence of 
secretagogues employing the microspectrofluorimetry technique. 
5. To measure mRNA gene expressions for CCKA receptor and a-amylase in order to 
identify if reduced transcription of these proteins are responsible for pancreatic 
insufficiency in STZ-induced type I DM. This part of the study employed RT-PCR 
using a-amylase and CCKA receptor specific primers. 
6. To measure mRNA translation mediating proteins using western blotting in order to 
detect if protein synthesis and/or signal transduction pathways mediating protein 
synthesis is involved in the general reduction of digestive enzyme production and 
atrophy noticed in pancreatic insufficiency. 
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CHAPTER 2 
MA'I'ERIALS AND METHODS 
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2.1 Induction of diabetes 
Adult male Wistar rats weighing about 250 - 275 g were employed in this study. They 
were supplied by the Animal Service of the University of Central Lancashire, University of 
Granada, and the University of Extremadura, Spain. Type I DM was induced in male 
Wistar rats by a single intraperitoneal injection (I.P.) of STZ —(60mg kg'; Sigma, S-0 130; 
Sharma et cii., 1985). STZ was dissolved in a citrate acid buffer solution (0.1 M citric acid; 
Sigma, C-0759 and 0.1 M sodium citrate; Sigma, S-4641 pH 4.5). Age-matched control 
rats received an equivalent volume of citrate acid buffer solution alone. Diabetes was 
confirmed 4 days following STZ injection and immediately prior to humanely killing of the 
animal 7 - 8 weeks following STZ injection prior to experimentation. Glucose was 
measured using a glucose meter (Accu-Chek, Roche Diagnostics). This study had the 
relevant ethical clearance from the Ethics Committee of the University of Central 
Lancashire, University of Granada, and the University of Extremadura, Spain to undertake 
the experiments. 
2.2 Investivation of pancreatic juice flow using an 'in vivo' rat 
preparation in normal and diabetic conditions 
All experiments were preformed on overnight fasted rats. Age-matched control and STZ-
diabetic rats were anaesthetised with approximately 1 g kg 1 body weight of I.P. urethane. 
Following general anaesthesia, the trachea was exposed and intubated; the jugular vein was 
exposed and cannulated, and known concentrations of either CCK-8 or atropine were 
administered via this cannula. After performing a laparotomy, the stomach pylorus was 
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ligated and the common bile pancreatic duct was exposed and cannulated at its entrance to 
the duodenum for the collection of pancreatic juice. The haepatic end of the bile pancreatic 
duct was also cannulated thus diverting bile into the duodenum (Singh et al., 1992). All 
areas of tissue exposed by the surgical procedure were covered by moist swabs soaked in 
saline (0.9 %). Throughout the experimental period, the body temperature of the animals 
was maintained between 36 °C and 38°C by the use of heating lamps to warm the 
surrounding air. Each animal was subjected to only one time course of experiments. 
Figure 2.1 shows the time course of experimental protocol for the collection of pancreatic 
juice. After 30 min of flow stabilisation, pancreatic juice was collected in pre-weighed 
capillary tubes (volume = 1 ml) at 20 min intervals. Pancreatic juice collected between 0 - 
20 and 20 - 40 min was taken as the mean basal or resting secretion value. CCK-8 infUsion 
(150 pmol kg' h) commenced following the basal collection, i.e. at 40 min through the 
jugular vein cannula at a rate of 2 ml W'. Pancreatic juice was collected over a period of 
100 min at 20 min intervals (5 collections). All drugs were freshly prepared in 0.9 % (w/v) 
sodium chloride solution taking into account the body weight of the animal using the 
following equation: 
p.1 of 106 
 M CCK-8 (stock) = (0.45 * X) + 6 ml saline solution (0.9% NaCl 
X = body weight of animal 
After the collection of 5 drug infusion samples, CCK-8 infusion was stopped and pancreatic 
juice was collected for a further 60 min at 20 min intervals. For the measurement of blood 
glucose concentration, blood samples were also taken at 20 min intervals from the tail vein 
of the animal throughout the whole experimental time course. 
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Figure 2.1. Experimental protocol illustrating the time course for the collection of 
pancreatic juice flow in the anaesthetised rat. 
To determine the effects of insulin alone on pancreatic juice secretion, the islet hormone 
was administered via a single injection at a concentration of 1 U into the interperitoneal 
region at 40 min after the second basal sample was taken. In order to investigate the effects 
of insulin in combination with CCK-8, insulin was administered via the same route as soon 
as CCK-8 infusion commenced. Diabetic rats received a dose of 4 U of insulin. To 
determine the effects of atropine, a single dose of atropine (2 mg kg') was administered 
through the cannulated jugular vein after the basal samples were taken and 10 min prior to 
insulin administration. In experiments where atropine (2 mg kgj, CCK-8 (150 pmol kg 1 
h') and insulin (1 U/4 U) were administered, atropine was first administered via the 
cannulated jugular vein 10 min prior to insulin and CCK-8 delivery. 
M. 
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Secretory rates were determined by re-weighing pre-weighed capillary tubes assuming the 
density of secretion was equal to water. All samples for total protein and amylase 
determinations were diluted 1:80 with saline (0.9 %) and frozen immediately following 
collection. Animals were killed humanely at the end of the experiments by urethane 
overdose followed by cervical dislocation. 
Total protein concentrations in the samples were estimated by the method of Bradford, 
(1976) and total amylase concentrations were determined by the method of Noelting & 
Bernfield (1948) as modified by Hickson (1970). Pancreatic juice flow secretory rates were 
expressed as p1 mm 1 , total protein output as pg mm 4 and total amylase output as mU min 
2.2.1 Determination of amylase activity in pancreatic luice: Technigue of 
Noelfing and Bernfield (1948) as modified by Hickson (1970) 
This is a colourimetric method, which measures the amount of reducing sugar released 
from starch substrate during incubation with a sample containing amylase. The amount of 
reducing sugar liberated is determined from a standard curve relating maltose concentration 
to optical density. 
Pancreatic juice samples were collected from in 'in vivo' preparations, diluted appropriately 
(1:80) in saline (NaCl 0.9 %), aliquoted and stored in the freezer at - 18 °C. When required 
aliquoted samples were allowed to defrost at room temperature. A volume of 100 p1 of the 
diluted samples were added to 10 ml of 2 % starch substrate solution at 38 °C. 'Substrate 
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blank' tubes contained 100 p1 of buffer added to 10 ml starch substrate solution. After 5 
min of incubation at 38°C, all tubes were cooled in ice-cold water. A volume of I ml from 
each sample was pipetted rapidly into 5 ml maltose reagent. This contained 4 g 3,5-
initrosalicylic acid, 120 ml 2 M sodium hydroxide solution, 120 g sodium potassium 
tartrate, made up to 1000 ml with distilled water. The 'reagent blank' tube contained 1 ml 
buffer added to 5 ml maltose reagent. All the sample, substrate blank and reagent blank 
tubes were vortexed and heated for 10 min in boiling water. After incubation, the tubes 
were cooled in ice-cold water and 1 ml from each tube diluted in 10 ml distilled water and 
vortexed. The optimum densities (OD) of the diluted solutions were read against the 
'reagent blank' at 520 nm in a spectrophotometer (Novaspec II, Pharmacia Biotech). A 
standard graph relating maltose concentration to optical density was plotted; the amount of 
reducing sugar liberated from the substrate during incubation with pancreatic juice was 
determined from this. A unit of amylase activity linearly related to concentration in the 
juice was calculated from the following equation (Willstätter etal., 1923): 
K 	 = 	 I 	 Logjo r 	 a 
La - rn 
(a = max amount of reducing sugar yielded by substrate; iii = amount released during 
incubation; t = incubation time (minutes). 
Total amylase output in the pancreatic juice sample was expressed as mU min* 
2.2.2 Measurement of total protein in pancreatic juice samples using the 
Bradford method (1976) 
The Bradford protein assay is a dye-binding assay based on the differential colour change 
of a dye in response to various concentrations of protein (Bradford, 1976). This technique 
is based on the observation that the absorbance maximum for an acidic solution of 
Coomassie Brilliant Blue 0-250 shifts from 465 nm to 595 nm when binding to protein 
occurs. 
Pancreatic juice was collected, diluted appropriately with saline solution (0.9 %), aliquoted 
and stored in the freezer at -18 °C. Protein standard dilutions ranging from 0.5 - 10 mg m1' 
BSA (bovine serum albumin) were prepared from a I mg mF' stock BSA solution. This 
stock solution was prepared by adding 25 mg BSA to 25 ml distilled water. When required 
aliquoted samples were allowed to defrost at room temperature. A volume of 50 j.xl of the 
standards and diluted samples were pipetted into dry test tubes. A volume of 50 p1 of 
distilled water was also added in a test tube as a 'blank'. To all tubes 2.5 ml of dye reagent 
was added, vortexed and incubated for about 20 min at room temperature. The absorbance 
of each protein standard was measured verses the reagent blank at 595 nm in a 
spectrophotometer (Novaspec II, Pharmacia Biotech). The total protein concentration in 
each sample was determined against a protein standard concentration curve and results 
expressed as pg min* 
me 
2.3 General 'in vitro' methods 
This study employed adult male age-matched control and STZ-diabetic Wistar rats 
weighing between 200 - 400 g. Animals were humanely killed by a blow to the head 
followed by cervical dislocation. The pancreas was then quickly removed and placed in a 
modified Krebs Henseleit (KH) physiological salt solution. The pancreas was then 
trimmed of fat, connective tissue, and lymph nodes and dissected into small segments for 
the measurement of amylase secretion. 
2.3.1 Measurement of a-amylase secretion from pancreatic acini using the 
Phadebas method 
Amylase release was determined as described previously using the Phadebas reagent 
(Gardner & Jackson, 1977; Jensen et al., 1982). The excised pancreas was quickly 
removed and placed in washing buffer (0.2 % BSA). Pancreatic acini were isolated using 
enzymatic digestion with 43.75 U ml' of Type V collagenase (Sigma, C-9263). The gland 
was injected with 2 ml collagenase to create pockets of collagenase within the gland. The 
pancreas was then passed into a 50 ml volumetric flask and a fw -ther 2 ml of fresh 
collagenase solution was added. The flask was placed in a 37 °C shaking water bath 
(maximum speed) for 10 mm. After incubation, the flask was shaken thoroughly and the 
supernatant transferred into a clean centrifuge tube. To this tube cold collagenase-stop 
solution containing 4 % BSA was added to bring the volume up to 11 - 13 ml. On the 
other hand, 4 ml of clean collagenase solution was added to the flask and digested for 10 
min in the same conditions. The above step was repeated for a total incubation time of 30 
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mm. Thereafter, the flask was removed from the water bath, shaken and the suspension 
poured into a clean centrifUge tube. To the partially digested gland, approximately 4 - 5 ml 
of washing solution was added and the flask was shaken thoroughly. The above procedure 
was once again repeated. Finally, after incubation the remaining gland pieces were filtered 
through double gauze into a centrifuge tube and the volume bought up to II - 13 ml with 
cold collagenase-stop solution. All the centrifuge tubes were incubated for 4 min 800 g. 
After incubation the supernatant was discarded from each tube and 2 ml of washing 
solution added. The cells were resuspended and transferred into one tube. If necessary, the 
resuspended pancreatic acinar cells were filtered again through double gauze and the 
filtered cell suspension was made up to 14 ml with washing solution. The cells were 
centrifuged at 2000 g for 2 min and were finally resuspended in incubation solution (1 % 
BSA). From the cell suspension the following tubes were prepared: (a) zero tubes - these 
tubes were used to determine the background activity (or noise) which was subtracted from 
all amylase determinations, (b) total tubes - these tubes were used to measure the total 
amylase content in the cells to be released, (c) basal tubes - these tubes were used to 
measure resting amylase secretion in the absence of stimuli, and finally (d) test tubes - 
these tubes were used to determine amylase secretion in the presence of stimuli. In the zero 
tubes, a volume of 300 R1  of cell suspension was added and the tubes were centrifuged at 
2000 g for 2 mm. From these tubes, 100 p1 of supernatant was retained. In the total tubes 
500 p1 of cell suspension was added together with 5 ml of lysis solution. These tubes were 
centrifuged at 2000 g for 2 min and 300 p1 of supernatant was retained. To the basal and 
test tubes 500 p1 of cell suspension was added. The appropriate amount of secretagogue 
was added to the corresponding test tubes. The test and basal tubes were then incubated for 
30 min at 37°C in a shaking water bath. After the incubation period, 300 i-'l  from each tube 
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was transferred into centrifhge tubes and were centrifuged at 2000 g for 2 mm. A volume 
of 100 jil of supernatant from each tube was retained. To all tubes except for total tubes 
200 M1  of lysis solution was added. A volume of 2 ml of Phadebas substrate solution 
(Phamacia Diagnostics) was then added to all tubes and incubated for 5 min at 37°C. After 
incubation, 500 R1  of NaOH solution (0.5 M) was added to all tubes and the resulting tubes 
were diluted with 8 ml of distilled water. The tubes were finally centrifuged at 3000 g for 4 
min before the absorbance was read. The absorbance of the supernatant was determined 
using a spectrophotometer at a wavelength of 620 nm. Pancreatic amylase release was 
expressed as the percentage of amylase activity present in the acini at the beginning of 
incubation that was released to the extracellular medium during incubation (% of total). 
2.3.2 Determination of total protein using the Lowry method (1951) 
The Lowry procedure was first described in 1951 and is based upon copper complexes with 
protein under alkaline conditions. When Folin-phenol reagent (phosphor-molybdic-
phosphotungstic reagent) is added, it binds to the protein and causes a change of colour 
from yellow to blue (Lowry et al., 1951). 
The pancreas once dissected, cleaned by removing surrounding connective and fatty tissue 
and weighed was placed in a 5 ml vial and frozen at 80 °C. On the day of use, the tissue 
was allowed to defrost in the fridge at 4 °C. After the tissue had defrosted, 3 ml of a 0.01 % 
Lanthium Chloride (LaCI3) solution was added into the vial containing the tissue and 
sonicated until the tissue had digested. The digested tissue sample was diluted 1:100 with 
distilled water. Protein standard dilutions ranging from 50 - 250 pg mF' BSA were 
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prepared from a 0.5 mg rn! 4 stock BSA solution. A volume of 500 p1 of each protein 
standard was added to a test tube. A volume of 1 ml of sample was added into two 
duplicate tubes. To the sample and standard tubes, 5 ml of Lowry reagent (to make 100 ml: 
1 ml 2 % w/v sodium potassium tartrate, 1 ml 1 % w/v copper sulphate, 98 ml 2 % w/v 
sodium carbonate in 0.1 M NaOH) was added. The tubes were vortexed and allowed to 
stand for 30 min at room temperature. Equal volumes of Folin reagent (Folin-Ciocalteau 
reagent) was diluted 1:1 with distilled water and 500 p1 added to each tube. Once added, 
the tubes were vortexed rapidly and again left to stand for 30 min at room temperature. The 
absorbance's of all the tubes were read at 595 nm on a spectrophotometer (Novaspec II, 
Pharmacia Biotech). The total protein concentration (jig mlj in each standard dilution was 
then plotted against the absorbance reading. The tissue samples were treated in the same 
manner and the total protein in each sample was determined by plotting the absorbance 
reading of the sample at 595 nm against the protein standard concentration. 
2.3.3 Measurement of ions using the flame atomic absorbance 
spectrometer (FASS) 
On the day of use, previously frozen pancreatic tissue was allowed to defrost in the fridge 
at 4°C. After the tissue had defrosted, 3 ml of a 0.01 % Lanthium Chloride (LaCI3) solution 
(made with Millipore water) was added into the vial containing the tissue and sonicated 
until the tissue had fully disintegrated. The digested tissue samples were then diluted 1:100 
with Millipore water. Appropriate standard ion solutions were made ranging from 0.1 - 20 
jig ml' from a standard stock concentration of 20 jig mF' of either iron (Fe 2 ), calcium 
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(Ca2 ), magnesium (Mg2 ), potassium (IC), sodium (Na) and zinc (Zn 2 ). The 
concentrations of these ions were determined in the pancreatic samples by the use of FASS. 
The flame atomic absorption technique detects metals and metalloids and is based on the 
fact that ground state metals absorb light at specific wavelengths. During combustion, 
metal ions in a solution were reduced to free, unexcited ground state atoms by means of a 
flame whose temperature ranges from 2100 - 2800 °C. A light beam from a lamp whose 
cathode is made of the element being determined was passed through the flame. A device 
such as photomultiplier detected the amount of reduction of the light intensity due to 
absorption by the analyte, and this was directly related to the amount of the element in the 
sample. The amount of light absorbed was measured against a standard curve and ion 
content results were expressed as jtg mY' per g of tissue. 
2.3.4 Measurement of intracellular free Ca 2 and M22 concentrations 
usinQ fura 2-AM and magfura 
For the measurement of [Ca 2+ 
 ]i and [Mg2 ]1 the excised pancreas was washed and placed in 
cold modified Krebs-Ringer-HEPES (KRH) solution (base solution). The composition of 
the base solution used here was as follows: 130mM NaCl, 5 mM KCI, 20mM HEPES, 1.2 
mM KH2PO4, 1 m'vI MgSO4.7H20, 10 mM Glucose (pH 7.4). The pancreas was finely 
minced and its segments digested in 5 ml 130 U ml' collagenase solution at 37°C for 40 
min with continuous shaking (maximum speed). The partially digested tissue was then 
washed five times with KRH containing soybean trypsin inhibitor (STI) (0.1 mg m1) and 
BSA (2 mg ml') (solution 1). Following gentle pipetting using five different diameter 
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pipette tips, acini were filtered through a double layer of muslin gauze. Next, acinar cells 
were centrifuged at 800 g for 4 min at 4 °C. The supernatant was removed and the cell 
pellet resuspended and centrifuged in approximately 10 ml of 5 % w/v BSA solution. 
Again the supernatant was removed and the cell pellet resuspended and centrifuged in KRH 
containing STI (1 mg ml'), BSA (2 mg ml') and 250 sl CaCl2 0  M) (solution 2). At this 
stage, the supernatant was once again removed and solution 2 added up to 4 ml. The cell 
suspension was loaded with either 2 jsM fura 2-acetylmethoxy ester (AM) or 2 jiM magfiira 
for Ca2 and Mg2 , respectively to the 4 ml cell suspension (Streb & Schulz, 1983; Francis 
et at, 1990b; Lennard & Singh, 1992). After loading, the cell suspension was incubated 
for 30 min in a 37 °C water bath with medium shaking speed. The cell suspension was then 
resuspended and centrifuged at 2000 g in 10 ml modified KRH containing base solution 
and 100 i-'l  of CaCl2 (solution 3). The final volume of cell suspension depended on the 
amount of cells obtained. Normally, three experiments were run using one pancreas, 
therefore the volume was bought up to 6 V2 - 7 ml. The tubes containing the cells were kept 
on ice. 
For quantification of cell fluorescence, a Perkin-Elmer LS-SB or LS-50 spectrophotometer 
was used. A volume of 2 ml of cell suspension was placed in a quartz cuvette and stirred 
continuously at 37 °C. The cell suspension was excited by a fluorescent xenon source at 
wavelengths of 340/380 nm for Ca 2 or 330/370 nm for Mg 2 and the fluorescence emission 
read at 510 nm. Slits were set at 10 nm. After an initial period of 60 sec and once the 
emission signal had settled to stable baseline fluorescence, a known volume of CCK-8 (220 
p1) was added directly to the cell suspension in the cuvette to give a final concentration of 
108 M. At the end of each experiment and for calibration purposes, digitonin (0.001 M, 
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200 p1) was added to the cell suspension in the cuvette to permeabilise the cells fully so 
enabling Ca 2 entry and thus providing a MAXIMUM calcium signal from the cells 
(Rmax). Following this addition, EGTA (ethylene glycol 3-aminoethylether-N,N,N',N' 
tetracetic acid) (0.1 M, 500 p1) was added to dissociate Ca 2 and Mg2 from the fura-2 
molecules and hence give a MINIMUM calcium signal (Rmin). The final [Ca 2 ]1 and 
[Mg2 ]1 was calculated as previously described (Giynkiewicz ci cxl., 1985; Raju ci cxl., 1989; 
Tsien, 1981) using the following equation to predict fluorescence as a function of either 
[ca 
 2+ ]i or [Mg2 J. 
F = Fmi n + (Fmax - Fm in) ([Ca2 ]1 /Kd) / 1 + [Ca2 ] / Kd 
Therefore: [Ca2 ]1 = Kd (F - Fm jn) 
(Kmax - F) 
Where Kd = 190 nm 
2.3.5 Measurement of intracellular free Ca 2 concentrations in single 
pancreatic acinar cells using fura 2-AM and 
microspectrofluorimetry 
The [Ca2 ]1 in single pancreatic acinar cells was measured using an established method 
(Camello ci cxl., 2000). For this series of experiments, fura 2-AM loaded acinar cells (see 
above) were placed on a glass coverslip attached to an open Perspex perfusion chamber and 
continuously perfused with buffer (containing no STI or BSA) at room temperature. 
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Secretagogues were administrated via an injection tube attached to the perfusion chamber. 
Fluorescence intensity was measured using a photomultiplier-based 
microspectrofluorimeter connected to an inverted microscope fitted with a 40X objective. 
For ratiometric measurements of [Ca 2 ], 340 and 380 nm were selected for excitation and a 
510 nm emission filter was used. Background fluorescence was subtracted. 
The final [Ca 2+ 
 ]i was calculated by the method described by Grynkiewicz et al., (1985) 
respectively. 
2.3.6 Protocol for measuring mRNA gene expression for CCKA receptor 
and a-amylase using RT-PCR 
Age-matched control rats and STZ-induced diabetic rats were humanely sacrificed exactly 
6 weeks post citrate buffer/STZ injection, the pancreas excised and frozen immediately in 
liquid Nitrogen aseptically and stored at 80 °C. Total RNA was isolated from pancreatic 
tissue using Tn-Reagent (Sigma, T-9424), based on the acid guanidinium thiocyanate-
phenol-chloroform RNA extraction method (Chomczynski & Sacchi, 1987). Frozen 
pancreatic tissues were transferred directly into 2 ml RNase-free Eppendorf tubes 
containing 1000 M1  Tn-Reagent per 100 mg tissue. Samples were homogenised 
immediately using a Polytron homogeniser (Ultra-Turrax T8) until the tissue was fully 
digested. The homogenised samples were incubated at room temperature for 5 mm. A 
volume of 100 p1 BCP (I -bromo-3-chloropropane) was added to the sample tubes and 
vortexed for 15 sec. The samples were then left for 15 min at room temperature before 
centrifbgation at 12000 g for 15 min at 4 °C. During centrifugation, the mixture is seen to 
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separate into an upper aqueous phase containing the RNA, an interphase containing the 
DNA and a red lower organic phase containing the proteins, including the RNases. 
Approximately 500 p1 of the upper aqueous phase was carefully transferred to a fresh 1.5 
ml Eppendorf tube and 500 p1 of isopropanol was added to precipitate the RNA. This 
solution was left for 5 - 10 min at room temperature before being centrifuged at 12000 g for 
8 min at 4 °C. The supernatant was collected and a volume of 1 ml of RNase-free ethanol 
(75 %) was added to the sample wbes and again centrifuged at 7500 g for 5 min at 4 °C. 
This process was repeated a further two times to ensure the guanidinium salts were 
eliminated. The remaining supernatant was removed and the visible RNA pellet was then 
air-dried for 5 mm. Care was taken not to completely dry the RNA pellet. The RNA pellet 
was then resuspended in 20 p1 RNase-free water. A 10 p1 aliquot of the RNA was 
dissolved in TE buffer (10 mM Tris-HCI, 1 mM EDTA, pH 8) and the quantity and purity 
of RNA was measured by reading the absorbance at 260, 280 and 240 nm. The 
concentration was calculated as C = 40 ng/pl x Aoo. 
The integrity of the isolated RNA from both control and STZ-induced diabetic pancreatic 
tissue was analysed using agarose gel electrophoresis run at 50 V. RNA (2 pg) was loaded 
on a I % agarose gel made with TAE buffer followed by staining with ethidium bromide 
and examination under ultraviolet light. Only the RNA samples that showed two sharp 
(28s and 18s) ribosomal RNA bands with a 2:1 ratio after separating by electrophoresis 
were used for further experimentation. 
For cDNA synthesis, I pg of RNA was incubated using Oligo-p[dT]15 as a hexamer primer 
in a reaction mixture with AMV reverse transcriptase (RI) using a First Strand eDNA 
Synthesis Kit (Roche Diagnostics). First strand cDNA synthesis was carried out at 25 °C 
in 
for 10 min followed by 42 °C for 60 mm (primer annealing) and then 99°C for 5 mm 
(denaturing), and then cooled to 4 °C for 5 mm. The resulting single-stranded eDNA was 
amplified in a RealTime PCR using CCKA receptor and a-amylase specific primers. SYBR 
green (LightCycler FastStart DNA Master'UJS 
 SYBR Green 1 Kit, Roche Diagnostics) was 
used for the amplifications. Reaction mixtures contained 2 Lil of the first-strand eDNA, 0.5 
iM gene specific primers (TIB Molbiol), 0.2 mM dNTP (deoxynucleoside triphosphate), 
40 U/mI Taq DNA Polymerase, 1.5 mM M902, reaction buffer and SYBR Green I dye 
provided in the reaction mix kit. The primers for the amplification of ct-amylase cDNA 
were designed on the basis of the mRNA sequence of rat pancreas amylase (MacDonald et 
al., 1980). The designed primers were: 5'—GCCTACTGACAGAGCCCTTG--3' (forward) 
and 5'—TGGTCCAATCCAGTCAUCA-3' (reverse), corresponding to nucleotides 912-
932 and 1131-1151 of the amylase eDNA sequence. Thermal cycling conditions were 
denaturation at 95 °C for 10 mm, amplification (54 0C/1 sec; 72 °C/9 sec; 64°C/40 see) and a 
final elongation at 40 °c for 30 sec for 40 cycles. Genomic DNA was assayed alongside the 
primers to verify that the primers would not amplify genomic DNA. 
For amplification of the CCKA receptor mRNA, RT-PCR was carried out using the sense 
and antisense primers which corresponded to the nucleotide sequence of rat CCKA receptor. 
The designed primers were: 5'-GGCATTGCTGTCCAGGTATF-3' (forward) and 5'-
ATGACCCCACCTTAGGTTCC-3' (reverse), corresponding to nucleotides 1484-1504 and 
1704-1724 respectively, of the CCKA receptor eDNA sequence. Thermal cycling 
conditions were denaturation at 95°C for 10 see, amplification (95 0C/1 sec; 54°C/1 sec; 
72 °C/9 see) and a final elongation at 40 °c for 30 sec for 45 cycles. At the end of each 
cycle, the fluorescence was measured in a single step in channel F! (gain 1). After the 45th 
cycle, the specimens were heated to 95°C and rapidly cooled down to 65°C for 15 sec. All 
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heating and cooling steps were performed with a slope of 20°C/s. The temperature was 
then raised to 95°C in slope of 0.1°C/s and fluorescence was measure continuously 
(channel Ft, gain 1) to obtain data for the melting curve analysis. Again genomic DNA 
was assayed alongside the primers to verify that the primers would not amplify genomic 
DNA. 
Amplification was detected by measuring the fluorescence signal of SYBR Green 1. When 
bound to double-stranded DNA, the SYBR Green 1 dye emitted a fluorescence signal that 
was detected at 530 nm. Fluorescence crossover values were used to determine mRNA 
levels in samples 
To confirm that the correct amylase and CCKA receptor mRNA had been amplified, gel 
electrophoresis analysis of the RT-PCR amplicons were carried out. The PCR products 
were separated electrophoretically on a 2 % TAE agarose gel, stained in ethidium bromide 
and the bands visualised under ultraviolet light. A single band corresponding to the correct 
amplicon size was observed for cz-amylase and CCKA receptor of 220 and 221 base pairs 
(bp), respectively. 
2.3.7 Western blot method to measure translational proteins 
Proteins were extracted from 8 control and STZ-induced diabetic pancreas. Approximately 
30 mg of tissue was homogenised on ice in 0.6 ml of homogenisation buffer (50 mM Tris-
HCL; 0.1 % Triton-X; 1 mM EDTA; 1 mM EGTA; 50 mM NaF; 10 mM 0-
glycerophosphate; 5 mM Na pyrophosphate; 0.1 % 2-mercaptoethanol; 100 nM okadaic 
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acid; 50 iM sodium orthovanadate; I tablet of a protease inhibitor cocktail). Samples were 
rotated for 60 min at 4 °C, before being centrifuged at 13000 g for 10 mm. Protein 
concentration of the supernatant was measured using the Bradford assay and adjusted to 2 
mg m14 by diluting in SDS sample buffer (3.55 ml deionised water, 1.25 ml 0.5 M Tris-
I-ICL, pH 6.8; 2.5 ml glycerol; 2 ml 10 % (w/v) SDS; 0.2 ml 0.5 % (wlv) bromophenol 
blue). 
Samples (20 jig) were electrophoresed in running buffer (I % SDS; 192 mM Glycine; 25 
mM Tris-base; pH 8.3) on a 10 % SDS-PAGE (13.5 % high-bis gel for 4E-BP1) gel at 100 
V for 30 min through the stacking layer and then 200 V until the dye marker reached the 
bottom of the gel. Precisely, 10 jil of a rainbow molecular size marker was loaded in to the 
final lane in order to later confirm detection of the correct protein size. Following 
conclusion of electrophoresis, the polyvinylidene difluoride (PVDF) membrane was 
permeabilised in 100 % methanol for 1 min before both the gel and pre-wetted membrane 
were equilibrated in transfer buffer (192 mM glycine; 25 mM Tris base; 20 % w/v 
methanol; pH 8.3) for 30 mm. The transfer was run for 2 h at a constant 100 V. Upon 
completion of transfer, the unifonnity of loading was checked with Ponceau S before the 
membrane was incubated in 30 ml of blocking buffer (TBS with 0.1 % Tween-20; 5 % w/v 
non-fat milk powder) for 2 h. Following incubation with the blocking buffer the membrane 
was washed 3 times for 5 min with wash buffer (TBS with 0.1 % Tween-20) in 30 ml with 
gentle agitation. Samples were exposed to the following pan antibodies: anti-NFiB 
(NEB3034; 1:2000); anti-PKB/AKT (Courtesy of Sir P. Cohen; 1:2000); anti-p70 S6K 
(NEB9202; 1:2000); anti-ERKI/2 and anti-4E-BPI (courtesy of Prof C.G. Proud; 1:1000) 
overnight at 4°C. Phosphorylation status was measured using: phospho-PKB (NEB927 1; 
JI 
Ser473; 1:2000); phospho-p70 56K (NEB9205; Thr389; 1:2000); phospho-ERK1/2 
(p44/p42) (NEB9 101; Thr202/Tyr204; 1:2000); and phospho-4E-BP 1 (NEB9459; 
Ser37/46; 1:2000) also overnight at 4 °C. The following morning, the membrane was rinsed 
in wash buffer 3 times for 5 min each time in 30 ml. The membrane was then incubated for 
1 h at ambient temperature with gentle agitation in 30 ml of blocking buffer containing the 
appropriate secondary antibody, either: HRP-linked anti- mouse IgG (NEB 7072; 1:2000); 
anti- rabbit IgG (NEB7074; 1:2000) or anti-sheep IgG (courtesy of Chris Proud; 1:5000). 
The membrane was cleared in wash buffer 3 times for 5 min in 30 ml wash buffer. 
Membranes were exposed to ECL chemiluminescent detection reagents mixed 1:1 in 10 ml 
for 1 mm. Membranes were partially dried, wrapped in saran and exposed to X-ray film. 
X-ray films were scaniied using a Biorad Imaging densitometer (Model GS-670) to detect 
the relative band intensity. Each band was identified and the optical density volume 
adjusted by subtraction of the background. All values obtained from one blot were 
normalised to the average resting control band intensity which was set to 1. 
2.4 Statistical Analysis 
For in vivo experimentation, all data are presented as means ± S.E.M. Given that 
pancreatic juice secretion was very stable during the unstimulated (basal) period; values for 
the two corresponding samples (flow rate, protein secretion and amylase secretion) were 
averaged. Statistical comparisons within the two groups (above resting values) were done 
by one-way analysis of variance (ANOVA) followed by the post-hoc Bonferroni test. 
Correlations were examined by the method of Pearson. Differences in the secretory 
parameters between control and diabetic animals prior to insulin addition (basals), as well 
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as those in body and pancreas weight were tested for significance with the independent 
samples Student's t-test. The SPSS software was used in all cases (SPSS for windows, 
version 11.0.1, 2001). 
For in vitro and molecular experiments, statistical significance was assessed by the use of a 
Student's t-test and a one-way ANOVA. All data are expressed as means ± S.E.M. Only 
values with P<0.05 were accepted as significant. 
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CHAPTER 3 
EFFECTS OF INSULIN AND CCK-8 ON 
PANCREATIC JUICE SECRETION IN THE 
ANAESTHETISED RAT IN THE ABSENCE 
AND PRESENCE OF THE MUSCARINIC 
CHOLINERGIC ANTAGONIST ATROPINE 
M. 
3.1 Introduction 
Although the pancreas is usually regarded as two separate organ systems, morphological 
and functional evidence suggests that inter-relationship and interaction between the 
exocrine and endocrine portions occur (Williams &.Goldfine, 1993; Owyang, 1993; Singh 
et al., 2004; Patel et al., 2004c). Moreover, a number of clinical and experimental studies 
indicate that the pancreatic exoerine function is altered in DM, but neither this dysfunction 
has been fully characterised nor its mechanism precisely established. In vitro studies 
(Okabayashi et at, 1988b; Singh, 1985; Juma et at, 1997; Singh & Adeghate, 1998; Singh 
et at, 1999; Singh et aL, 2001) conducted in pancreatic segments and acinar cells have 
shown the existence of a potentiation between the islet peptides and the classical pancreatic 
secretagogues in the regulation of exocrine secretion in healthy rats and that this interaction 
is impaired when the animal is rendered diabetic. 
In vivo, insulin seems to act as a trophic factor to maintain the tissue level of amylase 
(Duan & Erlanson-Albertsson, 1992) and there is a general agreement that both exogenous 
(Kanno & Saito, 1976; Saito et at, 1980; Park et at, 1993) and endogenous (Saito et at, 
1980; Park et at, 1993; Lee et at, 1990; Lee et at, 1996; Iwabe et at, 2001) insulin can 
potentiate the action of CCK-8 on exocrine pancreatic secretion in healthy rats. In contrast, 
there are many contradictory reports regarding the effects of insulin alone on the secretory 
activity likely with the use of different species, preparations (isolated perfused pancreas vs. 
anaesthetised animal) and experimental conditions. Thus, while earlier studies failed to 
demonstrate an effect of endogenous or exogenous insulin on the basal secretion of 
amylase, fluid and total protein in the isolated perfused rat pancreas (Kanno & Saito, 1976; 
Saito ci at, 1980), clear increases have been reported more recently (Park ci at, 1993; Lee 
ci aL, 1996). There are only a few studies examining this topic in the whole animal 
preparation and their results are divergent again, showing either no effect of insulin (Iwabe 
ci al., 2001) or a small stimulation of basal pancreatic flow rate (Ferrer ci at, 2000). For 
this reason, an in vivo experimental model of anaesthetised rats was employed under basal 
conditions in order to better characterise the secretagogue effects of exogenous insulin and 
CCK-8 on exocrine pancreatic secretion in healthy and STZ-induced diabetic rats. 
3.2 Methods 
All methods were as stated in chapter 2. 
3.3 Results 
3.3.1 General characteristics of control and diabetic rats 
The general characteristics of age-matched control and diabetic rats together with basal 
secretory parameters and basal [Ca 2 ]1 and [Mg 2+  ]i are shown in Table I. The results show 
that diabetic rats and the pancreas weighed significantly less (P<0.05) and have 
significantly elevated (P<0.05) blood glucose level and significantly reduced (P<0.05) 
plasma insulin concentration compared to age-matched control rats. In contrast, resting 
(basal) pancreatic juice flow was significantly increased (Pc0.05) ii diabetic rats compared 
to control rats, whilst the pancreatic juice of diabetic animals contains significantly less 
(P<O.05) protein and amylase concentrations compared to the juice of control rats. There 
was no significant change in basal [Ca 2+ 
 ]i in both groups of rats although the level was 
slightly higher in diabetic acinar cells. However, basal [Mg 2+ 
 ]i was significantly reduced 
(P<0.05) in pancreatic acinar cells of diabetic rats compared to acinar cells of age-matched 
control rats. 
Table I. General Characteristics of normal and diabetic rats after 7 - 8 weeks of STZ-
treatment 
Experimental Conditions 
	 Age-matched Control STZ-induced DM 
Weight of animals (g) 
Blood glucose level (mg d1 1 ) 
Pancreatic weight (g) 
Plasma insulin (ng mi-I) 
Resting (basal) pancreatic juice flow (ul mm 1 ) 
Basal protein output (ug mm") 
Basal amylase output (U mm") 
Basal [Ca2t]i (nM) 
Basal [Mg2 ]i (mM) 
391.83 ± 37.91 (20) 
92.40 ± 2.42 (44) 
1.30 ± 0.07 (20) 
20.63 ± 7.52 (10) 
0.56 ± 0.046 (10) 
0.34 ± 0.011(10) 
0.069±0.011(10) 
109.40± 15.41 (18) 
0.96 ± 0.06 (18) 
*190.12±5.41(20) 
*>500 (27) 
*1.02 ± 0.05 (20) 
*4.80 ± 1.28 (10) 
*1.28 ± 0.16 (8) 
*0.084 ± 0.021 (8) 
*0.00001 ± 0.000001 (8) 
130.62± 17.66(10) 
*0.86 ± 0.04 (10) 
Data are mean ± S.E.M., n values are shown in brackets and indicate the number of 
animals, *pc0.05 comparing control with diabetic. 
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3.3.2 Effect of CCK-8 in control and diabetic rats 
Figure 3.1 shows the time course of pancreatic juice flow rate (ii!  miii) in control (solid 
squares) and diabetic (solid circles) rats in basal condition (the first time-course point) and 
following infusion of 150 pmol CCK-8 kg 4 fr' for 1 It (next 5 time course points). 
Thereafter, CCK-8 infusion was ceased and pancreatic juice flow collected for another 60 
mm (last 3 time-course points). The results reveal that CCK-8 can evoke a large transient 
increase in pancreatic juice flow in normal rats compared to basal, reaching a peak within 
the first 10 mm. Thereafter, flow declined gradually even in the continuous presence of 
CCK-8. On complete removal of CCK-8, flow rate declined even further to reach the basal 
level. On the other hand, diabetic rats have a high basal flow rate and CCK-8 infusion 
increased this, gradually reaching a maximum after 40 min of CCK-8 infusion, followed by 
a gradual decline to below the basal level. On removal of CCK-8, flow rate continued to 
decline reaching a significantly lower (P<O.O/) basal level compared to the initial basal 
flow rate. Throughout these time-course experiments, pancreatic juice flow rate was 
significantly (P<0.01) higher (except for the first 20 min of CCK-8 infusion) in diabetic 
rats compared to control rats. 
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Figure 3.1. Time course of pancreatic juice flow rate (p1 minj in age-matched control 
(solid squares) and STZ-induced diabetic (solid circles) rats in basal conditions (first time 
point), during CCK-8 infusion (150 pmol kg' h' for 100 mm, as indicated by the solid 
line) and following the cessation of CCK-8 infusion (last 3 time points). Each point is mean 
± S.E.M. n = 8 - 10. #P<o 
 05 as compared with the respective basal (one-way ANOVA plus 
post-hoc Bonferroni test). Note that CCK-8 was infused immediately after the basal 
collection in this and subsequent figures in this chapter. Note also that diabetic animals 
produced elevated pancreatic juice flow compared to control animals. 
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Figure 3.2. Time course of protein output (iig min) in pancreatic juice in age-matched 
control (solid squares) and STZ-induced diabetic (solid circles) rats in basal conditions 
(first time point), during CCK-8 infusion (150 pmol kg' h 1 for 100 mm, as indicated by 
the solid line) and following the cessation of CCK-8 infusion (last 3 time points). Each 
point is mean ± S.E.M. n = 8 - 10. tP<0.05 as compared with the respective basal (one-
way ANOVA plus post-hoc Bonferroni test). Note that diabetic animals produced 
significantly (Pc0.05) less protein during the first 40 min of CCK-8 infusion compared to 
control. 
Figure 3.2 shows the time course of protein output (jig min) in pancreatic juice from age-
matched control (solid squares) and diabetic (solid circles) rats. In control rats, CCK-8 
infusion resulted in a significant (P<O.OI) and rapid increase in protein output reaching a 
maximum within 20 min of the hormone infusion. Thereafter, protein output declined 
steeply and continued to decline even further after CCK-8 removal to reach a level below 
the initial basal output. In diabetic rats, CCK-8 infusion resulted in a significant (P<0.01), 
but delayed, increase in protein output compared to basal, reaching a maximum after 40 
min of CCK-8 infusion. Thereafter, protein output plateaued for 40 min followed by a 
rapid decline. On removal of CCK-8, protein output declined further to the same level as 
the initial basal value. Taken together, the results show that diabetic rats produced 
significantly less (Pc0.01) protein in the juice during the first 40 min of CCK-8 infusion 
compared to control rats. 
The time course changes in amylase output in pancreatic juice of age-matched control 
(solid squares) and diabetic (solid circles) rats following CCK-8 infusion are shown in 
Figure 3.3. The results reveal that CCK-8 infusion can result in a marked and significant 
increase (P<O.OI) in amylase output in the juice of age-matched control rats compared to 
the initial basal secretion, reaching a maximum within the first 20 min of CCK-8 infusion. 
Thereafter, amylase output declined gradually even in the presence of the gut hormone. On 
removal of CCK-8, amylase output declined even further to below the initial basal value. 
In contrast, in diabetic rats CCK-8 infusion had virtually no effect on amylase output 
throughout the time course of infusion compared to the extremely low basal value (see inset 
of Figure 3.313). From all the experiments, it was apparent that the diabetic rats failed to 
secrete any significant amount of amylase. 
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Figure 3.3. (A) Time course of amylase output (U minj in pancreatic juice in age-
matched control (solid squares) and STZ-induced diabetic (solid circles) rats in basal 
conditions (first time point), during CCK-8 infusion (150 pmol kg' h 4 for 100 mm, as 
indicated by the solid line) and following the cessation of CCK-8 infusion (last 3 time 
points). (B) Inset showing detailed time course of amylase output in diabetic rats for 
comparison. Each point is mean ± S.E.M. n = 8 - 10. #p<95 as compared with the 
respective healthy controls (one-way ANOVA plus post-hoc Bonferroni test). Note that 
diabetic animals produced virtually no amylase in pancreatic juice. 
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3.3.3 Effect of insulin in control rats 
Exogenous bolus of insulin injection at a concentration of 1 U produced in healthy rats an 
increase in pancreatic flow rate that after 40 min reached statistical significance compared 
to basal (P<0.05), and remained significantly elevated for a fUrther 60 mm (Figure 3.4a). 
There were also marked increases in amylase output, with maximal effects (P<0.05) at 40 
min after insulin administration (Figure 3.4b). Total protein output (Figure 3.4b) showed a 
significant (P<0.05) increase above basal but only at 40 min post-insulin. It is important to 
note that insulin caused in these rats a progressive reduction in blood glucose levels. 
Animals were hypoglycaemic at 40 min after insulin administration (Figure 3.4a), 
coincident with the increase in flow rate. Both parameters, flow rate and glycaemia, 
showed a highly significant (P<O.OI) negative correlation. It is well established that 
hypoglycaemia stimulates vagal pathways (Sobhani et al., 2002; Mearadji et aL, 2000). 
The vagus nerve contains cholinergic and non-cholinergic nerves that interact with different 
neurons of the enteric nervous system (Nelson et al., 1993). However, the exocrine 
pancreatic secretion induced by vagal stimulation in anaesthetised rats seems to be mainly 
mediated by acetylcholine as the final common agonist (Nelson et aL, 1993; Wisdom etal., 
1993). This prompted the investigation of the effects of insulin in the presence of the 
muscarinic cholinergic blocker, atropine. Interestingly, it was observed that the 
secretagogue action of insulin on flow rate (Figure 3.5a) and such other parameters as 
protein and amylase (Figure 3.5b) output were abolished by the previous administration of 
atropine (0.2 mg kg 1 ) despite a similar reduction in glycaemia (Figure 3.5a). Furthermore, 
the strong negative correlation between flow rate and blood glucose levels was lost in these 
experiments. 
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Figure 3.4. Time-course effects of insulin (1 U) on (a) pancreatic juice flow rate (solid 
circles) and blood glucose levels (solid triangles) and on (b) the secretion of amylase (x-
shaped crosses) and protein (solid squares) in healthy anesthetized rats. Time = 0 mm 
represents the basal secretion after 8 h of fasting. The arrow indicates the point of insulin 
administration. Five experiments were conducted in separate rats. Thus, all data are means 
± S.E.M. of n = 5, except for basal values where n = 10. For each parameter, *,Dc0.05 as 
compared with the respective basal (one-way ANOVA plus post-hoc Bonferroni test). Note 
the reciprocal relationship between the insulin-induced hypoglycaemia and pancreatic juice 
flow rate. 
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Figure 3.5. Time course effects of I U bolus injection of insulin on (a) pancreatic juice 
flow rate (solid circles) and blood glucose levels (solid triangles) and on (b) the secretion of 
amylase (solid triangles) and protein (solid squares) in atropinised healthy anesthetized rats. 
A bolus of atropine sulphate (0.2 mg kg') was administered via the jugular vein catheter 
immediately before insulin administration (indicated by the arrow). Time = 0 mm 
represents the basal secretion after 8 h of fasting, before the administration of the drugs. Six 
experiments were conducted in separate rats. Thus, all data are means ± S.E.M. of n = 6, 
except for basal values where n = 12. For each parameter, "P<O.OS as compared with the 
respective basal (one-way ANOVA plus post-hoc Bonferroni test). Note that atropine 
blocked the secretagogue effects of insulin. 
3.3.4 Effect of insulin in diabetic rats 
In diabetic rats, insulin at a concentration of 4 U did not significantly stimulate exocrine 
pancreatic secretion (Figure 3.6a and b). There was a clear fall in blood glucose levels 
(Figure 3.6a). However, the rats did not become hypoglycaemic. In atropinised diabetic 
rats, a similar lack of changes in secretory parameters was found. Figures 3.7a, b and c all 
show that the presence of atropine (0.2 mg kgj did not significantly affect the 
secretagogue action of insulin on flow rate (Figure 3.7a), and such other parameters as 
protein (Figure 3.7b) and amylase (Figure 3.7c) secretion. 
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Figure 3.6. Time course effects of 4 U of insulin on (a) pancreatic juice flow rate (solid 
circles) and blood glucose levels (solid triangles) and on (b) the secretion of amylase (x-
shaped crosses) and protein (solid squares) in diabetic anesthetised rats, 7 - 8 weeks after 
STZ injection. Time = 0 min represents the basal secretion after 8 h of fasting. The arrow 
indicates the point of insulin administration. Five experiments were conducted in separate 
rats. Thus, all data are means ± S.E.M. of n = 5, except for basal values where ii = 10. Note 
the reduced rates of amylase and protein secretion throughout the entire experimental 
period (compare Y axis scales in Figure 3.4) and the lack of significant effects of insulin on 
the secretory parameters under study 
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Figure 3.7a. Time course effects of 4 U of insulin alone (solid squares), or a combination 
of 4 U of insulin with atropine (0.2mg kg') (solid triangles) on pancreatic juice flow rate 
from diabetic anaesthetised rats. A bolus of atropine sulphate (0.2 mg kg') was 
administered via the jugular vein catheter immediately before insulin administration 
(indicated by the arrow). Time = 0 min represents the basal secretion after 8 h of fasting, 
before the administration of the drugs. Six experiments were conducted in separate rats. 
Thus, all data are means ± S.E.M. of n = 6, except for basal values where ii = 12. 
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Figure 3.7b. Time course effects of 4 U of insulin alone (solid squares), or a combination 
of 4 U of insulin with atropine (0.2 mg kg) (solid triangles) on pancreatic juice protein 
output from diabetic anaesthetised rats. A bolus of atropine sulphate (0.2 mg kg') was 
administered via the jugular vein catheter immediately before insulin administration 
(indicated by the arrow). Time = 0 min represents the basal secretion after 8 h of fasting, 
before the administration of the drugs. Six experiments were conducted in separate rats. 
Thus, all data are means ± S.E.M. of n = 6, except for basal values where ii = 12. 
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Figure 3.7c. Time course effects of 4 U of insulin atone (solid squares), or a combination 
of 4 U of insulin with atropine (0.2 mg kg') (solid triangles) on pancreatic juice amylase 
output from diabetic anaesthetised rats. A bolus of atropine sulphate (0.2 mg kg') was 
administered via the jugular vein catheter immediately before insulin administration 
(indicated by the arrow). Time = 0 min represents the basal secretion after 8 h of fasting, 
before the administration of the drugs. Six experiments were conducted in separate rats. 
Thus, all data are means ± S.E.M. of n = 6, except for basal values where n = 12. 
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3.3.5 Effect of CCK-8 combined with insulin in control rats 
When CCK-8 was infused in combination with insulin in the anaesthetised healthy rat, a 
rapid and significant (P<0.05) increase in the rate of pancreatic juice flow was 
demonstrated compared to the effect of either CCK-8 or insulin administered alone. A 
maximum rate was reached after 100 min of inflision (Figure 3.8a). Figure 3.8b illustrates 
pancreatic flow rate and blood glucose levels in the combined presence of atropine, CCK-8 
and insulin. The presence of atropine caused a significant reduction in pancreatic juice 
flow rate during the full time course of the experiment. Animals were hypoglycaemic at 80 
min after insulin and CCK-8 administration (Figure 3.8b), incoincident with the increase in 
flow rate compared to Figure 3.5a. 
No significant (P<0.05) increase in protein (Figure 3.8c) was shown in response to 
combined CCK-8 and insulin administration compared to both drugs alone. 
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Figure 3.8a. Time course effects of 1 U of insulin alone (solid triangles), CCK-8 (150 
pmol kg' h') alone (solid squares), and a combination of insulin (1 U) and CCK-8 (150 
pmol kg' h') (solid circles) on pancreatic juice flow rate from healthy anaesthetised rats. 
Time = 0 min represents the basal secretion after S h of fasting, before the administration of 
the drugs (indicated by the arrow). Six experiments were conducted in separate rats. Thus, 
all data are means ± S.E.M. of ii = 6, except for basal values where n = 12. For each 
parameter, *pco.os 
 as compared with the respective basal (one-way ANOVA plus post-
hoc Bonferroni test). 
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Figure 3.8b. Time course effects of a concentration of 1 U of insulin and CCK-8 (150 
pmol kg' h') on pancreatic juice flow (solid line) and blood glucose levels (dashed line) in 
atropinised healthy anaesthetised rats. Time = 0 min represents the basal secretion after 8 It 
of fasting, before the administration of the drugs (indicated by the arrow). Six experiments 
were conducted in separate rats. Thus, all data are means ± S.E.M. of n = 6, except for basal 
values where a = 12. For each parameter, *pc095 
 as compared with the respective basal 
(one-way ANOVA plus post-hoc Bonferroni test). 
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Figure 3.8c. Time course effects of 1 U of insulin alone (solid triangles), CCK-8 (150 
pmol kg' hO') alone (solid squares), and a combination of insulin (1 U) and CCK-8 (150 
pmol kg' h') (solid circles) on pancreatic juice protein output from healthy anaesthetised 
rats. Time = 0 min represents the basal secretion after 8 h of fasting, before the 
administration of the drugs (indicated by the arrow). Six experiments were conducted in 
separate rats. Thus, all data are means ± S.E.M. of n = 6, except for basal values where n = 
12. For each parameter, *p<5 as compared with the respective basal (one-way ANOVA 
plus post-hoc Bonferroni test). 
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Figure 3.8d. Time course effects of 1 U of insulin alone (solid triangles), CCK-8 (150 
pmol kg' h) alone (solid squares), and a combination of insulin (1 U) and CCK-8 (150 
pmol kg' h) (solid circles) on pancreatic juice amylase output from healthy anaesthetised 
rats. Time = o min represents the basal secretion after 8 h of fasting, before the 
administration of the drugs (indicated by the arrow). Six experiments were conducted in 
separate rats. Thus, all data are means ± S.E.M. of n = 6, except for basal values where a = 
12. For each parameter, *p<.05 
 as compared with the respective basal (one-way ANOVA 
plus post-hoc Bonferroni test). 
3.4 Discussion 
The results of this study have demonstrated marked and significant differences in the 
characteristics of diabetic rats and the functions of the diabetic pancreas compared to age-
matched controls. Following the induction of STZ, diabetic animals gained significantly 
less weight. This may be due to the fact that they eat less which in turn results in weight 
toss (Ahmed et al., 1998). As a result of this, the pancreas may have gained significantly 
less weight. STZ-induced type I DM is associated with significantly elevated blood 
glucose levels compared to control. STZ is an antibiotic, which selectively destroys the 3-
cells of the endocrine pancreas (Sharma et al., 1985; Ahmed et al., 1998) resulting in a 
decrease in insulin secretion and the subsequent hyperglycaemia as seen in this study 
(Kumar & Clark, 2002; Sharma etal., 1985). In the current study, not only hyperglycaemia 
but also other hallmark symptoms of STZ-induced experimental diabetes such as polydipsia 
and polyuria were observed. The results of this study have also revealed that the functions 
of the diabetic exocrine pancreas are altered markedly following induction of diabetes. 
There was a significant increase in basal pancreatic juice flow in diabetic rats compared to 
healthy age-matched control animals. This could be seen as a surprising finding. The 
increase in flow in the diabetic rats may be due to an adaptive mechanism to compensate 
for the decreases in basal protein output and amylase secretion. 
The gut hormone CCK-8 is a powerful secretagogue in the exocrine pancreas (Chey, 1993; 
Singh et at, 1992). Infusion of CCK-8 in both age-matched control and diabetic rats 
resulted in significant increases in pancreatic juice flow and total protein output compared 
to their respective basal values. However, in the diabetic rats, the CCK-8 evoked increase 
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in juice flow was much higher compared to the responses obtained in age-matched control 
rats. In fact, the major differences compared with control rats concerned not the magnitude 
but the time course of the response. The absolute values of flow rate during the CCK-8 
infusion period were not significantly different between diabetic and control animals. 
However, it can be confirmed that the net effect of the secretagogue on volume secretion 
was clearly attenuated after the induction of experimental diabetes (Patel et al., 2004a). 
This is supported by earlier findings (Okabayashi et al., I 988b) which demonstrated that in 
diabetic animals there was a right-ward shift of the dose-response curve of juice secretion 
to a CCK-8 analogue. With regards to amylase secretion, CCK-8 administration resulted in 
a significant increase compared to basal value in age-matched control rats. In contrast, in 
the diabetic rats CCK-8 infusion resulted in little or no change in amylase secretion 
compared to the very low basal secretion. Diminished secretion of amylase in response to 
CCK-8 and CCK-8 analogues has been repeatedly described in diabetic animals regardless 
whether in vivo or in vitro preparations were used (Juma et al., 1997; Okabayashi et at, 
1988b; Otsuki et at, 1984; Singh et aL, 1999; Sofrankova & Dockray, 1983; Yang & Zhu, 
1994). 
The question which now arises is; what is the mechanism for this decrease in digestive 
amylase secretion during DM? It has been suggested that this deficiency in amylase 
secretion in diabetic rats is due in part to decreased amylase mRNA levels, amylase 
synthesis, its content andlor its activity (Duan et aL, 1992; Duan & Erlanson-Albertsson, 
1992; Yang & Zhu, 1994). In addition, the flow rate and protein output data of this study 
indicate the existence of changes in the secretagogue-induced secretory mechanisms. 
Furthermore, a post-receptor defect in CCK-8 leading to impaired ability of this peptide to 
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initiate its cellular response has been postulated in STZ-induced diabetic rats (Otsuki et al., 
1984; Sofrankova & Dockray, 1983). 
The effects of insulin on pancreatic exocrine secretion in healthy rats have been 
investigated previously. Studies using different experimental preparations and approaches 
suggest that insulin plays a role in potentiating pancreatic secretion stimulated by eating a 
meal, such classical secretagogues being CCK, secretin, ACh and even EFS (Iwabe et al., 
2001; Juma et at, 1997; Kanno & Saito, 1976; Lee et at, 1990; 1996; Park et at, 1993; 
Saito et at, 1980; Singh & Adeghate, 1998; Singh et at, 1999; 2001). However, the effects 
of insulin alone, i.e. on unstimulated pancreatic secretion remain unclear. Thus, although 
the existence of IRs on pancreatic acinar cells is well known (Sankaran etal., 1981), insulin 
has been shown to have little or no effect on amylase secretion from pancreatic lobules, 
segments or isolated acinar cells (Juma et at, 1997; Singh, 1985; Singh & Adeghate, 1998; 
Singh et al., 1999; 2001). In vivo studies show both modest (Ferrer et at, 2000; Lee et at, 
1996; Park et at, 1993) and no stimulatory effects (Iwabe et at, 2001; Kanno & Saito, 
1976; Saito et at, 1980) of insulin alone. 
The results of this study have shown that exogenous applications of insulin (1 U per rat) 
produced a significant elevation in the pancreatic volume, amylase and total protein 
secretion compared to basal in age-matched healthy control rats. The present results are 
consistent with earlier findings in anaesthetised rats (Sofrankova, 1984) showing that 
exogenous insulin (10 U kg') enhances the secretion of pancreatic juice and amylase 
compared to basal secretion. In a recent study investigating the effects of three doses of 
exogenous insulin Ferrer et at, (2000) found that only the intermediate dose (approx. 0.7 U 
kg' mm 1 over 60 mm) increased pancreatic flow rate as compared with a control saline 
infusion, although this was not accompanied by changes in enzyme output. These 
discrepancies may be due in part to the fact that white Sofrankova (1984) and this study 
used a bolus of insulin, the hormone was given as a slow intravenous infusion in the study 
of Ferrer et aL (2000). In contrast to previous studies, this study demonstrated a 
potentiating effect of insulin on CCK-8—evoked pancreatic juice secretion and amylase 
output in healthy control rats. However, insulin failed to produce any potentiating effects 
on CCK-8-evoked secretory responses in diabetic rats. The potentiation by insulin seems 
to require the presence of intact islets, since potentiation has been confirmed in the isolated 
perfused pancreas but not in isolated acini of acinar cells (Juma el aL, 1997; Singh & 
Adeghate, 1998). There is much evidence for a role of insulin on the regulation of the 
biosynthesis of pancreatic digestive enzymes and the potentiation of nerve-mediated and 
secretagogue-evoked secretory responses. The precise mechanism of the potentiation 
between the islet hormones and secretagogues is not yet fully established. 
An important part of the present study was to elucidate the mechanism for the observed 
stimulatory effect of insulin on exocrine secretion. Since blood and pancreatic juice 
samples were taken simultaneously, the relation between the time course changes in 
secretory parameters and blood glucose concentrations could be studied. An immediate 
effect of insulin was, of course, a decrease in blood glucose levels, suggesting that observed 
results might be explained by hypoglycaemia-induced activation of vagal cholinergic 
pathways. This is supported by several studies employing animals. First, there was no 
increase in exocrine secretion at 20 min post-insulin. At this time, the islet hormone was 
clearly acting at the systemic level since a significant fall in glycaemia was noted as 
compared with the corresponding basal. However, glucose concentrations were still within 
the physiological range. The fact that insulin increased significantly the secretion of 
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pancreatic juice flow, protein output and amylase secretion only after 40 mm, when marked 
hypoglycaemia was evident, agrees with the idea that the primary stimulus is 
hypoglycaemia and not insulin itself. Second, correlation analysis showed a strong 
negative correlation between flow rate and blood glucose. Additional support for a 
mediation of the central nervous system comes from the atropine experiments, showing that 
the 'secretagogue" effects of insulin on exocrine pancreatic secretion in vivo were 
prevented in the presence of this muscarinic receptor antagonist atropine (Patel et ci., 
2004b). Insulin-induced hypoglycaemia activates vagal nuclei by producing central 
intracellular glucopenia (Mearadji et aL, 2000; Sobhani et aL, 2002). It is worth noting 
here that, similar to direct efferent vagal activation induced by electrical stimulation of the 
vagal trunks (Wisdom et ci., 1993), central glucopenia evokes in anaesthetised acute fistula 
rats marked increases in flow, total protein and amylase output (Appia et ci., 1984). These 
responses are, especially the secretion of protein, in large part due to ACh acting on 
muscarinic receptors on acinar cells, because they are inhibited to a large extent by atropine 
(Nelson et aL, 1993; Wisdom et aL, 1993), as seen in this study. Consistent with this 
mechanism are observations that ACh acts on isolated acinar cells as a full agonist for 
enzyme release (Williams et ai., 1978). 
Experiments are required to examine the effects of euglycaemic hyperinsulinemia on 
exocrine pancreatic secretion in the healthy anaesthetised rat. Studies in intact dogs (Berry 
& Fink, 1996) have shown that in such conditions there is no stimulation of the exocrine 
pancreas, which also suggests an indirect—hypoglycaemia-mediated-effect of insulin in the 
whole animal preparation. Reports that acute hyperglycaemia inhibits human pancreatic 
function through the suppression of the vagal cholinergic tone (Lam cit ci., 1999) further 
supports this study. 
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35 Conclusion 
In conclusion, the results of this study have revealed that, under basal conditions, the 
secretory thnction of the exocrine pancreas is altered markedly following induction of 
diabetes. The first finding was a significant increase in unstimulated pancreatic flow rate in 
the diabetic rats compared to healthy controls, similar to previous reports in perfused 
pancreas of STZ-induced diabetic rats (Okabayashi et at, 1988b). The enhanced basal 
secretion of fluid in diabetic animals may be related to alterations in the duct system 
(Bertelli et al., 2001), and was associated in our study with a significant reduction in the 
secretion of both amylase (Okabayashi et at, 1988b; Sofrankova & Dockray, 1983) and 
total protein. Acute insulin administration (4 U) to anaesthetised diabetic animals did not 
significantly change any of the secretory parameters studied. Mean blood glucose levels 
were near 500 mg dF 1 prior to insulin and these values reached around 385 mg dF' 120 mm 
after the administration. Failure to achieve hypoglycaemic levels with the dose of insulin 
employed prevented this study from confirming whether the indirect stimulatory effect of 
insulin observed in the healthy rats of this study was occurring (and to what extent) in 
chronic diabetic rats after 7 - 8 weeks of STZ injection. 
114 
CHAPTER 4 
INTERACTIONS OF INSULIN WITH 
EiThER ACII OR CCK-8 ON EXOCRINE 
PANCREATIC SECRETION AND ON Ca 2 
and Mg2 HOMEOSTASIS IN AGE- 
MATCHED CONTROL AND DIABETIC 
RAT PANCREATIC ACINAR CELLS 'IN 
VITRO' 
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4.1 Introduction 
One of the long-term complications of DM is exocrine pancreatic insufficiency. The 
inability of the pancreas to secrete adequate amounts of digestive enzymes especially 
amylase to break down carbohydrates leads to symptoms such as malnutrition and weight 
loss in patients. Many in vivo and in vitro studies have investigated the interactions of the 
metabolic islet hormone insulin on secretagogue-evoked enzyme secretion in healthy age-
matched control and STZ-induced diabetic animals. Insulin has shown to potentiate the 
secretory effects of the gut hormone CCK-8 and the autonomic neurotransmitter ACh in 
normal healthy conditions (Otsuki & Williams, 1983; Singh et at, 2001; Williams et at, 
1981). In contrast, in the diabetic state, insulin failed to enhance the secretory effects of 
either CCK-8 or ACh (Patel et at, 2004b; Singh & Adeghate, 1998). Both Ca 2 and Mg2 
have been implicated in either the potentiation or attenuation of secretion especially during 
DM (Altura & Altura, 1995; Komabayashi et al., 1996). The present study employed both 
acinar cells suspensions and isolated single pancreatic acinar cells to measure [Ca 2 ]1 
homeostasis in the exocrine pancreas. 
The cellular mechanism underlying the impairment of pancreatic acinar cells in diabetic 
conditions is still not fully understood. This part of my study investigated the effect of 
CCK-8, ACh and insulin on exocrine pancreatic secretion in an attempt to understand the 
cellular mechanism of DM-induced pancreatic insufficiency in vitro. 
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4.2 Methods 
All methods were as stated in chapter 2. 
4.3 Results 
4.3.1 Measurement of a-amylase secretion from pancreatic acinar cells 
Figure 4.1 shows the effect of different concentrations (10 - 10 M) of ACh on the 
percentage of total amylase output from age-matched healthy control and STZ-induced 
diabetic pancreatic acinar cells. The results illustrate that control pancreatic acini released 
significantly higher (P<0.05) levels of amylase compared to STZ-induced diabetic 
pancreatic acini. Maximum total amylase release was stimulated at a concentration of 10.6 
M ACh in control samples, whereas in diabetic samples, maximum amylase release was 
stimulated at a concentration of 10 M ACh. Figure 4.2 represents dose-response bar 
charts showing the effect of 10" - 10.8 M CCK-8 on total amylase output. A significant 
reduction (P<0.05, Student's t-test) in total amylase was illustrated in diabetic pancreatic 
acini compared to healthy controls in response to 1040, 
 10 and 108  M CCK-8 
concentrations. Figure 4.3 shows the effect of different concentrations of insulin on 
amylase output from pancreatic acinar cells. Pancreatic acinar cells from healthy control 
rats released significantly higher (P<0.05) amounts of total amylase compared to diabetic 
acinar cells in response to 106 
 M insulin. However, lower concentrations of insulin (10 
and 10.8 
 M) failed to elicit a significant difference in amylase release between both groups. 
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Figure 4.4 shows the effect of combining io- M insulin with either (A) 10 -7 M, (B) 106  M, 
(C) I V M or (D) IV M ACh on amylase release from healthy age-matched control and 
diabetic pancreatic acinar cells. A concentration of 108 
 M insulin was shown to have no 
significant effect on ACh-evoked amylase release in healthy control acinar cells. However, 
in diabetic acinar cells, insulin (10.8 
 M) elicited a significant increase (P<0.05) in amylase 
release at 104 
 M ACh compared to the effects of ACh alone (Figures 4.4D). Figure 4.5 
shows the effect of combining 10,7M 
 insulin with either (A) 10 M, (B) 106 
 M, (C) to M 
or (D) 104 
 M ACh on amylase release from healthy age-matched control and diabetic 
pancreatic acinar cells. Combining lO M insulin with ACh failed to produce any 
significant effect on amylase release in both age-matched control and diabetic pancreatic 
acinar cells. Moreover, although a higher concentration of insulin (106 
 M) revealed a 
significant difference between total amylase release in control and diabetic animals (Figure 
4.3), this concentration of insulin caused no significant effect on either control or diabetic 
pancreatic acinar cells stimulated with ACh of varying concentrations (Figure 4.6). 
Figure 4.7 shows the effect of 108 
 M insulin on different concentrations of CCK-8 (10' - 
1 V M) on the percentage of total amylase output from age-matched healthy control and 
STZ-induced diabetic pancreatic acinar cells. Unlike the above results with ACh, 108 
 M 
insulin significantly attenuated (P<0.05) both 10' ° and lO M CCK-8-evoked amylase 
release from control acinar cells (Figure 4.713 and C). No significant difference was shown 
in response to lO M insulin on either 10.11 
 or 10.8  M CCK-8-evoked amylase release in 
both control and diabetic groups (Figure 4.7A and D). A concentration of io M insulin 
caused a significant decrease in the percentage of total amylase output in control acinar 
cells stimulated with io M CCK-8 (Figure 4.8C). All other concentrations of CCK-8 
failed to exhibit significant affects from 10 M insulin stimulation in both control and 
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diabetic pancreatic acinar cells (Figure 4.8). A higher concentration of insulin (106 
 M) 
revealed again to attenuate 1040 
 M CCK-8-evoked amylase release from control pancreatic 
acinar cells compared to CCK-8 alone (Figure 4.913). Moreover, stimulation of 106 
 M 
insulin failed to produce any significant effect on CCK-8-evoked amylase release in both 
age-matched control and diabetic pancreatic acinar cells in the remainder of the dose-
response CCK-8 concentrations (Figure 4.9A, C and D). 
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Figure 4.1. Dose-response bar charts showing the effect of 10.8 - 10 4 M ACh on total 
amylase output from superfused healthy control and STZ-induced diabetic pancreatic acinar 
cells. Each point is mean ± S.E.M. n = 6 - 10, *p<0.05  (independent samples Student's t-
test). Note that stimulation with all ACh concentrations resulted in a significant difference 
between control and diabetic groups in the % of total amylase released. 
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Figure 4.2. Dose-response bar charts showing the effect of 10" - 10 M CCK-8 on total 
amylase output from superfused healthy control and 517-induced diabetic pancreatic acinar 
cells. Each point is mean ± S.E.M. n = 6 - 10, *p<aos (independent samples Student's t-
test). Note that diabetic pancreatic acinar cells secrete significantly (P<0.05) less amylase 
at 10" - 108 M CCK-8 compared to control. 
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amylase output from superfused healthy control and STZ-induced diabetic pancreatic acinar 
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test). Note that only a concentration of 10 M insulin evoked a significant difference 
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4.3.2 Measurement of total protein and ion contents in the homogenised 
pancreas of age-matched control and diabetic rats 
In another series of experiments, total protein and ion contents in the homogenised whole 
pancreases of control and diabetic rats were measured, in order to determine if diabetes was 
altering their concentrations. Total protein output from age-matched healthy control and 
STZ-diabetic pancreases were measured using Lowry's method (1953) and ion 
concentrations were measured using the flame atomic absorbance spectrometer (FASS) 
method, respectively. 
Figure 4.10 shows that the control pancreas contains significantly higher (P<0.05) levels of 
total protein (80.0 ± 4.8 pg ml' mg of tissue') compared to STZ-induced diabetic 
pancreatic tissue (63.29 ± 4.62 pg ml' mg of tissue'). These results are in agreement with 
previous studies in which the diabetic pancreas secretes significantly less amylase 
compared to the healthy control pancreas. 
Figure 4.11 illustrates the total amount of (A) Fe 2 (B) Ca2 (C) Mg2 (D) W (E) Na and 
(F) Zn2 present in homogenised whole pancreases of either age-matched control or STZ-
induced diabetic animals. The highest level of ion content in both control and diabetic 
pancreatic samples was Mg 2 followed by Ca2 , Fe2 , Zn2 , K and lastly Nat The control 
pancreases contained 208.6 ± 46.2 pg mF' of Mg 2 (g of tissue'; n = 6), compared to the 
diabetic pancreases which contained 257.6 ± 48.8 pg mF' of Mg 2 (g of tissu&'; ii = 6). 
Figure 4.11 F shows that control homogenised pancreases contained significantly higher 
(P<0.05) levels of Zn 2 (8.02 ± 0.82 pg ml' of Zn2 (g of tissue4 )) compared to STZ- 
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induced diabetic pancreatic tissue (4.60 ± 0.42 jig mi 4 of Zn2 (g of tissu6')). No 
significant difference was shown between the control and diabetic groups regarding Fe 2t 
Ca2t Mg2t K and Na* contents as shown by Figures 4.1 lÀ, B, C, D and E. 
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Figure 4.10. Bar charts showing total protein content (gg nff' per mg tissue) from age-
matched healthy control and STZ-induced diabetic rat pancreases. Each bar is mean ± 
S.E.M. n = 6, *p<9•5 
 as compared to the respective control (independent samples 
Student's t-test). 
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4.3.3 Effect of CCK-8 on FCa 2ii and FMg2 11 in pancreatic acinar cell 
suspensions 
Basal [Ca 2+ ]i in fura-2 loaded pancreatic acinar cells of age-matched control and diabetic 
rats was 115.0 ± 13.2 nM and 110.3 ± 8.0 nM, n = 6-8, respectively. Figure 4.12 shows 
the time course of changes in mean (± S.E.M.) [Ca 2 ]1 in suspensions of pancreatic acinar 
cells taken from age-matched control (solid squares) and diabetic (solid circles) rats either 
before or after the application of 10 M CCK-8. The mean (± S.E.M.) basal and CCK-8-
evoked initial peak of [Ca 2 ]1 are shown in the inset (Figure 4.12B) for comparison. The 
results indicate that CCK-8 can evoke a transient and significant increase (PC0.05) in 
[Ca2 ], reaching a maximum within 10 - 25 sec of the hormone application in both normal 
and diabetic pancreas. Thereafter, [Ca 2 ]1 declined to a plateau value but remained above 
the initial basal level in the continuous presence of CCK-8. Basal [Ca 2 ] was more or less 
similar in pancreatic acinar cells of both control and diabetic rats (see Table 1 and Figure 
4.12). In contrast, the CCK-8-evoked initial (peak) elevation in [Ca 2+ 
 ]i was significantly 
higher (P<0.05, Student's t-test) in pancreatic acinar cells of age-matched control rats 
(359.4 ± 27.5 nM) compared to diabetic animals (275.3 ± 11.5 nM, Figure 4.12B). 
Basal [Mg2 ] in Magftira-2 loaded pancreatic acinar cells of age-matched control and 
diabetic rats was 1.00 ± 0.06 nM and 0.88 ± 0.04 nM, n = 10 - 18, respectively. These 
values show a significant decrease (P<0.05) in basal [Mg 2+  ]i in diabetic acinar cells 
compared to healthy control pancreatic cells (see Table I and Figure 4.13). The time 
course of changes in mean (± S.E.M.) [Mg 2 ] in suspensions of pancreatic acinar cells of 
age-matched control (solid squares) and diabetic (solid circles) rats either before (basal) or 
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following application of 10 8 M CCK-8 are shown in Figure 4.13A. The mean (± S.E.M.) 
basal and CCK-8-evoked plateau phase of [Mg2]j 
 are shown in the inset (Figure 4.1313). 
Application of CCK-8 resulted in a small initial increase (above basal level) in [Mg 2 ]1 
followed by a gradual decline reaching a plateau phase (below basal level) after 2 min of 
CCK-8 application. Thereafter, [Mg 2+ 
 ]i remained more or less constant for the next 3 - 4 
min in the presence of CCK-8. The results presented in the inset of Figure 4.1313 reveal 
that mean [Mg 2+ 
 ji values during the plateau phase evoked by CCK-8 were significantly 
lower (PC0.05, Student's t-test) in pancreatic acinar cells of diabetic rats compared to age-
matched controls. 
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Figure 4.12. (A) Time course of mean (± S.E.M.) changes in [Ca 2+ 
 ]i before (basal values) 
and after CCK-8 (1 o- M) application (arrow) in suspensions of fura-2 loaded pancreatic 
acinar cells taken from age-matched control (solid squares) and diabetic (solid circles) rats. 
(B) The inset shows the mean (± S.E.M.) basal and CCK-8 evoked initial peak responses 
(15 - 25 sec following CCK-8 application) in control and diabetic acinar cells (n = 10 - 
18). Note that CCK-8 evoked a significant reduction (P<0.05) in peak [Ca2 ]1 during DM 
(compared with b). However, (c) and (a) were not significantly different from one another. 
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Figure 4.13. (A) Time course of mean (± S.E.M.) changes in [Mg 2 ]i before (basal values) 
and following CCK-8 (108 
 M) application (arrow) in suspensions of Magftira-2 loaded 
pancreatic acinar cells in age-matched control (solid squares) and diabetic (solid circles) 
rats. (B) The inset shows the mean (± S.E.M.) basal and CCK-8 evoked plateau phase of 
[Mg2 ] in control and diabetic pancreatic acinar cells (n = 10 - 18). Note that diabetic 
pancreatic acinar cells have significantly reduced (Pc0.05) basal and CCK-8 evoked 
[Mg2+ ] compared to control cells (compare a with c and b with d). 
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4.3.4 Effects of insulin, ACh and CCK-8 on FCa2i in single pancreatic 
acini 
Initial experiments to measure [Ca 2 ] were carried out using cell suspensions containing 
about 1 million cells in each cuvette. Therefore, it was decided that experiments were 
necessary in isolated single pancreatic acinar cells for investigating signalling mechanisms, 
such as exocytosis and Ca 2 signals when stimulated with secretagogues. 
No significant difference was shown in basal [Ca 2+ 
 ]i between acini from age-matched 
control (246.9 ± 7.53 nM, n = 98) and STZ-diabetic (169.5 ± 4.62 nM, n = 138) rats, 
respectively. Figure 4.14 shows original [Ca 2+ 
 ]i changes obtained with a 
microspectrofluorimeter and the Ca 2 indicator fura-2 AM before (0 mm) and after the 
application of CCK-8 (10.8 
 M) in a healthy control pancreatic acinar cell. The intensity of 
fluorescence shown by the colour red indicates the level of [Ca 2 ]1 within the single 
pancreatic acini. Figure 4.15A shows the time course of changes in mean (± S.E.M.) 
[Ca2 ] in single pancreatic acinar cells from age-matched control and diabetic rats either 
before or after the application of 10.8 
 M CCK-8. The results show that the application of 
CCK-8 resulted in a rapid transient increase in [Ca 2 ]1 (initial peak response) followed by a 
decline to a plateau phase during which the [Ca 2+ 
 ]i level remained above the basal. The 
mean (± S.E.M.) CCK-8-evoked peak [Ca 2 ]i response was significantly higher (Pc0.05) in 
control (3297.8 ± 349.5 nM, n = 25) compared to diabetic acini (2052.9 ± 146.6 nM, n = 
39), respectively (Figure 4.1513). Similarly, the mean (± S.E.M.) plateau values for control 
and diabetic acinar cells following CCK-8 application was 360.71 ± 22.3 nM (n = 25), and 
271.47 ± 14.8 nM (n = 39) after 5 min of CCK-8 application. In diabetic acini, the effect of 
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CCK-8 was less pronounced both in the initial peak response and the plateau responses. 
Figure 4.16 illustrates time course changes and mean (± S.E.M.) CCK-8-evoked peak and 
plateau (2 min and 5 min after peak response) [Ca 2 ]1 responses in the absence and presence 
of insulin (10.6 
 M). The mean CCK-8-evoked [Ca 2 ]1 peak response was significantly 
higher (Pc 0.05) in the presence of 10 M insulin (4087.8 ± 524.4 nM, n = 24) compared to 
CCK-8 administration alone (3297.8 ± 349.5 nM, n = 25) in healthy control pancreatic 
acini (Figure 4.1713). No significant difference in [Ca 2+  ]i was observed during the plateau 
phases in both control and diabetic groups as a result of insulin pre-administration (Figure 
4.17). Figure 4.18 shows the effect of ACh (10.6 
 M)-evoked [Ca 2 ] changes in single 
pancreatic acini from both control and STZ-diabetic rats in the absence and presence if 10 .6 
M insulin. DM was shown to significantly reduce (P<0.05) ACh-evoked peak [Ca2t ] 
when administrated alone and also when administered in the presence of insulin (10.6  M) 
(Figure 4.18). Although the presence of insulin (10.6  M) evoked a small insignificant 
increase in the ACh-evoked peak response in control pancreatic acini, a significant 
reduction (Pc0.05) in the ACh-evoked peak response was demonstrated in single diabetic 
pancreatic acinar cells in the presence of insulin. Insulin (10.6  M) was shown to 
significantly increase the ACh-evoked plateau response 2 min after the peak response 
(794.2 ± 41.8 nM, ii = 23) in healthy control acini compared to the effect of ACh (10 M) 
administration alone (434.3 ± 30.3 nM, n = 26) (Figure 4.18). 
Figure 4.20 shows no significant difference (Pc0.05) in basal [Ca 2+]i between zero (0 mM) 
and normal (1.2 mM) [Ca2 ] 0 mediums in either healthy control or STZ-diabetic acinar 
cells. In a zero extracellular Ca 2 medium, basal [Ca 2+ 
 ]i in control pancreatic acini was 
226.0 ± 14.4 nM (ii = 19) and 161.9 ± 16.9 nM (ii = 16) in acini from STZ-diabetic rats, 
respectively. Figure 4.20 illustrates that DM significantly reduced CCK-8-evoked [Ca 2 ] 
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peak responses in both 0 mM [Ca 2 ] 0 and 1.2 mM [Ca2 j 0 mediums. The initial peak 
response was reduced from 3297.8 ± 349.5 nM (n = 25) in 1.2 mM Ca2 j0 to 2338.2 ± 447 
mM (n = 19) in 0 mM Ca 2 ] 0 in healthy control acini. Similarly, the peak response was 
also reduced from 2052.9 ± 146.6mM (n = 39) in 1.2mM [Ca 2 ] 0 to 954.3 ± 66.8 mM (n = 
16) in diabetic acini in 0 mM Ca2i0.  The exclusion of extracellular Ca 2 displayed a 
significant reduction (P.c0.05) in the CCK-8-evoked plateau phase of [Ca 2 ']1 2 min after 
the peak response in control pancreatic acini but remained elevated above the basal (Figure 
4.19 and 4.20). 	
CCK..S 
Figure 4.14. Original images of changes in [Ca 2 ]1 in a single control pancreatic acini 
before (0 mm) and following the application of CCK-8 (10.8  M) as indicated by the arrow 
for a period of 9 mm. Images are typical of 11 —25 single isolated cells from 6 animals. 
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Figure 4.15. (A) Original chart recordings of the time course of mean changes in [Ca 2 ]1 
before and after CCK-8 (10.8  M) application (indicated by the arrow) in healthy control and 
S'FZ-induced diabetic single acini. (B) Bar charts showing mean basal, CCK-8 (10.8  M)-
evoked peak and plateau phases (2 mm, 5 mm, and 10 min after the peak response) of 
[Ca211 in single healthy control and STZ-induced diabetic pancreatic acini. Each point is 
mean ± S.E.M. n = 11 - 39, *p.c0.05  as compared to the respective control (independent 
samples Student's t-test). Note that data in (B) were taken from (A) 
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Figure 4.16. (A) Original chart recordings of the time course of mean changes in [Ca 2 ']1 
before and after insulin (10 M) and CCK-8 (108  M) application (indicated by the arrows) 
in an healthy control single acini. (B) Bar charts showing mean basal, CCK-8 (10.8  M)-
evoked peak and plateau phases (2 min and 5 min after the peak response) of [C2i in the 
absence and presence of insulin (10 M) in single control pancreatic acini. Each point is 
mean ± S.E.M. n = 11 - 39, *p<05  as compared to CCK-8 alone (independent samples 
Student's t-test). Note that data in (B) were taken from (A) 
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Figure 4.19. Time course of mean (± S.E.M.) changes in [Ca21]i  before and after CCK-8 
(10.8 
 M) application (indicated by the arrow) in normal (1.2 mM) and zero (0 mM) 
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4.4 Discussion 
In STZ-induced diabetic animals, ACh (10.8 - 10 M) stimulation resulted in significantly 
less (P<0.05) total amylase release from pancreatic acinar cells in contrast to healthy age-
matched control animals. Similarly, CCK-8-evoked amylase release demonstrated to be 
significantly higher in healthy controls compared to diabetic pancreatic acinar cells. A 
concentration of 10.11 
 M CCK-8 evoked a detectable increase in amylase output in control 
acinar cells compared to diabetic acinar cells although no significant difference was found. 
These observations support previous findings from authors which have unanimously agreed 
that type I DM is associated with a decrease in digestive amylase secretion in vitro (Yago et 
al., 1999; Juma etal., 1997; Singh et aL, 1999; Otsuki et aL, 1995; Sofrankova & Dockray, 
1983; Kim et al., 2003) and in vivo (Patel et al., 2004a). The present study has 
demonstrated that insulin at concentrations of 10.8 
 and 10 7 M do not directly stimulate 
amylase secretion at levels significantly different from diabetic pancreatic acinar cells. A 
higher concentration of insulin (106 
 M) however, caused a significantly higher release of 
amylase from healthy controls compared to diabetic animals. When insulin was combined 
with either ACh or CCK-8, contradictory results were revealed. Not only did insulin (10 .8 
M) markedly enhance ACh (1 0 M)-evoked secretory responses in the diabetic pancreatic 
acinar cells, but insulin (10 8, 
 107 and 10.6 
 M) also exhibited to attenuate CCK-8-evoked 
amylase release in the isolated healthy control pancreas. The results from this study show 
that insulin mainly has little or no effect on exocrine pancreatic secretion, contradictory to 
findings that it can markedly potentiate the amylase secretory response to CCK-8 (Singh et 
al., 1999; Singh & Adeghate, 1998; Singh et aL, 2001; Juma et aL, 1997; Singh, 1985). 
Results obtained may suggest that for the potentiation to occur, the presence of a 
functioning islet-acinar axis is required, which is supported by findings using pancreatic 
segments instead of isolated acinar cells (Singh etal., 1999; 2001). The effects of insulin 
on the diabetic state of pancreatic acinar cells may not be due to an indirect action of the 
hormone involving glucose metabolism, since glucose has no potentiating effect on 
secretagogue-evoked amylase secretion (Danielsson, 1974). The well established theory 
that two secretagogues acting via different cellular mediators (e.g. Ca 2 or cAMP) can 
enhance one another becomes questionable at this stage. One suggestion to explain the 
action of insulin is that it may not act as a single intracellular messenger, but instead it may 
have several modes of action, one of which is its interaction with Ca 2 mobilised by either 
ACh or CCK-8. It has been previously suggested that a deficiency in amylase secretion 
may be either due to insensitivity of the secretory acini to CCK-8 (Okabayashi et al., 
1988a; Okabayashi et aL, 1988b; Otsuki et aL, 1995; Sofrankova & Dockray, 1983), an 
inhibition of amylase mRNA, amylase synthesis and activity of amylase (Duan & Erlanson-
Albertsson, 1990; 1992; Duan et aL, 1992) or a decrease in cellular Ca 2 mobilisation 
(Yago etal., 1999; Juma et aL, 1997; Singh et aL, 1999). The present study has shown that 
cytosolic Ca 2 concentration is significantly decreased in pancreatic acinar cells of 7 - 8 
weeks STZ-induced diabetic rats. Cellular free Ca 2 is an important physiological mediator 
in the stimulus-secretion coupling process (Yago et al., 1999; Petersen, 1992), so a 
decrease in [Ca 2 ]1 automatically resulted in inhibition of amylase release. Nevertheless, 
other workers have also demonstrated that diabetes is associated with the reduction in 
amylase mRNA and amylase synthesis (Duan & Erlanson-Albertsson, 1990; 1992; Duan et 
al., 1992). Although, there may be a decrease in both basal and secretagogue-evoked 
amylase secretion in DM, there may also be an inhibition of the mRNA amylase and the 
synthesis of amylase resulting in decreased amylase secretion. 
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The question that now needs to be addressed is, what is responsible for the reduction in 
amylase mRNA and the synthesis of amylase? 
The present results have shown that both basal and CCK-8-evoked [Mg 2+  ]i was 
significantly decreased during diabetes compared to the [Mg 2+ 
 ]i obtained in age-matched 
control pancreatic acinar cells. Reduction in plasma free Mg 2 is known to occur in DM 
(Altura & Altura, 1995), although in this study no significant difference was found in total 
Mg2 content in homogenised pancreases as a result of STZ—induced diabetes in rats. 
Within cells, Mg2 plays a vital role in numerous physiological and biochemical processes 
including the synthesis of RNA, DNA and the maintenance of their conformation (Yago et 
aL 2+  i, 2000). Moreover, Mg s recognised as a major co-factor for a wide range of enzymes 
(Yago et al., 2000). It is tempting to suggest that a reduction in [Mg 2 ]1 seen during DM in 
this study may be directly linked to the de-activation of the different enzyme systems which 
are responsible for mRNA amylase level and amylase synthesis, subsequently leading to 
reduced amylase secretion. 
DM is a chronic disorder affecting protein metabolism. This study revealed that total 
protein content from homogenised whole pancreases was significantly decreased in DM-
induced animals compared to healthy control animals. This coincides with past findings 
which showed a marked decrease in total protein secretion in diabetic anesthetised rabbits 
(Alvarez & Lopez, 1989) and rats (Patel et al., 2004a). It is known that certain inorganic 
trace elements such as zinc, iron, potassium and sodium play an important role in the 
maintenance of normoglycaemia by activating the 3-cells of the pancreas 
(Narendhirakannan et al., 2005). In the present study, the elemental composition in the 
pancreas of healthy control and STZ-induced diabetic rats was investigated. No significant 
ap 
difference (P<0.05) was displayed in potassium, sodium, calcium, magnesium, and iron 
trace elements between control and diabetic homogenised pancreatic tissue, respectively. 
Plasma potassium levels are not always a good indicator of intracellular levels; in acidosis 
the exchange of H and K ions leads to the depletion of intracellular potassium and 
elevated plasma potassium. The converse occurs in alkalosis. Hypokalaemia may lead to 
neurological, muscular and cardiac signs and is associated with DM (Foo et at, 2003) 
which may reflect sympathetic nerve dysfunction that commonly complicates diabetes. 
Iron is found in the body tissue enzymes and helps with energy metabolism. It is known to 
facilitate the oxidation of carbohydrates, protein and fat to control body weight, which is a 
very important factor in diabetes (Rajurkar & Pardeshi, 1997). Contradictory to results 
obtained in this study, Liu etal., (2000) observed that the concentrations of iron of middle-
aged and aged people with slight and severe diabetes were lower than those of the control 
group. Although calcium is involved in cellular processes such as secretion, a significantly 
lower concentration of this trace element would be expected to be observed in the diabetic 
pancreas as the condition is related to exocrine pancreatic insufficiency. This was, 
however, not shown in the results of this study. Again, unexpected results were also 
obtained from the measurement of magnesium content in the pancreas. Magnesium 
deficiency in patients with DM has been well established (de Valk, 1999; Gunn & Bums, 
1987; Mather & Levin, 1979) but no significant difference in this trace element was once 
again revealed between the control and diabetic pancreas in this study. Pancreatic J3-cells 
contain large amounts of zinc; one of the major roles of zinc is the binding of insulin in 
hexamers (Derewenda et al., 1989; Dodson & Steiner, 1998). Zinc status in diabetic 
patients and in animal models is significantly lower than healthy controls (Ho et at, 2001; 
Failla & Gardell, 1985; Honnorat etal., 1992; Isbir et aL, 1994; Terres-Martos et at, 1998) 
thus complimenting results found in this study. Deficiency of zinc causes diabetic 
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hyposmia, hypogeusia or coma (Gala, 1984). In type I and type II DM, patients were found 
to have altered zinc homeostasis, involving general zinc deficiency and reduced plasma 
zinc. However, it is not known whether this abnormal zinc homeostasis was a consequence 
of diabetes or another condition that contributes to the pathogenesis (Sondergaard et al., 
2003). Recent experiments employing zinc supplementation have shown to significantly 
reduce the severity of type I DM (based on hyperglycaemia (Winterberg et al., 1989), 
insulin level, and islet morphology in STZ-induced diabetic models (Ho et aL, 2001). The 
individual and combined supp!ementation of zinc and chromium has revea!ed to have 
potential beneficial antioxidant affects in type II DM patients (Anderson etal., 2001). 
Experiments in this study examining Ca 2 homeostasis in single pancreatic acini have 
demonstrated interesting results. Like the experiments conducted on pancreatic acinar cell 
suspensions, a significant and marked increase in the CCK-8-evoked initia! peak [Ca 2 ] 
response in age-matched control rats was higher compared to STZ-induced diabetic rats. 
Similar resu!ts were obtained by ACh stimulation in single pancreatic acini. The CCK-8-
evoked initial peak response in control pancreatic acinar cells in the presence of insulin (10 
6 
 M) induced a significant increase compared to the peak response induced by CCK-8 
alone. However, in diabetic acinar cells, the presence of insulin was shown to attenuate not 
only the effect of CCK-8 but also ACh stimulation alone in regards to the initial peak 
response. ACh (10.6 
 M) combined with insulin was also shown to potentiate the effect of 
ACh stimulation alone in the plateau phase of the [Ca 2 7]1 response. Whether the 
potentiating affects of insulin on CCK-8-evoked [Ca 2 ]i responses may be mediated by 
hypoglycaemia-evoked vagal cholinergic activation, the attenuating effect of insulin on 
both CCK-8 and ACh stimulation in diabetic animals remains to be unclear. These results 
question the literature whereby the intracellular mediator tyrosine kinase was recognised to 
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be involved in the potentiating effect and modulation of calcium in pancreatic acinar cells 
(Yule et al., 1994). As Mg2 deficiency has been established in patients with DM (de Valk 
et at, 1993; de Valk, 1999; Gunn & Burns, 1987; Mather et at, 1979), and plasma Mg 2 
levels have been reported to be inversely related to insulin sensitivity (Suárez etal., 1992), 
it is tempting to suggest that the attenuating action of exogenous insulin in diabetic animals 
is influenced by [Mg 2 ]1. Although several intracellular mediators including calcium, 
cAMP and tyrosine kinase may be associated with the interaction of insulin and the 
digestive secretagogues (Lam et al., 1999; Singh et al., 1999), the attenuating, potentiating 
or absent effect of insulin in both age-matched control or diabetic pancreatic acinar cells 
remains a controversial issue due to the incompatibility of certain results. 
The exclusion of extracellular Ca 2 caused a significant reduction in [Ca 2 ] peak responses 
from both age-matched control and diabetic single acini stimulated with CCK-8 (lO s M). 
The plateau phase 2 min after the initial peak response stimulated by CCK-8 administration 
from control acinar cells was also markedly reduced in 0 mM [Ca 2 ]0 . The influx of 
extracellular Ca 2 is stimulated when internal stores such as the ER are depleted of Ca 2 by 
an autoregulatory Ca 2 pathway (Hallam & Rink, 1989). A reduction in the initial peak 
response may suggest that the intracellular Ca 2 pooi may be depleted of Ca 2 . This 
depletion possibly could not be directly replenished due to the absence of extracellular Ca 2 
thereby causing a reduced response in [Ca 2 ] signals in response to agonist stimulation. 
The results obtained in this study illustrate that Ca 2 mobilisation within a cell is dependent 
upon intracellular Ca 2 stores as well as extracellular Ca 2 , to generate effective exocytosis 
and hence secretion. 
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In pancreatic acinar cells, agonists such as ACh and CCK-8 can induce repetitive local 
cytosolic Ca2 spikes, waves, or oscillations (Cancela et at, 2002; Berridge, 1993; 
Clapham, 1995; Petersen et at, 1994). It is thought that signal amplification due to CICR 
primarily mediated by IP3R and RYRs contribute to the generation of such Ca 2 responses 
(Berridge, 1993; Tepikin & Petersen, 1992; lino, 1989; Ito etal., 1999; Wakui etal., 1990; 
Kasai et al., 1993). Previous findings have shown that low concentrations of either ACh or 
CCK-8 can evoke markedly different patterns of cytosolic Ca 2 oscillations compared to 
higher concentrations of the same agonist in the isolated pancreatic acinar cells (Toescu et 
al., 1993; Yule et al., 1991; Osipchuk et al., 1990; Petersen et al., 1991b; Cancela et at, 
2002; Martinez et al., 2004). Although typical traces from the majority of the acinar cells 
were selected from both age-matched control and STZ-diabetic groups in this study, 
cytosolic Ca 2 spikes and oscillations were also witnessed and acquired (in approximately 
5-10% of all acinar cells) in response to agonist stimulation. 
The graph below (Figure 4.21) illustrates the time course of ACh (10.6  M)-evoked [Ca 2 ]1 
changes in a healthy control single pancreatic acini. Compatible with this graph below, 
original [Ca 2+  ]i images from the microspectrofluorimeter also shows oscillatory effects by 
ACh stimulation in fura-2 loaded pancreatic cells (Figure 4.22). 
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Figure 4.21. Time course of [Ca 2 ]1 changes before (basal value) and after ACh (10 M) 
application (indicated by the arrow) in one healthy control isolated single pancreatic acini. 
Several mechanisms have been proposed to explain the transformation of a local Ca 2 spike 
into a global Ca2 transient. Toescu et al., (1993) suggests that the pattern of agonist-
evoked cytosolic Ca 2 spiking depends on the resting Ca 2i1. Other authors suggest that 
cytosolic Ca2 oscillations depend on the receptor type, the agonist concentration and the 
intracellular buffering of Ca 2 by the mitochondria barrier which lies on the border between 
the apical granular pole and the rest of the cell (Park et al., 2001; Petersen et al., 1991a; 
Straub et al., 2000; Tinel et al., 1999). Previous literature has stated that Ca 2 spikes are 
always initiated at the trigger zone, the apical pole of the secretary granule-containing 
region of the cell (Kasai & Augustine, 1990; Nathanson et al., 1992; Toescu et al., 1992), 
therefore the region of the cell which is selected for [Ca 211 measurements is very important 
and must be taken into account. Park et al., (2004) suggested that dissociated single 
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pancreatic acinar cells preserve an intact Ca 2 signalling machinery but alter in shape and 
have impaired exocytotic functions compared to cell clusters. In this study, isolated single 
and clusters of two, three or four cells were used in each experiment as a model for 
measuring Ca 2 signalling. Significant validation regarding time course measurements of 
[Ca2 j in the cells were considered by selecting the whole cell rather than the basolateral 
area or the apical granular region. 
[Ca211 
ACh 	 Low ---------' High 
4, 	 Fura 2-AM Fluorescence 
0 min 	 2.30 min 	 2.45 min 	 3.17 min 	 3.42 min 	 3.57 mm 
4.22 min 	 4.27 min 	 4.47 min 	 4.52 rnin 	 12 min 	 13.47 mm 
Figure 4.22. Original images obtained with a microspectrofluorimeter and the Ca 2 
indicator fura-2 AM of Ca2 mobilisation in a cluster of isolated pancreatic acini before (0 
mm) and following application of ACh (10 M) as indicated by the arrow for a period of 14 
nun. Note that Ca 2 oscillations similar to above were recorded in roughly 20 % of all cells 
stimulated with either ACh (10 M) or CCK-8 (10.8  M). 
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The function of this intracellular Ca 2 wave is not entirely clear, although it appears to 
increase the efficiency of enzyme secretion of pancreatic acinar cells, presumably by 
coordinating the secretion of each individual cell. However, the mechanisms involved in 
the generation of global Ca 2 transients and global sustained Ca 2 elevations remains a 
controversial and unclear issue. 
Whilst precise care was taken to select cells for [Ca2*]j 
 measurements, it is important to 
note that the zymogen granule secretory machinery in pancreatic acinar cells is very 
susceptible to the isolation procedure. Thus, one must take into consideration that not all 
cells seen under the microscope were fully viable; most dissociated single cells showed 
clear exocytosis. An estimation of approximately 20 % of non-viable cells in healthy 
control rats and 50 % of non-viable cells in STZ-induced diabetic rats was observed. 
4.5 Conclusion 
In conclusion, the results of this part of the study have demonstrated that DM is associated 
with reductions in the secretory parameters including amylase output, total protein release, 
(Ca 2+]i and [Mg2 ]1. The decrease in the levels of [Ca 2 ]i and [Mg  2+ ]i as well as the reduced 
concentration of zinc may be closely linked to the reduction in amylase secretion and/or 
pancreatic insufficiency during DM. 
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CHAPTER 5 
MOLECULAR MECHANISM OF 
EXOCRINE PANCREATIC INSUFFICIENCY 
IN STZ-INDUCED DIABETIC RATS 
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5.1 Introduction 
During DM, the exocrine pancreas is unable to produce an adequate amount of digestive 
enzymes, especially amylase. This inadequacy is referred to as 'exocrine pancreatic 
insufficiency' (Kumar & Clark, 2002). Previous studies have shown that STZ-induced DM 
is associated with the destruction of pancreatic n-cells and decreased levels of insulin 
secretion (Ahmed et at, 1998; Yago etal., 1999), and the insensitivity of secretory acini to 
exogenous insulin and CCK-8 both in vitro (Williams & Goldfine,1993; Otsuki et at, 
1994; Singh et at, 1991) and in vivo (Patel etal., 2004b). Whilst many of the physiological 
aspects of pancreatic insufficiency have been investigated, this chapter attempts to examine 
potential molecular disturbances, which might explain the physiological changes 
highlighted in chapters 3 and 4 of this thesis. 
Pancreatic acinar cells possess large amounts of CCKA receptors, which when activated by 
CCK-8 mediate the secretion of digestive enzymes such as amylase through intracellular 
signalling pathways (Williams et aL, 2002) and is thus a potential area of dysregulation. 
The second gene of interest is amylase; a major product of the pancreas accounting for 
approximately 20% of total protein (MacDonald et at, 1980). Kim et at (1991) reported a 
decrease in amylase protein and mRNA levels in STZ-induced diabetic rats 6 days 
following STZ injection. The present study utilised a more chronic STZ state to assess 
whether the transcriptional activity of either pancreatic amylase or CCKA receptor gene are 
impaired. Examining the gene expression of CCKA receptor and amylase, a transcriptional 
target, would establish a greater understanding of mechanisms controlling DM-induced 
pancreatic insufficiency. 
157 
Finally, this chapter investigated marker proteins of protein synthesis and dysregulation, in 
order to elucidate if protein balance is disturbed in STZ-induced rats which might explain 
pancreatic atrophy and reduced enzyme secretion. 
5.2 Methods 
All methods were as stated in chapter 2. 
5.3 Results 
5.3.1 Expression of a-amylase and CCKA receptor mRNA in the healthy 
a2e-matched control and STZ-induced diabetic pancreas 
Eight control and seven STZ-diabetic rats were used to measure the gene expression of a-
amylase and CCKA receptor in the pancreas. Total RNA was extracted using Trizol reagent 
according to the method of Chomczynski & Sacchi (1987). RNA purity was determined by 
OD measurements at 260, 280 and 240 nm. The ratio of A260 / A280 of the RNA samples 
ranged from 2.1 - 2.17 for both control (n = 8) and STZ-diabetic samples (n = 7). The 
concentration of RNA was calculated as C = 40 tg/sl x 
 A260 x dilution factor. The mean 
concentration of RNA in both healthy control and STZ-diabetic samples was found to be 
4.123 pg/pl and 4.52 pg4il, respectively. The integrity of RNA from both control and 
diabetic pancreatic tissue was analysed on a 1 % agarose gel containing ethidium bromide 
at 0.1 gijii, and bands were visualised by ultraviolet light. All total RNA samples showed 
two sharp (28s and 18s) rRNA bands after separating by electrophoresis and thus were 
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suitable for qRT-PCR. Gene expression of the amylase and CCKA receptor were 
determined by RT-PCR using gene specific primers. This was followed by gel 
electrophoresis analysis of the RT-PCR amplicons. 
5.3.2 mRNA analyses 
The 'crossing point' is the arbitrary level at which fluorescence is said to rise appreciably 
above background. Therefore, the lower the crossing point, the higher the gene expression. 
The results of this study showed that amylase mRNA levels were significantly (P<0.05) 
reduced in diabetic pancreatic samples compared to age-matched controls (Figure 5.1). 
Healthy control animals had a significantly lower (P<0.05) crossing point value (8.54 ± 
0.131, n = 8 vs. 17.96 ± 0.272, n = 7) compared to diabetic animals. Figure 5.2A shows 
blots of CCKA receptor cDNA in the control and diabetic rat pancreas. The RT-PCR 
amplification product of CCKA receptor is shown in figure 5.213. The intensity of the 
amplified bands of the amplified CCKA receptor from the electrophoresis results remained 
unchanged between the two groups. Crossing point values obtained from the RT-PCR 
were 20.92 ± 0.104 (n = 8) and 21.52 ± 0.181 (ii = 7) for control and diabetic animals, 
respectively. 
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5.3.3 Translation mediating signal transduction 
The relative levels of ERKI/2, PKB, p70 S6K, 4E-BPI and NFicB all decreased in the STZ 
diabetic animals (all P<0.05). Conversely, the phosphorylation of ERKI/2 (Figure 5.6) 
and PKB (Figure 5.3) decreased (Pc0.05) whilst the phosphorylation of p70 S6K and 4E-
BPI all not statistically different in STZ-induced DM. Figure 5.7 shows an altered pattern 
of cellular protein ubiquitination between healthy control and STZ-induced diabetic rats. 
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Figure 5.1. (A) Electrophoresis of a-amylase eDNA PCR products stained with DNA 
binding ethidium bromide. (B) Bar charts showing quantitative lightcycler output of 
amylase mRNA. Each point is mean ± S.E.M. n = 7 - 8, p<005 as compared to the 
respective control (independent samples Student's t-test). Note that amylase mRNA is 
reduced >2-fold after 5 - 6 weeks of Sfl-induced diabetes. 
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Figure 5.2. (A) Electrophoresis of CCKA receptor cDNA PCR products stained with DNA 
binding ethidium bromide. (B) Bar charts showing quantitative lightcycler output of CCKA 
receptor mRNA. Each point is mean ± S.E.M. n = 7 - 8. Note that CCKA receptor mRNA is 
unchanged between healthy controls and following 5 - 6 weeks of Sfl-induced diabetic 
pancreatic samples. 
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Figure 5.3. Graphs and example representative immunoblots showing the effect of Sfl-
induced diabetes upon the relative protein levels of both total and phosphorylation of PKB 
at Thr308. All values were normalised to the relative intensity of the control bands. 
Immunoblots represent n = 8 healthy control (C) and STZ-induced diabetic (D) rats. Data 
are displayed as means ± S.E.M. n = 8, *pcaos 
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Figure 5.4. Graphs and example representative immunoblots showing the effect of Sfl-
induced diabetes upon the relative protein levels of both total and phosphorylation p70 S6K 
at Thr389. All values were normalised to the relative intensity of the control bands. 
Immunoblots represent n = 8 healthy control (C) and Sfl-induced diabetic (D) rats. Data 
are displayed as means ± S.E.M. n = 8, *p.<0.05. 
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Figure 5.5. Graphs and example representative immunoblots showing the effect of Sfl-
induced diabetes upon the relative protein levels of both total and phosphorylation 4E-BP1 
at Thr37/46. All values were normalised to the relative intensity of the control bands. 
Immunoblots represent n = 8 healthy control (C) and STZ-induced diabetic (D) rats. Data 
are displayed as means ± S.E.M. n = 8, *p<0.05. 
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Figure 5.6. Graphs and example representative immunoblots showing the effect of Sfl-
induced diabetes upon the relative protein levels of both total and phosphorylation ERK1/2 
at Thr202iTyr2O4. All values were normalised to the relative intensity of the control bands. 
Immunoblots represent n = 8 healthy control (C) and S12-induced diabetic (D) rats. Data 
are displayed as means t S.E.M. n = 8, *p.c  0.05. 
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Figure 5.7. Western blots of NFiB and ubiquitinated protein in the healthy control (C) and 
STZ-induced diabetic (D) rat pancreas (n = 4 for control and diabetic rats). Each lane 
represents one animal. The molecular weight markers show the approximate molecular 
weights of the ubiquitinated proteins. 
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5.4 Discussion 
This study aimed to clarify how chronic DM would affect gene expression of two mRNA 
species that have a role in pancreatic enzyme secretion. By measuring the mRNA receptor 
level of CCKA, which mediates CCK-8-induced amylase secretion, and amylase mRNA 
itself, this study identified a potential transcriptional defect contributing to pancreatic 
insufficiency. The second part of this study attempted to examine signal transduction in 
STZ-induced diabetes specifically of those proteins controlling protein synthesis and 
breakdown. The results identify potential explanations for decreased protein synthesis and 
increased breakdown. 
5.4.1 CCKA receptor and a-amylase gene expression 
The results of this study have demonstrated that STZ-induced DM is associated with a 
significant reduction in mRNA of the amylase gene. This finding provides a possible 
explanation for the reduced amylase secretion in STZ-induced diabetic rats in vitro and in 
vivo (Kim et al., 2000; Icks et al., 2001; Okabayashi et at, 1988a; Singh et al., 1999; 
2001). However, as total amylase protein was not measured in this study, it cannot be 
confirmed that this difference is present at a protein level, although Kim et at (2000) 
identified a reduced amylase protein level in an acute STZ state. Furthermore, chapters 3 
and 4 of this thesis showed reduced amylase secretion in response to CCK-8, thus 
potentially implying that a reduced protein level is also present in the chronic STZ state. 
However, a defect in amylase secretion or signalling pathways initiating secretion cannot 
be ruled out, and therefore this is speculative. 
There are reports of insensitivity of the CCK receptor to exogenous applications of CCK-8 
in STZ-induced diabetic rats compared to healthy control animals (Otsuki et al., 1994). 
The results of this study indicated no significant differences in the CCKA receptor mRNA 
in chronic STZ, thus suggesting that the gene expression level of the CCKA receptor is not 
responsible for this phenomenon. However, this does not rule out the possibility of post-
transcriptional dysregulation. 
It should be stated here that a limitation to the data provided by RT-PCR was that a 
housekeeping gene was not used to normalise the sample data to, and provide a reference 
point for inconsistencies in reverse transcription and RNA measurement. However, given 
the fact that the data are very consistent couple with the fact that CCKA receptor mRNA 
showed no differences between the diabetic and non-diabetic pancreas, it is suggested that 
the data strongly indicate an effect on amylase mRNA. Furthermore, in terms of PCR, the 
change in amylase mRNA was very large and the samples processed all at the same time, 
and thus highly unlikely to be an artefact of between-sample inefficiency in cDNA 
generation or RNA measurement. Nevertheless, the exact magnitude of change should be 
treated as qualitative. 
5.4.2 Signallinft pathways controlling genetic responses and translation 
Whilst some mechanisms of pancreatic insufficiency could be due to transcriptional 
defects, it could also be due to the reduced ability in the diabetic state to translate mRNA. 
Indeed, any noted reduction in protein synthesis could be causative in reduced protein 
available for total protein secretion as shown in chapter 4 of this study. Moreover, reduced 
169 
protein synthesis could provide a mechanism for atrophy and reduced weight of the 
pancreas as noted in type I STZ-induced DM (see Chapter 3). However, the signalling 
responsible for a reduction in pancreatic weight or juice flow in the STZ pancreas had not 
been previously examined. 
The current study found that the total concentration (native protein levels) of PKB, p70 
56K, 4E-BPI and ERKI/2 was actually at a lower level in the STZ-induced diabetic 
pancreas. The output of a signal transduction pathway is dependent on both the activity and 
total protein concentration levels as laid out by the metabolic control theory (de Vienne et 
al., 2001). Therefore, it is likely that this reduction in key total protein levels reduces 
translation signalling capacity and could mediate the pancreatic atrophy and reduce protein 
available for secretion. 
In contrast to decreasing total protein levels in STZ-induced diabetes, when examining the 
graphs which show protein phosphorylation there is a tendency, although not quite 
statistical significance, for increases in protein phosphorylation of p70 56K and 4E-BP 1 in 
STZ-induced diabetes. This at first seems unexpected since reduced total protein levels as 
shown here would presumably have been concomitant with blunted phosphorylation. One 
potential explanation for this is that in the face of reduced total protein levels (secretive 
enzymes, ribosomal proteins etc), as a defence mechanism to maintain protein mass, the 
cellular activity of these proteins actually increases in an attempt to maximise the output 
from remaining protein levels. This pattern has been previously shown to be evident in 
aged rats which actually show upregulation of p70 S6K activity despite the state of 
sarcopenia (Parkington et al., 2004). There was a decrease in PKB concentration which 
could be due to the absence of insulin. Since PKB is activated by insulin to promote 
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GLUT4 translocation and is downstream of the IR, perhaps the lack of circulating insulin 
leads to a downregulation of PKB expression since there is no longer the requirement for 
insulin to signal through this intermediate. This of course would be independent to the 
reduced levels of p70 S6K and 4E-BPI since these are also activated in a PKB independent 
manner, such as by nutrients through mTOR (Hara et al., 1998). 
5.4.3 ERK1/2 MAPK 
Interestingly, the MAPK protein ERKI/2 displayed a similar pattern to p70 S6K and 4E-
BPI by showing an increased phosphorylation in tandem with a reduced total protein level. 
ERKI/2 is in part responsible for mediating translation through phosphorylating p90 RSK 
(ribosomal protein p90 S6 kinase) which in turn activates eEF2K (Wang et al., 2001b). 
Activation of eEF2K regulates peptide elongation by phosphorylation of eEF2 enabling 
translocation of charged tRNA to the ribosome. Therefore, the increase in ERKI/2 
phosphorylation could lead to the enhanced phosphorylation of p90 RSK and thus eEF2l( 
and promote peptide elongation in order to counter the decrease in ERKI/2 native protein 
levels in an attempt to maintain pancreatic protein translation. Also the phosphorylation of 
ERKI/2 controls many transcription factors controlling genes involved in response to stress 
and growth factors. Therefore increased ERK1/2 phosphorylation suggests heightened 
transcriptional activity. 
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5.4.4 NFicB and ubiguitinated protein 
The protein NFiB has been implicated in TNF-alpha-induced tissue wasting, and has also 
been shown to be elevated in type I DM (Tanti et al., 2004). Furthermore, TNF-alpha 
levels have been shown to be increased in STZ-induced diabetic rats (El seweidy et al., 
2002). However, the current study actually showed a reduction in NFKB protein in chronic 
STZ.induced diabetes, which may attenuate any increased TNF-alpha signalling. These 
findings are difficult to reconcile given the overwhelming data concerning the role of NFiB 
signalling in the development of atrophy, and thus a plausible explanation is not available 
at this time. Perhaps though, as with the translational regulators, either the protein 
expression or translation of NFicB has been downregulated in order to minimise 
atrophy/apoptosis in the state of chronic advanced STZ diabetes, which has been shown to 
involve elevated cytokine levels (El seweidy etal., 2002). Furthermore, NFiB has a role in 
glucose stimulated insulin secretion (Hammar et al. 2005), and since this process is 
attenuated in STZ-induced diabetes, then the downregulation could be as the acinar cells no 
longer need NFKB to assist insulin secretion. The ubiquitination of total cellular proteins 
was clearly higher in the diabetic state. Since ubiquitination is the tag which marks 
proteins for proteolytic degradation, this suggests that there is elevated protein breakdown 
in the chronic STZ state. This would provide some explanation for the reduced protein 
levels of PKB, p70  S6K, 4E-BPI and ERKI/2 in this advanced stage of the type I 
metabolic disease state. 
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5.5 Conclusion 
In conclusion, the results of this study have highlighted possible explanations for pancreatic 
insufficiency through deranged transcription and translation in STZ-induced diabetes. 
Specifically, it has been demonstrated that STZ-induced diabetic exocrine pancreatic 
insufficiency may in part be due to an alteration in the mRNA expression of the amylase 
gene. In contrast, CCKA receptor mRNA was unaffected by STZ-induced DM, and thus is 
probably not important in mediating pancreatic insufficiency. Secondly, whilst total 
protein levels involved in mediating protein synthesis have been downregulated, the 
phosphorylation of these proteins is actually elevated. It is therefore, suggested that this 
increase in phosphorylation is a cellular defence mechanism in an attempt to maintain 
synthesis to counteract gross loss of protein as indicated by reduced levels of translation 
proteins and enhanced ubiquitination; both markers for increased global protein breakdown. 
These defects in translation mediating proteins and altered ERKI/2 activity may affect 
translation and transcription of secretory enzymes and also contribute to the considerable 
atrophy of the STZ-induced pancreas by altering the protein breakdown:synthesis ratio in 
favour of the breakdown. 
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CHAPTER 6 
GENERAL DISCUSSION 
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6.1 General discussion 
Exocrine pancreatic insufficiency is a condition synonymous with type I DM, and is 
associated with the maldigestion of carbohydrates; a factor contributing to morbidity. The 
studies within this thesis attempted to characterise some of the physiological and molecular 
mechanisms which underlie the development of pancreatic insufficiency in the hope to 
elucidate areas of potential therapy. Initial studies employed both in vivo and in vitro 
techniques in the rat to investigate the physiological mechanisms of type I STZ-induced 
diabetic pancreatic insufficiency compared to the healthy controls. Together, the results 
highlighted a variety of physiological defects which contribute to deranged digestive 
enzyme secretion in STZ-induced type I DM. Furthermore, alterations in some of the 
intracellular signalling mechanisms and genetics have been identified as potential mediators 
of the reduced total protein levels, enzyme secretion and pancreatic atrophy in STZ-induced 
DM. Together these studies have indicated the physiological processes and potential 
underlying defects controlling pancreatic insufficiency which appears to be mediated 
through: 
I. Reduced secretion of pancreatic amylase 
2. Disturbed [Ca 2+]i and [Mg2 ]1 homeostasis 
3. Pancreatic atrophy 
4. Altered intracellular signalling and gene regulation 
5. Deranged protein synthesis/breakdown 
Each section of data within this thesis will be summarised in the following paragraphs. 
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6.2 In vivo pancreatic juice secretion 
Experiments involving pancreatic juice secretion in vivo have demonstrated that in STZ-
induced diabetes there is a significant increase in juice flow but a reduction in both total 
protein and specifically of amylase; a major enzyme involved in the digestion of 
carbohydrates in response to CCK-8 stimulation. These findings may illustrate a 
derangement in the stimulus-secretion coupling process. Interestingly, when conducting 
the in vivo procedure, the pancreatic duct appeared enlarged in comparison to the healthy 
control rats. In support of this, an increased ductal dilation was also found in patients with 
tropical pancreatic diabetes (TPD) using ultrasonography (Mohan et al., 1985). This could 
offer a potential explanation for the significantly increased basal juice flow in the diabetic 
rats which may be an adaptive mechanism to compensate for the decreases in basal protein 
output and amylase secretion in response to CCK-8. Thus, whilst juice flow was higher in 
the STZ state, the 'quality' of protein secreted for digestion was reduced. 
The next study attempted to examine whether exogenous insulin potentiates CCK-8-evoked 
protein output and amylase secretion as seen in healthy control animals. However, the 
failure to achieve hypoglycaemia in the diabetic rats with the dose of insulin employed 
made these data inconclusive and thus, whether insulin has either a potentiating (Singh & 
Adeghate, 1998; Lee et al., 1996), attenuating, or little or no effect (Juma et at, 1997; 
Singh etal., 2001) on pancreatic secretion remains controversial. In order to examine the 
mechanism of insulin-evoked secretion, control rats were pre-treated with atropine, which 
proved to be sufficient to abolish the effects of insulin on secretory parameters. This 
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indicates that the effect of insulin on exocrine pancreatic secretion in the anaesthetised 
healthy rat is mediated by hypoglycaemia-evoked vagal cholinergic activation. 
6.3 In vitro pancreatic luice secretion 
The in vitro study employed the Phadebas test to measure amylase secretion in response to 
either ACh alone, CCK-8 alone or each in combination with the islet hormone insulin. In 
STZ-induced diabetic animals, various concentrations of either ACh alone, CCK-8 alone or 
10.6 M insulin alone led to the secretion of significantly less amylase compared to the 
healthy age-matched controls (Yago etal., 1993; Juma cial., 1997; Kim etal., 2003). The 
results were difficult to reconcile when insulin was combined with either ACh or CCK-8 
due to the lack of consistent results, especially as the presence of insulin showed to either 
potentiate or to attenuate the effect of ACh- and CCK-8-evoked amylase secretion from 
pancreatic acinar cells. This could be due to a difference in cell recovery and viability, 
since this was highly variable and difficult to control. However, these data clearly 
confirmed a reduction in secretagogue-evoked amylase secretion as a factor in pancreatic 
insufficiency in DM. 
Next in this study, total cellular ions such as Ca 2 , Zn2 , Fe2t K, Na and Mg2 which co-
regulate many pancreatic processes were measured. The content of Zn 2 in STZ-induced 
diabetic rats was significantly reduced compared to the healthy control rat. Since it has 
been shown that Zn 2 deficiency impairs both insulin secretion and production (Chausmer, 
1998), this may be a factor contributing to the inability to produce insulin in type I DM as 
well as islet cell destruction. On an intracellular level, [Ca 2 ]i and [Mg 2+ ] i were both 
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decreased in CCK-8-evoked STZ-induced DM as illustrated by experiments in both 
pancreatic acinar cell suspensions and in single acini cells. The exclusion of extracellular 
Ca2 caused a significant reduction in [Ca 2+ 
 ]i peak responses in both control and diabetic 
single acini stimulated with CCK-8. This demonstrates that Ca 2 release from internal 
stores coupled with the influx of extracellular Ca 2 is necessary to generate effective 
exocytosis and hence enzyme secretion. Cellular free calcium is an important physiological 
mediator in the stimulus-secretion coupling process (Petersen, 1992; Yago et al., 1999) and 
is closely linked to [Mg2 ] (Mooren et al., 1997; Singh & Wisdom, 1995). Therefore, the 
reduction in CCK-8-evoked [Ca2H]I 
 peak responses, coupled with significant decreases in 
both basal and CCK-8-evoked [Mg 2 ] may be directly linked to the dc-activation of the 
different enzyme systems which are responsible for calcium-dependent amylase secretion 
(Patel et al., 2004a) (Figure 6.1). Other ions measured did not change significantly 
indicating no role for them in pancreatic insufficiency. Together these data suggest 
impairment of Ca 2 , Zn2 and Mg2 homeostasis in experimental DM. 
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Figure 6.1. Diagram illustrating 'CCK-8 resistance' in Sfl-induced DM. Exogenous 
CCK-8 application to diabetic rats produces a reduced Ca 2 release from the intracellular 
stores as well as a reduced plateau phase, indicating diminished extracellular Ca 2 entry 
into the acinar cell. Reduced [Ca 2 ]1 in STZ-diabetes (indicated by the green arrow) lead to 
lower stimulatory capacity for enzyme exocytosis. This is suggested to be a primary 
mechanism for pancreatic insufficiency in type I DM. 
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6.4 Gene regulation and cell signalling in STZ-induced diabetes 
After making multiple physiological measurements and showing that there was both a 
reduction in total protein as well as a reduction in amylase secretion in response to CCK-8, 
it was decided to examine any changes that may be responsible for such phenomena on a 
molecular level. In order to do this both western blotting and RT-PCR were utilised to 
analyse potential defects in both transcription and translation. 
Initial data identified that u-amylase mRNA was significantly reduced in chronic STZ-
induced DM. This provides a potential explanation for the reduction in amylase secretion 
(Patel et al., 2004a; Singh et al., 2004; Juma et al., 1997) by limiting amylase protein 
availability. However, since amylase protein was not measured this could not be 
confirmed. Furthermore, a reduction in amylase secretion could be an artefact of a defect 
in the stimulus-secretion coupling mechanism rather than of impaired a-amylase gene 
transcription or translation; as has been previously identified within this thesis. 
Nevertheless, these data provide a basis for impaired transcription of the a-amylase gene 
which can inevitably reduce the necessary protein template for increasing amylase protein 
mass, and is thus most certainly a contributory factor in pancreatic insufficiency. 
In contrast to these findings, there was no difference in CCKA receptor mRNA between 
control and STZ-induced diabetic animals, in agreement with previous literature where an 
acute state (<1 week) of STZ-induced rats was examined (Julien et al., 2002). The 
unchanged expression of CCKA receptor mRNA level suggests that the transcription of this 
gene is not under dysregulation in chronic STZ-induced DM and is therefore unlikely to 
EC 
contribute to pancreatic insufficiency. This however, does not rule out post-transcriptional 
dysregulation of the CCKA receptor. 
Following the examination of mRNA regulation, this study followed on to examine the 
cellular pathways controlling: I) transcription; since the amylase gene was affected in STZ-
induced DM, and 2) translation and protein breakdown markers; since pancreatic atrophy 
and total protein were reduced in this condition. Indeed, this warrants attention since the 
reduction in total protein secreted from the diabetic pancreas suggested that there may be a 
defect in protein synthesis in DM and/or breakdown, and furthermore it has been noted that 
in type I DM patients, the anabolic effects of insulin on protein homeostasis appear to be 
defective (Charlton & Nair, 1998). 
Whilst it was not possible to measure protein synthesis directly, it was possible to examine 
some of the cellular key mediators of the initiation of translation which directly control this 
process. Interestingly, those proteins involved directly in the initiation of translation, such 
as p70 S6K and 4E-BP 1 both showed marked reduction in protein levels in STZ-induced 
diabetes compared with control rats. It is suggested that this is an indicator of an impaired 
capacity to translate mRNA in this disease state. In contrast to this, the phosphorylation of 
all proteins measured actually showed increased activity. This is perhaps surprising, 
although it could be explained as a cellular mechanism to maintain homeostasis to increase 
synthesis in retort to enhanced protein breakdown and reduced cellular concentrations of 
translation mediating proteins. 
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Since net protein balance is dependent upon both synthesis and breakdown, it was also 
important to examine the degradation side. For example, reduced amylase might be a 
factor of increased breakdown rather than, or in combination with reduced/impaired 
synthesis/secretion. The fact that ubiquitination was increased in the diabetic state, 
suggested increased protein breakdown (Wojcikiewicz et al., 1999). In agreement with 
this, skeletal muscle protein breakdown has been shown to be significantly increased in 
insulin-deprived animals (Charlton & Nair, 1998) and in chronic haemodialysis patients 
with type H DM (Pupim et al., 2005), a process mediated by the ubiquitin-proteasome 
pathway. Interestingly, this study showed that NFKB protein was reduced in STZ-diabetic 
rats, which is somewhat contradictory to previous literature since acute STZ administration 
has been shown to induce NFiB activity in the pancreas (Ho et al., 2000), and pancreatic 
atrophy has been observed in STZ-induced DM (Patel et al., 2004a). This acute NFicB 
activation could be explained since the current studies employed a model of chronic STZ-
induced DM and perhaps the upregulation of NFICB is only transient and the pancreas 
atrophies quickly, although this is speculative as nobody has examined whether pancreatic 
atrophy is gradual or sudden. Also, perhaps downregulation of NFicB is a 'survival' 
mechanism to counteract elevated cytokine signalling in chronic DM when atrophy is very 
extreme, in order to prevent apoptosis and increased cytokine/proteasome expression of 
which NFicB transcriptionally regulates (Satoh et al., 2004). This would be cogent in 
preventing the increased release of cytokines from the pancreas which could target other 
tissues and contribute to whole-body inflammation. Finally, the data presented in this study 
could indicate that NFiB is not a major factor in pancreatic atrophy as it appears to be in 
other tissues, such as skeletal muscle (Atherton et al., 2005). As there has been little 
research on NFiB in pancreatic DM, the frill implications remain elusive. 
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The phosphorylation of the MAPK protein, ERK1/2 was increased in STZ-induced 
diabetes, thus suggesting heightened transcriptional activity. It is clear that ERKI/2 does 
not regulate a-amylase gene expression via any of its transcription factor targets, since a-
amylase gene expression was reduced to a large extent in the chronic STZ pancreas. 
However, once again the total protein of ERKI/2 was reduced. This could be a factor of 
reduced global translation. The reduced PKB concentration and phosphorylation are 
probably reflective of the fact that insulin signalling is negated to a large extent in STZ-
induced DM. 
Together, these data provide novel findings indicating disturbed intracellular signalling, 
gene transcription, and protein balance homeostasis which probably mediate many of the 
physiological changes described in chapters 3 and 4 of this thesis. A summary diagram of 
factors contributing to pancreatic insufficiency is illustrated in figure 6.2. 
183 
Control 	 I,1UTur 
CCK-8 from 
duodenum 	 CCK-8 from 	 CCK81 . - 
I 	 duodenum ABSENT/REOUÔED CCK- Iisuki insuffin 
MATRK 
— 
PKC. MARK, 	 PKC. MARK. 	 PKB 
olherpalliways 	 I 	 Y9H 
1 	 ----- ' p 
Tnnsc,1ion 	 Transa*,Iion 
doradJvatn 	 fwtor adwflon 
IJUQ.SJS 
Reduced 
Digestive 	 + 	 digestive 
enzyme niRNA enzyme mRNA 	
niytase e.g Amylase 	 e.g A 
Figure 6.2. Diagram showing some factors potentially contributing to the aetiology of type 
I DM (shown in dashed boxes). Healthy age-matched rats (left panel) and chronic STZ-
induced rats (right panel). Factors such as reduced CCK-8 secretion from the duodenum, 
CCK-8 receptor defects, disrupted stimulus-secretion coupling, reduced transcription 
(ERK1/2 MAPK), reduced translational initiation (p70 S6K and 4E-BP1) and increased 
protein breakdown (ubiquitination); could all contribute to reduced enzyme secretion. TF = 
Transcription factor. 
6.5 Scope for future work 
The studies in this thesis open up many possibilities for further investigations: 
1. Since many of the proteins involved in translation appear to be under dysregulation, it 
would be interesting to examine pancreatic protein synthesis by the incorporation of an 
amino acid tracer into in vitro isolated acinar cells. This would surely be able to 
reconcile the data showing increased phosphoiylation, but decreased total protein levels 
of translation factors. Furthermore, these experiments would show whether the atrophy 
of the diabetic pancreas is caused by reduced global protein synthesis. 
2. It would be interesting to examine components of the ATP-dependent ubiquitin-
proteasome pathway in order to investigate whether markers of protein breakdown are 
induced in STZ-diabetes. Such proteins could be ubiquitin ligases or other components 
of the proteasome, such as calcium-dependent proteases. This could be carried out by 
qRT-PCR and western blotting. 
3. It would be possible to do plasma based cytokine wide ELISA measurements in order 
to examine to what extent cytokines which are associated with atrophy are induced. 
Such factors as TNF-alpha, and various interleukins may indicate enhanced signalling 
to protein degradation in STZ-induced DM. 
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4. Although amylase secretion was measured, it would be of interest to assay the total 
protein level of amylase in the acinar cells (perhaps using western blotting), since this 
would help to indicate whether the reduced secretion is due to a secretory defect or a 
reduced protein due to impaired transcription and/or translation 
5. Some of the reduction in size of the diabetic pancreas might have been due to necrosis 
or in fact apoptosis rather than just cellular atrophy. Since there are markers of these 
phenomena, one could examine these in order to gain knowledge about the nature of the 
pancreatic atrophy. 
6. One interesting finding of this thesis showed that NFiB protein was actually reduced in 
STZ-diabetes. It was suggested that this was because the heightened signalling led to a 
downregulation of the protein, or that since its role in glucose stimulated insulin 
secretion is no longer required, it is downregulated. However, although it was not 
possible to examine the phosphorylation of NFKB at the time since no specific antibody 
was available, in future it would be valuable to: 1) measure NFicB DNA binding 
activity/nuclear translocation, or 2) measure the phosphorylation of its cytosolic binding 
partner bcB and upstream kinase IKK to examine specific cellular kinetics of this 
pathway. These experiments could show the significance of the reduced NFiB 
concentration and also show the activation of NFiB. 
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